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ABBREVIATIONS
The abbreviations used throughout this Thesis are those 
recommended by the Biochemical Journal in its Instructions to Authors 
(Biochem. J. (1986) 233, 3-21) with the following additions:-
CoASH, coenzyme A (reduced form)
BCOAD, branched chain 2-oxoacid dehydrogenase 
BRL, Buffalo rat liver 
BSA, bovine serum albumin
CCCP, carbonyl cyanide, m-chlorophenyl hydrazone
DHFR, dihydrofolate reductase
DOC, deoxycholate, sodium salt
DNP, 2,4-dinitrophenol
DTT, dithiothreitol
ER, endoplasmic reticulum
FCCP, carbonylcyanide p-trifluoromethoxyphenylhydrazone
Iodogen, 1,3,4,6-tetrachloro-3a(, 6o(-diphenylglycour il
Leupeptin, acetyl-L-leucyl-L-leucyl-L-argininal
LMM, low methionine medium
MMM, minus methionine medium
MSUD, maple syrup urine disease
NBL-1 bovine kidney
NEM, N-ethylmaleimide
NGM, normal growth medium
OGDC, 2-oxoglutarate dehydrogenase complex 
PBS, phosphate buffered saline 
PEG, polyethylene glycol 
PDH, pyruvate dehydrogenase complex 
PK-15, pig kidney
PMSF, phenylmethylsulphonylfluoride
PPO, 2,5-diphenyloxazole
SDH, succinate dehydrogenase
SRP, signal recognition particle
TEMED, N,N,N’,N’-tetramethylethylenediamine
TLCK, N-o(-^>-tosyl-L-lysine-chloromethyl ketone
TPCK, L-l-tosylamide-2-phenylethylchloromethyl ketone
TPP, thiamine pyrophosphate
Tween 20, polyethylenesorbitan monolaureate
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SUMMARY
Monospecific, polyclonal antisera were raised to purified
bovine heart succinate dehydrogenase (SDH), and to the individual
large (M^ = 70000) and small (M^ = 27000) subunits of this enzyme. The
specificities of the antisera were determined by immune blotting.
These antisera exhibited cross-reactivity with the corresponding
polypeptides in Buffalo rat liver (BRL), pig kidney (PK-15) and bovine
kidney (NBL-1) cell lines, and were employed to investigate some of
the events involved in the biogenesis of succinate dehydrogenase in
the BRL and PK-15 cell lines.
Newly-synthesised forms of the large and small subunits of SDH
were detected in cultured PK-15 and BRL cells labelled with 
35
[ Sjmethionine in the presence of uncouplers of oxidative phosphoryl­
ation. In both cell lines, the precursor forms of the large and small
subunits exhibit M values approx. 1-2000 and 4-5000 greater than the 
r
corresponding mature forms. When the uncoupler is removed in pulse- 
chase experiments, complete conversion of the precursor to the mature 
forms occurs within 45 min.
Studies on the kinetics of processing of the large subunit 
precursor revealed that reversal of precursor accumulation is rapid, 
with processing occurring with a half-time of 5-7.5 min. The 
accumulated precursor exhibits long term stability when PK-15 cells 
are maintained in the presence of DNP.
The arrangement of the large and small subunits of succinate 
dehydrogenase on the mitochondrial inner membrane was investigated by 
immune blot analysis of protease-treated bovine heart mitochondria
X V
(right side-out; outer membrane removed) or submitochondrial particles 
(inside-out). Both subunits were found to be absent from the 
cytoplasmic surface of the inner membrane. The bulk of the small 
subunit appears to protrude into the matrix compartment, since this 
subunit is degraded during protease treatment of submitochondrial 
particles, without the appearance of a membrane-associated fragment. 
The data obtained in this study suggests that the large subunit may 
interact with the matrix side of the inner membrane via two distinct 
regions; these are detected as membrane-associated fragments of 
32000 and 27000 after treatment of submitochondrial particles with 
papain or protease K.
An analogous biosynthetic study was performed on the mammalian 
branched chain 2-oxoacid dehydrogenase (BCOAD) multienzyme complex, 
a high-M^ assembly composed of multiple copies of a branched chain 2- 
oxoacid dehydrogenase (El), dihydrolipoamide acyltransferase (E2) and 
lipoamide dehydrogenase (E3). This was achieved using antisera raised 
to (a) the purified complex from bovine kidney (anti-BCOAD serum);
(b) the purified El subcomplex and (c) the E2 subunit isolated by 
preparative SDS/polyacrylamide gel electrophoresis. Both anti-BCOAD 
and anti-El sera exhibited a relatively low titre of antibodies to the 
E l j Z polypeptide. An unexpected finding of this study was that the 
lipoamide dehydrogenase (E3) component was present in 
immunoprecipitates of the PK-15 BCOAD complex which were obtained 
using an antiserum which lacked antibodies against E3. This finding 
suggests that the absence of E3 from most preparations of purified 
BCOAD complex does not reflect the physiological situation but is a 
result of the isolation procedure.
xv i
The precursor form of the BCOAD complex El subunit was detected 
in the pig kidney and bovine kidney cell lines. This species exhibited 
a value which was approx. 3000 greater than the mature-sized 
polypeptide. In contrast, the newly-synthesised E l s u b u n i t  evaded 
detection, largely due to the low immunogenicity of this polypeptide. 
The precursor form of the BCOAD complex E2 subunit was detected as a 
56000-M^ species and was therefore similar in size to the previously 
identified pre-E3 polypeptide. However, the separate identity of the 
56000 species and the E3 precursor was confirmed in 
immunocompetition experiments using unlabelled purified pig heart E3. 
The presequence of the BCOAD complex E2 precursor is markedly smaller 
than those of the E2 precursors of the analogous 2-oxoglutarate 
dehydrogenase and pyruvate dehydrogenase complexes, which both have 
values of approx. 8000.
CHAPTER ONE
INTRODUCTION
1.1 PROTEIN TARGETTING
1.1.1 TARGETTING OF SECRETORY PROTEINS
In recent years, attention has increasingly been focused on the
phenomenon of "protein targetting", i.e. the distribution of 
polypeptides from their cytoplasmic site of synthesis to their correct 
subcellular locations.
Initial insights into this area of Cell Biology were obtained 
from studies on proteins which are targetted to the extracellular 
space (secretory proteins). Using mainly pancreatic and liver cells 
(two cell types highly specialised for protein export), it was found 
that secretory proteins were produced on ribosomes bound to the 
endoplasmic reticulum (ER), and that newly-synthesised proteins did 
not appear in the cytosol but were transferred directly into the lumen
of the ER in vivo and of microsomal vesicles in vitro (Redman et al.,
1966; Chefurka and Hayashi, 1966). The authenticity of the latter 
observation was substantiated by Redman and Sabatini (1966), who 
demonstrated that even incomplete polypeptide chains, obtained using 
puromycin, were not located on the cytoplasmic side of the ER 
membrane. It was then shown that microsomes protect nascent chains of 
secretory but not of cytoplasmic proteins from proteolytic degradation 
(Sabatini and Blobel, 1970). These observations led to the concept 
that polypeptide chains synthesised by ribosomes bound to the ER are 
discharged vectorially through the membrane.
Several reasons have been put forward to explain the presence of 
a particular class of mRNAs (mainly those for secretory proteins ) in 
membrane-bound polysomes. The segregation of this class of mRNAs was 
proposed to occur via: 1) binding of incomplete initiation complexes
composed of mRNA and 40S ribosomal subunits to membrane-bound 60S 
subunits (Baglioni et al., 1971); 2) formation of a specific link 
between the mRNA and the membrane (Mechler and Vassalli, 1975); 3) 
attachment of bound polysomes via the N-terminal region of the growing 
polypeptide chain (Blobel and Sabatini, 1971).
Evidence for the third possibility was first presented by 
Milstein et al. (1972), who studied the in vitro translation of 
immunoglobulin light chain mRNA. These authors showed that a larger 
precursor containing extra amino acids at the N-terminus was 
synthesised in a reticulocyte lysate, but not in cell-free translation 
systems containing microsomal membranes. Similar higher precursors, 
only detectable in vitro in the absence of microsomes, were 
subsequently described for parathyroid hormone (Kemper et a l ., 1974), 
placental lactogen (Boime et al., 1975) and melittin (Suchanek et a l ♦ , 
1975).
These observations, together with the work of Blobel and 
Dobberstein (1975a,b) on the translocation of nascent immunoglobin 
light chains across microsomal membranes, led to the formation of the 
signal hypothesis. In its earliest form, this hypothesis made the 
following predictions; a) secretory polypeptides contain an N- 
terminal signal peptide which binds to the ER and initiates vectorial 
discharge of the growing polypeptide chain; b) this transport (and 
therefore binding) must start early, before the chain reaches a 
certain length, and be strictly coupled to protein synthesis; c) 
signal peptides are transient species which are removed by proteolytic 
cleavage before chain completion.
Since the advent of this hypothesis, progress has been made in 
obtaining a more detailed understanding of the molecular interactions
required for vectorial transport (reviewed by Walter et al., 1984). An 
updated version of the model is depicted in Fig.1.1.
It is now recognised that at least two components are required 
for the translocation event. The first of these is the signal 
recognition particle (SRP), an IIS cytoplasmic ribonucleoprotein 
consisting of six nonidentical polypeptides with values of between 
72000 and 9000 (Walter and Blobel, 1980) and one molecule of 7S RNA 
(Walter and Blobel, 1982). The SRP functions by recognising and 
binding to a nascent signal sequence once it has emerged from the 60S 
ribosomal subunit, and thus temporarily arrests translation (Walter 
and Blobel, 1981).
The second isolated component of the protein translocation 
machinery is the SRP receptor (Gilmore et a l ., 1982) or docking 
protein (Meyer et al., 1982); a 72000-M^ integral ER membrane protein 
which apparently mediates the interaction of SRP-arrested ribosomes 
with the endoplasmic reticulum. By virtue of this SRP-docking protein 
interaction, translation of the nascent polypeptide resumes and 
translocation into the lumen of the ER commences (Gilmore et al. ,
1982).
The steps following this initial targetting event are relatively 
poorly understood. Once targetting to the ER surface has occurred, the 
ribosome-SRP-docking protein interaction is postulated to be replaced 
by a direct interaction of the ribosome with other integral membrane 
proteins (Walter et a l ., 1984). Two ER-specific proteins, termed 
ribophorins I and II (Kreibich et al., 1978a,b) may be involved in 
this type of interaction.
Once a nascent protein has penetrated the ER membrane, its signal 
peptide is proteolytically removed by a specific integral membrane
Fig.1.1 Current Picture Of The Events Occurring During The
Translocation Of Polypeptides Across The Endoplasmic Reticulum 
(after Walter et al., 1984).
a; free (soluble) SRP 
b; ribosome-bound SRP 
c; translational arrest 
d; SRP-docking protein interaction 
e; membrane-bound SRP
A-C; translation of mRNA encoding a signal sequence
addressed to the ER protein translocating system 
D; interaction of SRP-arrested ribosomes with microsomal 
membrane
E; translocation of nascent polypeptide through membrane pore 
F; release of completed polypeptide into lumen of ER 
G; release of ribosome from the membrane
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endoprotease, termed the signal peptidase, which is located at the 
lumenal side of the membrane (Jackson and Blobel, 1977). Very 
recently, Evans et al. (1986) have reported the purification of signal 
peptidase from canine pancreatic microsomes. The purified enzyme 
described by these workers consists of a complex of six different 
polypeptides. However, the authors suggest that only one subunit is 
responsible for signal peptide removal, and that the structural 
association of the other subunits in stoicheiometric amounts may 
reflect their requirement in chain translocation; for instance they 
may form part or all of a hypothetical pore through which the nascent 
chain is proposed to cross the membrane (Blobel and Dobberstein, 
1975a). In the case of integral membrane proteins the translocation 
process is aborted prior to completion of the polypetide chain, 
resulting in its asymmetrical integration into the membrane. The 
information causing the arrest of translocation (a putative stop- 
transfer sequence) is most likely contained in the nascent chain and 
interpreted by the translocation machinery.
For many proteins which are transferred across the lipid bilayer 
of the endoplasmic reticulum, translocation is the first in a series 
of events which effect their transfer to locations such as the lyso- 
somes, Golgi apparatus, plasma membrane, or the extracellular space.
1.1.2 DISTRIBUTION OF NON-SECRETORY TARGETTED PROTEINS
The cotranslational, ER-mediated type of protein |translocation 
described above for secretory proteins is also involved in the 
targetting of lysosomal proteins (Erickson et al., 1981) and of 
certain classes of integral membrane proteins (Lingappa et a l . , 1978)
Fig.1.2 General Scheme For Distribution Of Proteins In Eukaryotes
Initiation of 
Protein Synthesis
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} Plasma MembraneMembrane-bound
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However, when the question of how cytoplasmically-synthesised 
polypeptides are translocated across the membranes of organelles such 
as chloroplasts, mitochondria, peroxisomes and glyoxysomes was 
addressed, it became clear that cotranslational transport was not the 
sole mechanism for translocation of proteins across membranes.
Initial approaches involved the use of cell-free protein 
synthesis systems for characterising the primary translation products 
of mRNAs that direct cytoplasmic synthesis of polypeptides destined 
for specific organelles. Using mRNA isolated from the unicellular 
green alga, Chlamydomonas reinhardti, Dobberstein et al. (1976) 
demonstrated that the small subunit of the chloroplast enzyme ribulose
1,5 bisphosphate carboxylase was synthesised as a higher M precursor, 
which could be converted to its mature form after completion of the 
polypeptide chain. In addition, it was found that the mRNA encoding 
the small subunit precursor was localised in preparations of free 
polysomes. These findings suggested that the small subunit precursor 
is transferred through the two chloroplast envelope membranes by a 
posttranslational mechanism. Supporting evidence for
posttranslational transport of chloroplast proteins was subsequently 
provided (Chua and Schmidt, 1978; Highfield and Ellis, 1978). Later 
studies on the biosynthesis of mitochondrial, peroxisomal and 
glyoxysomal proteins (Maccecchini et al., 1979; Robbi and Lazarow, 
1978; Zimmermann and Neupert, 1980) revealed that polypeptides were 
also transported into these organelles by a similar posttranslational 
mechanism. Our current understanding of the mode of distribution of 
cytoplasmically-synthesised polypeptides is summarised in Fig.1.2.
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1.2 BIOGENESIS OF MITOCHONDRIA
1.2.1 PERSPECTIVES
Mitochondria, like chloroplasts, are distinct among cellular 
organelles in that they possess an extranuclear genetic system. 
However, the information content of mitochondrial DNA is insufficient 
to account for the estimated several hundred different polypeptides 
which are found in a functional mitochondrion (cf. section 1.2.2). 
Indeed, synthesis of the full repertoire of mitochondrial polypeptides 
depends on the close cooperation of the mitochondrial and 
nucleocytoplasmic genetic systems, with the latter producing 
approximately 95% of all mitochondrial polypeptides. There is evidence 
to suggest that this cooperation is mediated by the protein products 
of both genetic systems (Felipo and Grisolia, 1984), although it is 
likely to occur at many different levels.
All the available data, and theoretical considerations, suggest 
that cellular membranes do not form de novo, but through the growth 
and division of pre-existing structures (Sitte, 1980; Yaffe and 
Schatz, 1984). Therefore, the biogenesis of mitochondria involves 
incorporation of many different cytoplasmically-synthesised 
polypeptides (as well as other components such as lipids) into 
pre-existing organelles. Moreover, mitochondria contain two membranes 
which give rise to four submitochondrial locations; the outer 
membrane, inner membrane, the intermembrane space, and the matrix, 
which is enclosed by the inner membrane. Since each of these submito­
chondrial locations contains a defined set of polypeptides (Ernster 
and Kuylenstierna, 1970), the incorporation process must be highly 
specific, and be mediated by an intramitochondrial sorting mechanism.
As illustrated in Fig.1.3, the biogenetic pathway pertaining to a 
cytoplasmically-synthesised mitochondrial polypeptide can be divided 
into five steps;
1) synthesis of the polypeptide (usually as a higher M precursor).
2) delivery and binding of the precursor to the mitochondrial 
surface.
3) translocation of the precursor across or into one or both 
mitochondrial membranes, depending on the final submitochondrial 
location of the polypeptide.
4) cleavage and/or other covalent modifications (processing) of the 
polypeptide chain to generate the mature protein.
5) assembly of mature polypeptides into functional holoenzymes, which 
in some cases involves their association with mitochondrial gene 
products.
1.2.2 THE MITOCHONDRIAL GENOME
All eukaryotes examined to date contain within their mitochondria 
multiple copies of an organelle-specific, double-stranded DNA 
molecule, which encodes several mitochondrial RNA and polypeptide 
components. Mitochondrial DNA ranges in size from approximately 15 
kilobase pairs in animals to 600-750 kilobase pairs in some higher 
plants. Much of this diversity is due to differences in the efficiency 
with which coding information is packed into the genome (Borst et al. ,
1984). The complete nucleotide sequences of the human, bovine, mouse 
and Xenopus laevis mitochondrial genomes have recently been determined 
(Anderson et a l ., 1981; Anderson et al., 1982; Bibb et al., 1981; Roe 
et a l ., 1985). These genomes are very similar in size and show the
Fig.1.3 Steps In The Biogenetic Pathway Of An Imported 
Mitochondrial Polypeptide
1; Precursor synthesis.
2; Delivery and binding of precursor to the mitochondrial 
surface.
3; Translocation.
4; Processing.
5; Refolding and assembly into functional units.
The N-terminal extension is represented by a zig-zag line and the 
mature sequence by a spiral.
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same organisation and complement of genes that code for highly 
homologous versions of 22 tRNAs, two ribosomal RNAs, and 13 proteins.
The two rRNA genes and 14 of the tRNA genes are located on the heavy 
(H) strand, as are 12 of the 13 protein-coding genes. Eight tRNA genes 
and one protein-coding gene are located on the light (L) strand.
Five of the protein-coding genes have been identified 
unambiguously as those for subunits I, II and III of cytochrome c 
oxidase, ATPase subunit 6, and cytochrome b. Moreover, a recent report 
by Chomyn et al. (1985) provides evidence that six of the remaining 
unidentified reading frames in human mitochondrial DNA encode 
components of the respiratory-chain NADH dehydrogenase. These findings 
imply that at least four multi-subunit enzymes of the mitochondrial 
inner membrane are formed through the physical association of 
mitochondrial and nuclear gene products.
The organisation of the mitochondrial genome in higher eukaryotes is 
extremely economical. Genes for the 22 tRNAs are interspersed between the 
ribosomal RNA and protein coding regions, possibly serving as 
punctuation points for processing of the primary transcripts. With the 
exception of the displacement loop region, there are very few 
noncoding nucleotides and A© <Xppa'rfift£introns - These features are 
indicative of an extremely specialised genome with little Opportunity 
for further simplification.
In many organisms the mitochondrial genetic code differs from the 
"universal" code utilised by nucleocytoplasmic and prokaryotic genetic 
systems, with different organisms using different variations. For 
instance, the code in mammalian mitochondria uses AGA and AGG as 
termination rather than Arg codons. The "universal" UAA termination 
codon is also used by mammalian mitochondria, although, in many cases,
this is generated by polyadenylation of pre-mRNAs which end in U or UA 
following their cleavage from the primary transcript (Anderson et a l .,
1981). Another common variation, found in the mitochondrial genetic 
code of higher eukaryotes, Saccharomyces cerevisiae (referred to 
hereafter as yeast), Neurospora crassa and Aspergillus nidulans is the 
use of the "universal" UGA stop codon as an additional Trp codon. The 
aforementioned economy of organisation of the mammalian mitochondrial 
genome is augmented by the existence of mitochondrial tRNA molecules 
which can recognise as many as four synonymous codons, rather than the 
two codons recognised by conventional tRNAs. Thus, the faithful 
reading of all codons in mitochondrial mRNAs is accomplished by only 
22 tRNAs. This finding has been substantiated by primary sequence 
analysis of several mitochondrially-synthesised polypeptides (Anderson 
et al., 1981).
1.2.3 PRECURSOR FORMS OF MITOCHONDRIAL POLYPEPTIDES
1.2.3.1 SITE OF SYNTHESIS OF PRECURSOR POLYPEPTIDES
Elucidation of which subcellular sites are involved in the 
synthesis of nuclear coded mitochondrial polypeptides has been crucial 
to an understanding of how mitochondria import these species in v ivo . 
Early studies which addressed this question looked at the biosynthesis 
of mitochondrial proteins such as cytochrome c and glutamate 
dehydrogenase (GDH) in vivo (Gonzalez-Cadavid, 1974; Kawajiri et al. , 
1977). In these experiments, animals were injected with radiolabelled 
amino acids and the distribution of labelled proteins into various 
subcellular fractions was monitored. In general, the highest specific 
activities of the precursors at the earliest time points were found in
the microsomal fractions.
The site of synthesis of glutamate dehydrogenase was also studied
by isolating free and membrane-bound polysomes from the livers of rats 
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injected with [ H]leucine. Nascent chains released from the ribosomes
were screened for nascent GDH with pepsin-digested antibodies to GDH.
A preferential reaction of anti-GDH antibodies with nascent chains
from membrane-associated polysomes was observed. This data suggested
that synthesis of mitochondrial precursors occurred on polysomes
associated with microsomal membranes.
However, there are now serious reservations which question
whether these findings have physiological significance, or reflect
artefacts of subcellular fractionation techniques. The first concerns
the extent of selective redistribution of newly-synthesised
mitochondrial proteins during tissue homogenisation. For instance,
Godinot and Lardy (1973) showed that radiolabelled GDH added to liver
homogenates becomes associated with microsomal membranes in an
apparently non-specific manner. Moreover, Robbi et al. (1978)
demonstrated that newly-synthesised cytochrome c ?was selectively 
released from mitochondria upon liver homogenisation and became bound 
to liver microsomes.
The second concerns the immune assays on nascent polypeptides 
associated with polysomes. Nascent chains tend to form aggregates and 
thus could cause non-specific precipitation. Indeed, the work of 
Kawajiri et al. (1977) did not provide rigorous proof that the 
immunoprecipitated nascent chains were related to GDH. Furthermore,
Hay et al. (1984) were unable to demonstrate either qualitative or 
quantitative changes in the rate of synthesis of several mitochondrial 
proteins or accumulation of their precursor forms by pulse-labelling 
temperature-sensitive mutants in the yeast secretory pathway at a
nonpermissive temperature. This finding suggests that any role of the 
secretory pathway in mitochondrial biogenesis is at most a minor one.
The most recent investigations of the subcellular site of 
synthesis of mitochondrial proteins have employed an alternative 
strategy to the pulse-labelling approach described above. Polysomes 
(either free or extracted from microsomes) or mRNA extracted from 
these polysomes were translated in cell-free systems, then the 
translation products were screened immunologically for specific 
mitochondrial proteins. Using this approach, the translation of 
cytochrome c, porin, and subunit 9 of the ATPase of N. crassa 
(Zimmermann et al., 1979; Freitag et al., 1982; Schmidt et al., 1983b), 
the outer membrane protein OMM35 of rat liver and several matrix 
enzymes of higher eukaryotes (Raymond and Shore, 1979; Morita et al., 
1981; Shore et a l ., 1981; Mihara et al., 1982b; Sonderegger et al. , 
1982) and of twelve mitochondrial precursors in yeast (Suissa and 
Schatz, 1982) occurs predominantly on free ribosomes. This suggests 
that, for these precursors at least, import into mitochondria occurs 
posttranslationally.
Additional evidence for a posttranslational import mechanism in
vivo comes from the fractionation of pulse-labelled yeast spheroplasts,
35
fibroblasts and hepatocytes. After a short pulse with [ S]methionine, 
labelled precursor forms of mitochondrial polypeptides are found in 
the cytosol, whereas mature forms are found inside mitochondria, 
protected from externally-added protease (Reid and Schatz, 1982;
Jaussi et al., 1981; Mori et al., 1981). The mature intramitochondrial 
form appears only after a lag period, indicating the existence of a 
cytoplasmic pool of precursor molecules.
In apparent contradiction to a posttranslational mechanism for
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protein import, cytoplasmic ribosomes have been found attached to the 
mitochondrial outer membrane in cycloheximide-treated yeast cells 
(Kellems and Butow, 1972; Kellems et al., 1974; Ades and Butow, 1980). 
When the mRNA extracted from these mitochondrially-associated 
polysomes was translated in vitro and compared with mRNA extracted 
from "free" cytoplasmic polysomes, it was found to be specifically 
enriched for mRNAs of mitochondrial proteins (Suissa and Schatz,
1982). In none of the twelve cases examined, however, was the total 
amount of mRNA for a particular mitochondrial polypeptide found to be 
predominantly or exclusively localised to the polysomes bound to 
mitochondria.
These observations suggest that if elongation of a mitochondrial 
polypeptide is inhibited (as with cycloheximide), some nascent 
polypeptide chains together with the attached polysome may bind to 
mitochondria. Whether the nascent protein chains are actually 
integrated into the mitochondrion prior to polypeptide completion 
remains to be settled. However, there is no firm evidence pointing to 
an obligatory role for cotranslational translocation (see section 
1.1.1) in the import of mitochondrial polypeptides.
1.2.3.2 MOLECULAR CHARACTERISTICS OF PRECURSOR MOLECULES
The identification of mitochondrial polypeptide precursors and 
of the events involved in their uptake into mitochondria has relied 
heavily on two principal approaches. One of these is an in vitro 
approach, in which isolated mRNA is translated in a cell-free system 
in the presence of a radioactive amino acid. The precursor form of a 
mitochondrial polypeptide can be immunoprecipitated from the
12
translation mixture using antibodies against its mature counterpart, 
provided that the precursor is also recognised by these antibodies. In 
most cases, the precursor form is observed as a band which migrates 
more slowly upon SDS/polyacrylamide gel electrophoresis than does the 
mature polypeptide (see below).
Posttranslational import can be accomplished and detected in 
vitro by adding isolated intact mitochondria to the cell-free system 
after translation has occurred, and immunoprecipitating imported 
(mature) polypeptides from reisolated mitochondria. The 
intramitochondrial location of radiolabelled polypeptides can be 
verified by demonstrating that they are resistant to externally-added 
protease.
An alternative in vivo approach also employs a highly specific 
antiserum against a mature polypeptide to recognise its precursor 
form. Whole cells are subjected to "pulse" or "pulse-chase" labelling 
with a radioactive amino acid, then immunoprecipitation is performed 
on cytosolic and mitochondrial fractions, or on detergent extracts of 
whole cells. In some cases, the difficulties associated with the short 
half-lives of precursors in the extramitochondrial pool have been 
circumvented by labelling cells under conditions where import into the 
mitochondrion is inhibited, e.g. in the presence of uncouplers of 
oxidative phosphorylation (see section 1.2.5).
More recently, the techniques which are now available for 
isolating and manipulating genes have been used to study the molecular 
features of the import process. Many nuclear genes encoding mito­
chondrial polypeptides have been isolated and partially characterised. 
By sequencing the cloned genes, it has been possible to identify the 
presence of a cleavable signal sequence in the precursor molecule,
provided that the N-terminal of the mature protein is known. Molecular 
cloning studies have been performed largely in Saccharomyces 
cerevisiae , because of the suitability of this organism to genetic 
manipulation, and since many of the biochemical studies of mito­
chondrial protein import have been performed in yeast.
Since 1979, when it was reported that the nuclearly encodedc?(-»
0 - »  and^-subunits of the yeast ATPase were initially synthesised as
higher M precursors (Maccecchini et al., 1979), many laboratories
have described higher M precursor forms of a large number of
mitochondrial polypeptides. These precursors possess M^ _ values which
are between 500 and 10000 greater than their mature counterparts
(Table 1.1). In those cases which have been directly investigated, it
has been shown that the difference in M value results from an N-
r
terminal polypeptide extension. It is likely that N-terminal 
extensions will prove to be the rule, but the possibility that 
modifications occur also at the C-terminus cannot be excluded.
There is no apparent correlation between the size of the N- 
terminal extension and the final intramitochondrial location of the 
mature protein. Furthermore, precursors to different subunits of a 
hetero-oligomeric assembly have no standard number of additional amino 
acids (Maccecchini et a l ., 1979; Lewin et al., 1980; Mihara and 
Blobel, 1980; Teintze et al., 1982).
A few of the mitochondrial polypeptides which are imported into 
internal locations are synthesised without a cleavable polypeptide 
extension. Among these are two inner membrane proteins; the adenine 
nucleotide translocase (Zimmermann and Neupert, 1980) and thermogenin 
(Freeman et al., 1983); a matrix protein, 2-isopropylmalate synthase 
(Gasser et al., 1982b; Hampsey et a l ., 1983), and cytochrome c, a
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component of the intermembrane space (Korb and Neupert^ 1978; 
Zimmermann et al., 1979). With one possible exception (Shore et a l ., 
1981), all of the proteins of the mitochondrial outer membrane studied 
so far are synthesised without a transient polypeptide extension (Hay 
et al., 1984).
There is evidence to suggest that the extramitochondrial 
precursor forms of at least some mitochondrial proteins are markedly 
different in conformation from their intramitochondrial mature 
counterparts. For example, the extramitochondrial precursor of the N. 
crassa adenine nucleotide translocase binds to hydroxylapatite, 
whereas the mature form does not (Zimmermann and Neupert, 1980), 
although the primary sequence of the mature protein is identical to 
that of the initial translation product. Another example is seen in 
the case of cytochrome c; antibodies raised to apocytochrome c 
recognise the apoenzyme, but not the holoenzyme, and vice versa (Korb 
and Neupert, 1978).
Conformational differences between precursor and mature
polypeptides are also suggested by intermolecular associations. The
precursor to rat liver ornithine transcarbamylase sediments as a
particle of 14S, much faster than the mature trimeric enzyme at 6S
(Miura et al., 1981). Aggregates of precursors are also found for the
in vitro-synthesised adenine nucleotide translocase (Zimmermann and
Neupert, 1980), and for theo(- and ^-subunits of the yeast ATPase
(Hay et a l ., 1984). The in vivo-synthesised precursor of the -subunit
(M = 56000) behaves as a 500000-M species on gel filtration, 
r r
However, it is not known whether the y^-subunit precursors form large 
homo-oligomers, aggregates with precursors of other subunits or are 
associated with cytosolic import factors.
1.2.3.3 FEATURES AND FUNCTIONS OF MITOCHONDRIAL SIGNAL SEQUENCES
Although precursor molecules have proved difficult to isolate in 
appreciable quantities, the amino acid sequences of approximately 
thirty cleavable mitochondrial signal sequences have been deduced by 
DNA sequence analysis of the corresponding cloned genes (Reid, 1985; 
von Heijne, 1986). These sequences do not show extensive primary 
sequence homology; however, most share similar overall characteristics. 
Signal sequences of mitochondrial matrix or inner membrane proteins 
are usually basic, being rich in the hydroxylated amino acids serine 
and threonine and in the positively-charged amino acids arginine and 
lysine. The latter residues occur more or less periodically along the 
sequence and are usually separated by three to five uncharged 
residues. Signal sequences are usually devoid of acidic residues.
The N-terminal extensions of proteins exposed to or present in 
the intermembrane space contain a long stretch of uncharged amino 
acids adjacent to an N-terminal region rich in basic and hydroxylated 
residues (Kaput et al., 1982; Sadler et a l ., 1984). Although proteins 
of the outer membrane are generally synthesised without a cleavable 
signal sequence (see section 1.2.3.2), the N-terminal sequence of at 
least one outer membrane protein (the yeast 70000-M^ outer membrane 
protein) resembles signal sequences of intermembrane space proteins, 
in that the basic N-terminus is followed by a stretch of uncharged 
residues (Hase et al., 1984). Therefore, in the remainder of this 
section, the term "presequence" is used to include such non-cleaved N- 
terminal sequences.
When mitochondrial polypeptide precursors synthesised in v itro 
are treated with processing protease isolated from the mitochondrial
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matrix, the resulting mature-sized polypetides are no longer imported 
into isolated mitochondria (Gasser et al., 1982b). This finding 
indicated that the cleavable extension is essential for directing 
precursor polypeptides into mitochondria, but did not exclude the 
possibility that some information is also provided by that part of the 
precursor molecule which is retained in the mature protein. However, 
characterisation of the information contained within mitochondrial 
presequences has been achieved recently using a combination of 
deletion analyses and gene fusion experiments (Hurt and van Loon,
1986; Douglas et al., 1986).
Hurt et al. (1984) showed that the cleavable N-terminal 
polypeptide of the yeast cytochrome c oxidase subunit IV precursor is 
sufficient to direct a foreign cytosolic protein (mouse dihydrofolate 
reductase; DHFR) into the matrix of yeast mitochondria in vitro. 
Similar conclusions have been reported for the targetting of cytosolic 
proteins by the transient polypeptides of other imported matrix 
proteins, including human ornithine transcarbamylase (Horwich et a l .,
1985), yeast 5-aminolevulinate synthase (Keng et al., 1986) and yeast 
alcohol dehydrogenase III (van Loon et al., 1986). Conversely, 
imported mitochondrial proteins lacking all or even some of their own 
presequences are not imported into mitochondria (Hurt et a l ., 1985; 
van Loon and Young, 1986). Mitochondrial presequences thus contain 
information which functions in ’’intracellular targetting".
The gene fusion experiments referred to above showed that a given 
cleavable presequence could be fused to more than one protein and 
effect its import into mitochondria. This strongly suggests that; 1) 
these N-terminal sequences act, and probably fold, independently from 
the mature protein; 2) the mature segment of the precursor polypeptide
need not participate in targetting of a protein to the mitochondrion.
Gene fusion experiments have revealed also that the presequences 
of mitochondrial polypeptide precursors contain information for 
"intramitochondrial sorting" as well as for intracellular targetting.
Van Loon et al. (1986) have shown that the first 32 amino acids of the 
cleavable presequence of cytochrome c^ (an inner membrane protein 
protruding into the intermembrane space) targets mouse DHFR to the 
mitochondrial matrix. However, inclusion of the remainder of the 
complete presequence, which contains a stretch of 19 uncharged 
residues, results in the appearance of DHFR in the intermembrane 
space; unlike cytochrome c^, DHFR does not reinsert into the inner 
membrane via its C-terminal end. Thus, the membrane-anchoring sectors 
within presequences of intermembrane space proteins appear to have a 
crucial role in preventing transport of the entire precursor into the 
matrix.
Additional evidence for the existence of multiple targetting
signals within mitochondrial presequences comes from studies on the
yeast 70000-M^ outer membrane protein. Although this protein is
synthesised without a cleavable polypeptide extension, its 12 N-
terminal residues can direct an attached protein to the yeast
mitochondrial matrix in v ivo and in vitro (Hurt et al., 1985b). In
contrast, the N-terminal 41 residue segment of the 70000-M outer
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membrane protein (which contains the putative outer membrane anchor 
sequence) directs an attached foreign protein to the mitochondrial 
outer membrane (Hase et al., 1984).
The information obtained from gene fusion experiments has prompted 
the formation of a model for intracellular targetting and intra­
mitochondrial sorting of imported mitochondrial proteins (Hurt and van
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Loon, 1986). This model proposes that N-terminal presequences of 
imported mitochondrial proteins can consist of a relatively simple, 
linear array of short matrix-targetting domains, stop-tranfer domains 
and cleavage sites. A matrix-targetting domain (which consists of a 
periodic array of basic amino acids) directs an attached protein 
specifically to mitochondria and across both mitochondrial membranes. 
If a matrix-targetting domain is followed by a stop-transport domain 
(which contains a long, uninterrupted stretch of uncharged residues 
followed by charged residues), protein transport across the 
mitochondrial inner and/or outer membrane is prevented; the protein
becomes a component of the outer membrane or becomes a protein exposed
to or released into the intermembrane space. Cleavage sites may be 
present for proteolytic removal of all or part of the presequence.
The localisation of proteins to the mitochondrial outer membrane 
(rather than the inner membrane) may be due to a greater proximity of 
matrix-targetting and membrane-anchoring sequences in outer membrane 
proteins, such that matrix penetration of the N-terminus is prevented. 
However, differential membrane specificity of the two anchoring 
sequences cannot be ruled out at this stage.
Clearly, there are exceptions to the above model. Examples
include the import of cytochrome c, which is targetted to the inter­
membrane space without a cleavable polypeptide extension (Hennig and 
Neupert, 1981), and of subunit VI of the cytochrome bc^ complex, which 
is synthesised with an acidic N-terminal extension (van Loon et al., 
1984).
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1.2.4 BINDING OF PRECURSORS TO THE MITOCHONDRIAL OUTER MEMBRANE
The second step in the biogenetic pathway of nuclearly encoded 
mitochondrial proteins requires the specific interaction of precursor 
polypeptides with the cytoplasmic face of the mitochondrial outer 
membrane. Since precursor molecules have been shown to possess 
specific "mitochondrial targetting" signals, one would predict the 
existence of receptor molecules on the mitochondrial surface which 
recognise these signals. Indeed, the available evidence strongly 
implicates the participation of such receptor molecules in the import 
process.
The most extensive evidence for a mitochondrial import receptor 
comes from studies by Neupert and coworkers on the import of 
cytochrome c into N. crassa mitochondria. These studies have exploited 
the fact that relatively large amounts of apocytochrome c can be 
prepared chemically. Although the precursor form of cytochrome c does 
not contain a cleavable polypeptide extension, its maturation involves 
covalent attachment of haem. Thus, the cytochrome precursor is 
equivalent to apocytochrome c which has been prepared by chemical 
removal of the haem group from the holoenzyme.
The apocytochrome c receptor has been detected by its ability to
bind radiolabelled precursor in an in vitro assay. The precursor was
synthesised in a cell-free translation system in the presence of 
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[ S]methionine, then incubated with isolated mitochondria. Under 
suitable conditions, the extramitochondrial apocytochrome c was 
converted to intramitochondrial holocytochrome c (Hennig and Neupert,
1981). Only a small fraction of the apocytochrome c was recovered with 
reisolated mitochondria. To study binding in the absence of net
transport, deuterohaemin (an inhibitor of the haem attachment step) 
was added to the mitochondria before adding precursor proteins. Under 
these conditions, about half of the apocytochrome c was found 
associated with mitochondria which was sensitive to externally-added 
protease. Thus, in the presence of deuterohaemin, apocytochrome c 
appears to accumulate on the outer surface of the mitochondrion.
The sites to which apocytochrome c is bound are apparently 
specific and relevant to the import pathway. Firstly, apocytochrome c 
which is very tightly bound to the mitochondria can be released by 
addition of excess chemically prepared apocytochrome but not by 
holocytochrome c, a finding indicating reversibility as well as 
specificity of the binding reaction. Secondly, when the inhibition of 
haem attachment is reversed with protohaemin, apocytochrome c bound to 
the mitochondrial surface is transported into mitochondria and 
converted to the holoenzyme.
The existence of more than one type of import receptor is 
suggested by the finding that the binding sites involved in the 
import of apocytochrome c are not required for entry of other 
cytoplasmically-synthesised polypeptides into mitochondria. Whereas 
the appearance of intramitochondrial, radiolabelled holocytochrome c 
was almost completely blocked using unlabelled apocytochrome c, the 
import of the adenine nucleotide translocase and of the ATPase subunit 
9 was unaffected under the same conditions (Zimmermann et al., 1981). 
Moreover, when the import of the adenine nucleotide translocase was 
inhibited by elastase treatment of isolated N. crassa mitochondria, 
import of the ATPase subunit 9 was unaffected by the same level of 
protease (Zwizinski et al., 1984). Taken together, these data suggest 
that at least three types of binding site are involved in the import
of precursor polypeptides into mitochondria.
The precursor binding activity appears to involve polypeptide 
components of the mitochondrial outer membrane. This is inferred from 
the findings that mild protease treatment of isolated mitochondria 
inhibits their ability to bind and import precursors (Gasser et al., 
1982b; Argan et a l ., 1983; Zwizinski et al., 1984), and that isolated, 
right side-out outer membrane vesicles are capable of binding 
specifically precursors, in a manner which is rapid and apparently of 
high affinity. Such binding was shown to be exclusive to the 
cytoplasmic surface of the mitochondrial outer membrane, being absent 
from preparations of inner membrane or microsomes (Riezman et al., 
1983b). As with isolated mitochondria, the precursor binding capacity 
of outer membrane vesicles is sensitive to mild protease treatment.
It is highly unlikely that each species of imported precursor has 
its own receptor on the mitochondrial surface. In recent studies, 
purified 3-ketoacyl-CoA thiolase was found to inhibit the in vitro 
import of three other mitochondrial polypeptide precursors into rat 
liver mitochondria (Miura et al., 1985). This result indicated that a 
common mitochondrial component participates in the matrix delivery of 
these proteins in rat liver. In addition, analysis of the polypeptide 
composition of the mitochondrial outer membrane by SDS/polyacrylamide 
gel electrophoresis reveals a relatively small number of protein bands 
(Riezman et al., 1983a; Shore et a l ., 1981).
There is evidence to suggest that the binding of precursor 
molecules to the surface of mitochondria is mediated by soluble 
cytoplasmic components. In an in vitro import assay, import of pre­
ornithine transcarbamylase into rat liver mitochondria requires a 
factor contained in rabbit reticulocyte lysate (Argan et al., 1983;
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Miura et al., 1983). Similarly, the in v itro import of pre-ATPase -
subunit into yeast mitochondria requires a factor present in yeast
cytosol or rabbit reticulocyte lysate (Ohta & Schatz, 1984). In both
cases, the cytosolic factor exhibited properties typical of a protein.
The yeast cytosolic factor was estimated by gel filtration to have an
M value of 40000 (Ohta & Schatz, 1984). 
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More recent studies indicate that a protein import factor 
associates with the ornithine transcarbamylase precursor before 
binding of the factor-precursor complex to mitochondria (Argan and 
Shore, 1985). The import factor, however, does not bind to 
mitochondria in the absence of precursor. Thus, the association of 
precursor with the cytosolic factor may be required for the binding to 
components on the mitochondrial surface.
It has also been suggested that a cytoplasmic RNA moiety is 
required for import of precursor polypeptides into mitochondria 
(Firgaira et al., 1984). This suggestion was based on the finding that 
posttranslational addition of ribonuclease to a cell-free translation 
system inhibited subsequent import of a range of polypeptide 
precursors into the rat liver mitochondrial matrix. However, a 
subsequent report (Burns and Lewin, 1986) provides evidence which 
indicates that the inhibition of import by ribonuclease is an effect 
of degraded ribosomes in the cell-free translation mixture, rather 
than a requirement of the import process for RNA.
1.2.5 TRANSLOCATION AND ENERGY DEPENDENCE
Once bound to the cytoplasmic face of the mitochondrial outer 
membrane, a cytoplasmically-synthesised precursor polypeptide inserts
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into this lipid bilayer to become a component of the outer membrane, 
or is translocated into the mitochondrial interior to eventually 
become a component of the intermembrane space, inner membrane or 
matrix. Although very little is known about the mechanism of protein 
translocation, the existence of a number of different import pathways 
has been established.
Translocation of precursor polypeptides into or across the 
mitochondrial inner membrane is energy dependent. This was initially 
indicated by Nelson and Schatz (1979), who showed that in pulse- 
labelled yeast spheroplasts, the import of precursors of theo(-,p-
uncoupler of oxidative phosphorylation, or by depleting the level of 
matrix ATP in non-respiring yeast strains. Subsequently, it was shown 
that the import of the adenine nucleotide translocase was blocked by 
CCCP (Zimmermann et al., 1981). From these observations, however, it 
was not possible to distinguish rigorously between a requirement for 
matrix ATP or for an electrochemical potential across the inner 
membrane, since the addition of uncoupler renders the inner membrane 
permeable to protons and simultaneously stimulates the hydrolysis of 
ATP by the ATPase (Heytler, 1979). However, Nelson and Schatz 
proposed that matrix ATP was probably the immediate energy donor for 
import, since respiration deficient ) yeast strains, which cannot
form an appreciable membrane potential, still import proteins from the 
cytosol.
Definitive evidence to the contrary has since been obtained by 
investigating in vitro import in the presence of respiratory chain 
inhibitors, ionophores or uncouplers of oxidative phosphorylation.
and of two subunits of the
cytochrome bc^ complex was blocked in the presence of CCCP, an
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Gasser et al. (1982a) used an in vitro import system in which 
precursor-containing reticulocyte lysate was gel-filtered to remove 
energy sources, and isolated mitochondria were treated with cyanide to 
inhibit respiration. The cyanide-treated mitochondria were incubated 
with the gel-filtered lysate in the presence of ATP. Under these 
conditions, a large fraction of the ATPase -subunit precursor was 
imported into mitochondria. This import was entirely dependent on 
added ATP and could be blocked by addition of either carboxy- 
atractyloside, an inhibitor of the adenine nucleotide translocase or 
oligomycin, an inhibitor of the proton-translocating ATPase.
The inhibition of protein import by these two compounds indicates 
that added ATP must enter the mitochondrion and be hydrolysed by the 
F^Fg-ATPase for translocation to occur. Since oligomycin inhibits 
hydrolysis of ATP by the ATPase, it should increase the concentration 
of ATP in the mitochondrial matrix. Therefore, the observation that 
oligomycin blocks protein import suggested that matrix ATP is not the 
direct source of energy for translocation. This was confirmed by 
demonstrating that the inhibitory effect of oligomycin could be 
overcome by presenting mitochondria with a substrate for respiration, 
thus restoring a transmembrane electrochemical potential. Therefore, 
the ability of mitochondria to import proteins correlated with 
conditions where the electrochemical potential gradient would be 
expected to be relatively large, regardless of the matrix ATP 
concentration.
Schleyer et al. (1982) studied the energy requirement associated 
with import of the ATPase subunit 9 precursor into N. crassa 
mitochondria. Import was inhibited using a combination of oligomycin 
and antimycin A, an inhibitor of electron transfer through the
cytochrome bc^ complex. The translocation activity could be restored 
upon addition of ascorbate and tetramethylphenylenediamine (TMPD), 
thereby allowing reduction of cytochrome c and the subsequent 
regeneration of a proton electrochemical potential gradient by the 
activity of cytochrome c oxidase. The matrix ATP concentration should 
be unaffected by the addition of ascorbate and TMPD, yet import 
proceeded efficiently, again implicating a requirement for an 
electrochemical potential gradient across the mitochondrial inner 
membrane.
The electrochemical potential gradient ( £ j ) is the sum of a 
proton gradient (ApH) and the potential generated from the separation 
of charged species across the inner membrane (A^). To investigate the 
relative importance of ApH and in protein translocation into or 
across the mitochondrial inner membrane, Pfanner and Neupert (1985) 
developed a buffer system in which in vitro import of the adenine 
nucleotide translocase from the receptor-bound state was monitored, 
while ApH and A ^  were manipulated. Using this buffer system, it was 
found that import could be driven by a valinomycin-induced potassium 
diffusion potential, whereas imposition of a A p H  did not stimulate 
import. In addition, the protonophore CCCP did not abolish the import 
driven by a potassium diffusion potential. These results suggest that 
the membrane potential itself is the required energy form for
import, rather than a proton gradient.
The import of proteins into the mitochondrial outer membrane 
occurs in an energy-independent manner (Gasser and Schatz, 1983; 
Freitag et al., 1982). Similarly, the import of cytochrome c into the 
intermembrane space does not require a transmembrane electrochemical 
potential gradient (Zimmermann et al., 1981), presumably because the
26
mitochondrial inner membrane is not directly involved in the import of 
this protein. Surprisingly, the import of other soluble intermembrane 
space components such as cytochrome b^ and cytochrome c peroxidase is 
energy dependent (Reid et al., 1982). However, these findings are 
rationalised by evidence which indicates that the maturation of these 
two proteins involves partial translocation of their respective 
precursors across the mitochondrial inner membrane (Reid et al. , 1982; 
see also section 1.2.6).
Several findings indicate that translocation rather than 
proteolytic processing of precursors is the energy dependent step in 
protein import. Firstly, the import into the inner membrane or matrix 
of precursors which are synthesised without a cleavable polypeptide 
extension (e.g. isopropylmalate synthase or the adenine nucleotide 
translocase) requires energy, although no proteolytic processing is 
involved (Gasser et al., 1982b; Hampsey et al., 1982; Schleyer et a l .,
1982). Secondly, processing is still catalysed by a partially purified 
matrix protease (see section 1.2.6). Thirdly, the transport and 
processing of cytochrome c peroxidase are temporally separated; the 
initial transport step is blocked by CCCP, whereas subsequent 
processing is not (Reid et al., 1982).
Schleyer and Neupert (1985) have monitored the intermediate 
reactions during protein import into mitochondria. Translocation 
intermediates were trapped within the mitochondrial membranes by 
inhibiting translocation either at low temperature, or by pre-binding 
specific antibodies to the mature part of precursor proteins. Under 
such conditions, the N-terminal presequence was translocated into the 
matrix and removed by the matrix processing protease, while the major 
part of the precursor molecule was still outside the mitochondrial
outer membrane. These data suggest that at least some mitochondrial 
precursors may cross the outer and inner membranes through regions 
where the two membranes are in close proximity, in agreement with 
earlier electron microscopic evidence of mitochondrially-bound 
ribosomes which are preferentially present at sites where outer and 
inner membrane come into close contact (Kellems et al., 1975).
The precise role played by the membrane potential in precursor 
translocation remains to be determined. However, Schleyer and Neupert 
(1985) have shown that an energised inner membrane is required only 
for the initial translocation of the N-terminal portion (containing the 
positively-charged presequence), but not for that of the remainder of 
the precursor molecule. In addition, the insertion of synthetic 
presequences into lipid vesicles is facilitated by a valinomycin- 
induced diffusion potential across the liposome membrane but only if 
the inside of the vesicle is negatively charged, i.e. of the same 
polarity as that found in intact respiring mitochondria (Roise et al. ,
1986). Thus, the membrane potential may mediate translocation by 
exerting an electrophoretic effect on positively-charged N-terminal 
sequences.
1.2.6 PROCESSING OF PRECURSOR MOLECULES
During or shortly after their transmembrane passage, most 
mitochondrial precursor polypeptides undergo processing, thereby 
generating the mature form of the protein. Processing most commonly 
involves the proteolytic removal of the transient N-terminal extension 
from the precursor via one or two cleavage events. The first of these 
cleavages is catalysed by a soluble component of the mitochondrial
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matrix in yeast, rat and Zea mays (B8hni et a l ., 1980, 1983; McAda and
Douglas, 1982; Mori et al., 1980; Miura et al., 1982). Its activity is
maximal at neutral pH, is insensitive to serine protease inhibitors,
but is inhibited by chelators of divalent metal ions such as 1,10-
phenanthroline, EDTA, and GTP. This inhibition could be at least
2+ 2+
partially reversed by addition of an excess of Zn or Co (B8hni et
2+
al., 1983; Conboy et al., 1982) or Mn (McAda and Douglas, 1982). It 
is not known which of these cations is normally present in the active 
enzyme.
The yeast matrix protease has been partially purified (McAda and 
Douglas, 1982; Btthni et al., 1983). B8hni et al. (1983) demonstrated 
that this enzyme is responsible for the cleavage of several higher M^ 
precursors of imported mitochondrial polypeptides; it may in fact 
cleave all mitochondrial precursors with N-terminal extensions. In 
this respect the enzyme may be considered to have a broad specificity. 
In contrast, the yeast matrix protease is highly specific for native 
precursors, being inactive towards denatured precursors and non- 
mitochondrial proteins. This conformational requirement indicates that 
the protease does not simply recognise a particular amino acid 
sequence, but rather some three-dimensional domain of the precursor. 
Since the partially purified protease cleaves in vitro-synthesised 
precursors in the absence of mitochondria, it appears that the 
conformation of at least the N-terminal precursor regions are similar 
in solution and during (or soon after) translocation into the matrix.
The matrix protease appears to be an endoprotease since partially 
processed intermediates are not normally observed. Confirmation of 
this situation requires detection of the intact N-terminal peptide 
after processing, but this has not yet been achieved.
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The processing of some proteins of the intermembrane space 
involves the matrix protease described above; a situation which would 
not be predicted from the submitochondrial location of such proteins. 
Cytochrome b^ (a soluble intermembrane space component) and cytochrome 
c^ (which is attached to the inner membrane with its bulk protruding 
into the intermembrane space) have been shown clearly to be processed 
by two distinct proteolytic cleavage events. It is highly likely that 
another soluble intermembrane space protein, cytochrome c peroxidase 
also follows the same route (Teintze et al., 1982; Gasser et al.,
1982b; Ohashi et al., 1982; Reid et al., 1982; Daum et al., 1982a,b).
The suggested pathway for the maturation of these three 
cytochromes is as follows. The first of two cleavages is catalysed by 
the matrix protease and yields intermediate forms of each protein 
which migrate electrophoretically between the mature and precursor 
forms. These intermediates are firmly bound to the inner membrane and 
protrude into the intermembrane space. The second cleavage, which 
yields the mature-sized polypeptides, occurs on the outer surface of 
the inner membrane. The mature forms of cytochrome b^ and cytochrome c 
peroxidase are released as soluble components of the intermembrane 
space, whereas mature cytochrome c^ remains anchored in the inner 
membrane.
In yeast, at least, the enzyme responsible for the second 
cleavage is different from the matrix protease, since it is resistant 
to chelating agents and highly sensitive to detergent (Daum et a l ., 
1982b).
Intermediate forms of yeast cytochromes b^ and c^ can be 
generated by incubating in v itro-synthesised precursors of these two 
proteins with partially-purified matrix protease (BtJhni et al., 1983).
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Such intermediate forms can also be detected in vivo. Intact yeast 
cells or spheroplasts were pulse-labelled while their mitochondria 
were uncoupled, so that the precursor forms of cytochromes b^ and c^ 
accumulated in the cytosol (Gasser et al., 1982b; Ohashi et al., 1982; 
Reid et a l ., 1982). Following a chase period when the block on import 
was reversed, the intermediate forms of the cytochromes, and 
subsequently their mature forms appeared.
The cytochrome c peroxidase precursor is cleaved to an 
intermediate form by the partially-purified matrix protease (Gasser et 
al., 1982b), and its processing in vivo is blocked by 1,10- 
phenanthroline (Reid et al., 1982), suggesting a role for the matrix 
protease. However, no cytochrome c peroxidase intermediate has been 
detected in vivo. Cleavage of the cytochrome c peroxidase precursor by 
the matrix protease is relatively slow and therefore may be rate 
limiting. If this were the case, the intermediate would not then be 
detected for kinetic reasons.
During its maturation, cytochrome c^ undergoes covalent 
attachment of haem. Ohashi et al. (1982) have investigated when this 
reaction occurs in relation to the two proteolytic cleavages. This was 
achieved using a haem-deficient yeast mutant which lacked 5- 
aminolevulinate synthase. When this mutant was pulse-labelled in the 
absence of haem precursors, it was found that the intermediate form of 
cytochrome c^ was accumulated. When the pulse-labelled cells were 
chased in the presence of 5-aminolevulinate, the accumulated inter­
mediate form was converted to mature cytochrome c^. Thus, the second 
processing step is dependent on the availability of haem, presumably 
because haem attachment to the intermediate renders it sensitive to 
the second protease.
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Besides proteolytic cleavage and the haem attachment described 
above, other forms of processing of mitochondrial precursors are 
known. These include covalent attachment of flavin nucleotides, 
incorporation of cofactors such as TPP or pyridoxal phosphate, the 
methylation of amino-acyl side chains, and acetylation of the mature 
amino-terminus (Hay et a l ., 1984). Mature cytochrome c contains £- 
aminotrimethyllysine in N. crassa (De Lange et al., 1970) and wheat 
germ (De Lange et al., 1969) and its N-terminus is acetylated in many 
mammals (Margoliash, 1966). On the whole, the roles played by the 
enzymes effecting such modifications are poorly defined, although it 
is clear that non-proteolytic processing (as in the aforementioned 
case of cytochrome c^) can be essential for generation of a functional 
protein.
1.2.7 ASSEMBLY OF IMPORTED PROTEINS INTO FUNCTIONAL UNITS
The final stage in the biogenetic pathway of an imported mito­
chondrial polypeptide is the acquisition of a functional conformation 
in the correct submitochondrial location. In many cases, this involves 
specific interactions with other homologous or heterologous subunits. 
Biogenesis of four of the respiratory complexes of the inner membrane 
is especially complicated, since their assembly entails physical 
association of nuclear and mitochondrial gene products. In comparison 
with the preceding steps in the pathway, the terminal assembly event 
is least well understood, largely because of a lack of adequate 
methodology for the investigation of such intermolecular interactions.
To date, three main criteria have been used in the assessment of 
whether polypeptides imported into mitochondria in vitro become
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assembled in a manner which is representative of that occurring in 
living cells. These are: 1) the imported protein is shown to have 
reached its correct submitochondrial location; 2) it should be 
associated with the appropriate homologous or heterologous subunits in 
a structure resembling the native one; and 3) the assembled subunits 
should exhibit biological activity.
Subfractionation of isolated yeast mitochondria after import of 
in vitro-synthesised precursors has shown that imported cytochrome b^ 
(an intermembrane space protein) and isopropylmalate synthase (a 
matrix component) are recovered predominantly in their correct sub­
mitochondrial fractions. However, a disproportionately large amount of 
radiolabelled, imported polypeptides was isolated with the 
mitochondrial membranes. The membrane-bound forms may represent 
intermediate steps on the maturation pathways of these proteins 
(Gasser et al., 1982b). On the other hand, two imported inner membrane 
proteins were found exclusively in the membrane fraction.
Proper orientation within a membrane has been inferred for two 
imported mitochondrial proteins since they share a physical property 
with the corresponding mature counterpart. The imported form of the 
outer membrane porin in yeast (Gasser and Schatz, 1983; Mihara et a l ., 
1982) and in N. crassa (Freitag et al., 1982) resembles mature porin 
in its high resistance to proteolysis. Also, the N. crassa adenine 
nucleotide translocase behaves like the authentic mature protein in 
that it does not bind to hydroxylapatite in the presence of carboxy- 
atractyloside (Schleyer and Neupert, 1984).
Evidence for correct homo-oligomer formation by imported 
translation products has been obtained in the case of ornithine 
transcarbamylase. Kalousek et al. (1984) showed that the imported and
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processed form of in vitro-synthesised ornithine transcarbamylase, but 
not the precursor, binds to a ligand affinity column which recognises 
native ornithine transcarbamylase. Furthermore, a significant portion 
of radiolabelled subunits which were eluted from the affinity matrix 
comigrated with the native, trimeric enzyme on a gel filtration 
column.
No such binding to the affinity matrix was observed for the 
mature-sized monomer or dimer. Moreover, processing by a mitochondrial 
matrix fraction failed to yield trimeric enzyme, despite producing 
ample amounts of mature-sized monomer. These data indicate that 
trimeric ornithine transcarbamylase composed of mature-sized subunits 
can be assembled in vitro by intact mitochondria following 
translocation and proteolytic processing.
It has been suggested that in vitro import of rat carbamyl 
phosphate synthase (Campbell et al., 1982) and yeast phenylalanyl tRNA 
synthase (Diatewa and Stahl, 1981) leads to new enzyme activity. 
Further experimentation is required to clarify this point, the main 
problems being to find a system with low background enzymic activity 
and to import sufficient precursors to generate detectable activity.
Finally, Lewin and Norman (1983) have provided strong evidence 
for the proper assembly of newly imported o(-, ($- a n d ^ -  subunits of 
the yeast F^ ATPase. Isolated yeast mitochondria were incubated with 
radiolabelled, in vitro-synthesised precursors, and newly-assembled F^ 
ATPase was detected by autoradiography of the isolated enzyme. 
Incorporation of labelled subunits into the enzyme did not occur in 
the presence of uncouplers or a divalent metal ion chelator, nor did 
it occur when submitochondrial particles were incubated with mature-
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sized in vitro-synthesised subunits. Furthermore, labelled subunit 
incorporation was not competed out when excess unlabelled subunits 
were added after import of radiolabelled polypeptides had taken place. 
These findings are indicative of de novo assembly of ATPase domains 
rather than exchange of labelled subunits with unlabelled subunits of 
Fj on the mitochondrial membrane.
1.2.8 UNANSWERED QUESTIONS AND FUTURE DIRECTIONS
Since the initial description of posttranslationally-imported 
higher M m i t o c h o n d r i a l  polypeptide precursors (Maccecchini et al., 
1979), the volume of literature pertaining to mitochondrial protein 
import has expanded at a dramatic rate. Major advances in the field 
include the detection of putative import receptors, elucidation of 
the nature of the energy dependence of import, discovery of different 
import pathways and, more recently, the application of recombinant DNA 
technology to examine the signalling information present in 
mitochondrial presequences.
Despite this progress, there are still considerable gaps in our 
knowledge of mitochondrial biogenesis. The mechanisms which coordinate 
the synthesis and assembly of nuclear and mitochondrial gene products 
remain obscure. Furthermore, little is known about the molecules which 
constitute the import machinery. Indeed, the putative outer membrane 
receptor molecules have not yet been isolated and shown to exhibit 
bona fide receptor-like activity.
A recent report by Hurt et al. (1986) has shown that the 
cleavable presequence of an imported chloropiast protein directs 
attached polypeptides into yeast mitochondria, albeit with relatively
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low efficiency. This finding raises the intriguing question of how 
cytoplasmically-synthesised polypeptides are sorted between 
mitochondria and chloroplasts in plant cells.
Future research into mitochondrial biogenesis is likely to place 
considerable emphasis on a genetic approach, especially in yeast. Such 
an approach will allow further analysis of the sequence requirements 
for precursor targetting and submitochondrial localisation, and also 
the isolation of mutants which are defective in mitochondrial 
assembly.
Yaffe et al. (1985) have already described a temperature 
sensitive yeast mutant (mas 1) which is deficient in a matrix-located 
processing protease activity. This mutation results in arrest of 
growth and accumulation of the precursor forms of imported 
mitochondrial polypeptides. Restoration of temperature resistant 
growth to mas 1 mutant cells can be achieved using isolated fragments 
of yeast genomic DNA. Thus, analysis of the cloned gene will determine 
if MAS 1 is the structural gene for the matrix protein and allow 
further biochemical and genetic studies. By isolating and 
characterising a large number of mas mutants it should be possible to 
identify most of the components involved in mitochondrial protein 
import.
1.3 MULTIENZYME COMPLEXES
A consequence of the high degree of internal organisation found 
in eukaryotic cells is the existence of membrane-bounded intracellular 
compartments, which are physically and biochemically distinct.
However, the compartmentation of cellular metabolism can be regarded
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as occurring at other levels of cellular organisation, via the
existence of "inicrocompartinents" (Hess, 1980). The smallest
metabolically significant compartments are the active sites of
o
enzymes. These are in the Angstrom range and serve to concentrate and 
sequester substrates and cofactors. Such compartments are formed most 
simply by the tertiary structure of a single polypeptide chain.
The next highest level of microcompartmentation is exhibited by 
oligomeric and multifunctional enzymes and multienzyme complexes. Both 
homo- and hetero-oligomeric proteins probably arose because they were 
energetically more stable than the monomeric state. In addition, the 
aggregated state affords the establishment of cooperative interactions 
between active sites, or between regulatory and catalytic subunits. 
These interactions form the basis for the allosteric regulation of key 
steps in cellular metabolism. In contrast to oligomeric enzymes, which 
catalyse a single reaction, multifunctional enzymes or multienzyme 
complexes catalyse two or more steps in a metabolic sequence. As a 
result of their multiple active sites, the latter two types of protein 
are effective in channelling products of one reaction which are then 
used as substrates for the next reaction.
The next highest level of microcompartmentation is found in 
extremely sophisticated supramolecular structures such as ribosomes or 
the mitochondrial electron transport chain. The former represents a 
series of catalysts organised in an aggregate which permits the 
sequestration of substrates (amino acids), cofactors (ATP and GTP) and 
reaction products (elongating polypeptide chains) away from the bulk 
phase of the cytosol; the latter catalyses the transfer of electrons 
from NADH or FADH^ to oxygen. Once electrons enter this chain they 
are effectively sequestered away from the aqueous environment on
either side of the mitochondrial inner membrane until they emerge from 
cytochrome c oxidase and combine with protons and oxygen to form 
water.
A number of multienzyme complexes have been studied and isolated 
from both prokaryotic and eukaryotic sources. These include the fatty 
acid synthase (Lynen, 1972) and 2-oxoacid dehydrogenase complexes 
(Reed, 1974; Perham, 1975) and the multienzyme complexes involved in 
aromatic amino acid biosynthesis (Yanofsky and Crawford, 1972; Lumsden 
and Coggins, 1977), which are composed of 2-6 enzymes and have M^ _ 
values ranging from approx. 150000 to several million. The 2-oxoacid 
dehydrogenase complexes, particularly that responsible for the 
oxidation of branched chain 2-oxoacids, are described in greater 
detail in sections 1.4-1.7.
1.4 2-OXOACID DEHYDROGENASE COMPLEXES
The overall reaction catalysed by the 2-oxoacid dehydrogenase 
complexes can be represented as:
R-C0-C00H -f- CoA-SH + NAD*’’ ----------- ^ R-CO-SCoA + C02 + NADH + H+
where R represents the alkyl group of a 2-oxoacid (see below). These 
dehydrogenases consist of a family of three related multi-enzyme 
complexes, which, in eukaryotic cells, are located within the mito­
chondrion, probably loosely associated with the matrix side of the
4
inner membrane. Each of the three complexes occupies a key position in 
intermediary metabolism, as illustrated in Fig.1.4.
The 2-oxoglutarate dehydrogenase complex (OGDC) is a tricarboxylic
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Fig.1.4 Metabolic Roles Of The 2-0xoacid Dehydrogenase Complexes
(after Yeaman, 1986).
1, transamination;
2, trans-sulphuration;
3, branched chain 2-oxoacid dehydrogenase;
4, pyruvate dehydrogenase;
5, 2-oxoglutarate dehydrogenase.
The broken lines indicate that several reaction steps are involved.
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acid enzyme, whilst pyruvate dehydrogenase complex (PDH) catalyses the 
committed reaction in the catabolism of carbohydrate. The branched 
chain 2-oxoacid dehydrogenase (BCOAD) complex catalyses an 
irreversible step in the oxidation of the branched chain amino acids 
leucine, isoleucine and valine. The BCOAD complex may also be involved 
in the catabolism of methionine and threonine, since it is reported 
that 2-oxobutyrate (Pettit et al., 1978) and A-methylthio-2- 
oxobutyrate (Jones land Yeaman, 1986) can also be used as substrates by 
this complex (see Fig.1.5).
Although the three complexes are structurally and functionally 
distinct, they can each be isolated as a functional high-M^_ assembly 
which contains multiple copies of three major component enzymes; El, a 
substrate specific, TPP-requiring 2-oxoacid dehydrogenase; E 2 , a 
dihydrolipoamide acyltransferase which is specific for each complex 
and contains covalently bound lipoic acid, and dihydrolipoamide 
dehydrogenase (E3), a flavoprotein which, in virtually all organisms 
studied so far, is a common component of the three multienzyme 
complexes.
Deficiencies in the activities of the 2-oxoacid dehydrogenase 
complexes lead to pathological states, including various forms of 
metabolic acidosis. PDH deficiency is manifested by lactic acidaemia 
and BCOAD complex deficiency results in branched chain 2-oxoacidaemia 
or maple syrup urine disease (MSUD). Two structural bases for the 
latter inborn error of metabolism have been identified. A vitamin 
responsive form of MSUD has been described, where administration of 
high levels of thiamine to affected patients leads to decreased 
urinary output of branched chain 2-oxoacids and increased BCOAD 
complex activity in peripheral leukocytes (Fernhoff et al., 1981).
This finding suggests that a mutant El component is responsible for 
at least some cases of the vitamin responsive form of the disease. In 
addition, Danner et al. (1985) have shown that the BCOAD complex in 
fibroblast mitochondria from a thiamine nonresponsive MSUD patient 
lacks specifically the E2 component.
In the case of the mammalian PDH, an additional polypeptide 
component, termed component or protein X has recently been identified 
(De Marcucci and Lindsay, 1985; Jilka et a l ., 1986). This polypeptide 
has been shown to be similar to E2, in that it undergoes acetylation 
via a lipoic acid moiety (Hodgson et al., 1986; De Marcucci et a l ., 
1986a), although a precise role for X has yet to be established. To 
date, no evidence has been obtained for the existence of an equivalent 
component in the OGDC or BCOAD complexes.
Studies on the quaternary structure of the complexes have revealed 
that in both bacteria and mammals, the E2 component forms a 
symmetrical core around which are arranged the El and E3 components. 
However, the stoicheiometry and arrangement of the components of the 
three mammalian complexes differs in each case (see section 1.5).
1.5 STRUCTURE AND FUNCTION OF THE BCOAD COMPLEX
The BCOAD complex was originally purified from bovine kidney, and 
was found to consist of a 52000-M^ component and an El component 
composed of two subunits, termed o( and ^  , which have M^ _ values of 
46000 and 35000, respectively (Pettit et al., 1978). The E3 component 
was found to be absent from the purified complex. Subsequently, BCOAD 
complex has been purified from bovine liver (Danner et a l ., 1979; 
Heffelfinger et al., 1983), rabbit liver (Paxton and Harris, 1982),
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rat kidney (Odessey, 1982) and Pseudomonas putida (Sokatch et a l ♦,
198l} . The E2, Elc< and El^ components from each of these sources
exhibit highly similar, or identical values to the corresponding 
bovine kidney subunits. The preparations of bovine kidney BCOAD 
complex described by Danner et al. (1979) and Heffelfinger et al. 
(1983) are distinct in that they contain endogenous E3.
The three major component enzymes of the BCOAD complex act in 
sequence to catalyse the overall oxidative decarboxylation reaction, 
as illustrated in Fig.1.5. El catalyses the decarboxylation of the 2- 
oxoacid, with formation of a hydroxyacyl-TPP derivative (reaction 1). 
El then catalyses the reductive acylation of the covalently bound 
lipoic acid cofactor of the dihydrolipoamide acyltransferase (reaction 
2). The acyl group ip then transferred by E2 to the CoA acceptor, 
leaving the lipoic acid in the reduced state (reaction 3). E3 
catalyses the reoxidation of the dihydrolipoyl moiety, with NAD as 
the ultimate electron acceptor (reactions 4 and 5).
The mammalian BCOAD complex is organised about an oligomeric
core of E2 polypeptides; this is apparently composed of 24 subunits
which are arranged in groups of three about the 8 vertices of a cube.
The molecules of El are distributed on the surface of the E 2 ,cube,
attached by non-covalent bonds (Pettit et al., 1978). The results of
limited tryptic digestion of bovine liver BCOAD complex suggest that
the branched chain E2 component may consist of two domains; one which
forms the core aggregate and contains the transacylase active site,
and a second which contains the lipoyl moiety. Chuang et al. (1985)
have shown that the trypsinised E2 maintains a highly assembled core
structure which contains two related lipoate-free tryptic fragments.
These are a 22000-M species and a 26000-M species from which the
r r
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Fig.1.5 Sequence Of Reactions Catalysed By The Branched Chain 
2-0xoAcid Dehydrogenase Complex 
(after Reed and Yeaman, 1987).
TPP, thiamin diphosphate; LipS^ and Lip(SH)^, lipoyl moiety and
its reduced form; CoASH, coenzyme A; FAD, flavin adenine nucleotide;
+
NAD and NADH, nicotinamide adenine dinucleotide and its reduced 
form; El, branched chain 2-oxoacid decarboxylase; E 2 , dihydrolipoamide 
acyltransferase; E3, dihydrolipoamide dehydrogenase.
R = (CH^^.CH- ; 2-oxoisovalerate (3-methyl-2-oxobutanoate),
R = (CH^.CH^).(CH^).CH- ; 2-oxo-3-methylvalerate (3-methyl-2- 
oxopentanoate),
R = (CH^^.CH.CH^- » 2-oxoisocaproate (4-methyl-2-oxopentanoate).
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smaller^fragment is derived. The larger of the two fragments exhibits 
transacylase activity; however proteolytic conversion of this species 
to the 22000-M^ limit polypeptide renders the inner core catalytically 
inactive. Thus, the E2 component of the BCOAD complex is apparently 
analogous to the equivalent components of the pyruvate and 2- 
oxoglutarate dehydrogenase complexes, whose structures have been 
investigated more extensively. Limited proteolysis and electron 
microscopy of the PDH E2 component has revealed that it consists of a 
compact domain and a flexible extended domain (Bleile et al., 1979; 
Hale and Perham, 1979; Kresze and Ronft, 1980; Bleile et al., 1981). 
The compact domain contains the acetyltransferase active site, and 
forms the basis of the E2 "inner core" which is visible in the 
electron microscope. The extended domain, which is readily released 
from the inner core by limited proteolysis, contains the covalently 
bound lipoic acid moiety or moieties. Proton nuclear magnetic 
resonance spectroscopy has provided evidence that the lipoyl and 
active site domains are connected via a highly mobile segment of the 
polypeptide (Perham et al., 1981; Packman et al., 1984). This segment 
is thought to facilitate interaction of the lipoyl moiety with the 
active sites of the three component enzymes (Hackert et al., 1983).
1.6 REGULATION OF THE BCOAD COMPLEX
The overall activity of the BCOAD complex is regulated by end- 
product inhibition (by NADH and the appropriate Acyl CoA products), 
and, in common with the pyruvate dehydrogenase complex, by covalent 
modification via a phosphorylation/dephosphorylation cycle (Reed et 
al., 1985). BCOAD complex is phosphorylated by a specific kinase which
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copurifies with the complex and is tightly bound to the E2 core (Cook
et al., 1985), although the subunit structure of this regulatory
enzyme has not yet been elucidated.
2"f"
In the presence of Mg ions and ATP, the kinase phosphorylates
two serine residues which are closely grouped on the o( subunit of the
El component (Cook et a l ., 1984). The V of the phosphorylated
—  —  max
decarboxylase is drastically reduced, resulting in inactivation of the
complex. Phosphorylation of one of the two serine residues correlates
closely with inactivation; the role of the second phosphorylatable
site remains unclear (Cook et a l ., 1983). Recently, the amino acid
sequences of the tryptic phosphopeptides containing the inactivation
sites of the pyruvate and branched chain 2-oxoacid dehydrogenases have
been shown to share considerable homology (Cook et a l ., 1984);
however, the phosphopeptide from PDH contains a second phosphorylatable
serine residue. This presumably explains why only two sites of
phosphorylation are present within the BCOAD complex, compared to the
three sites observed in PDH (Yeaman et al., 1978).
Dephosphorylation and concomitant reactivation of the BCOAD
complex is catalysed by a distinct phosphatase which is relatively
loosely attached to its substrate, being lost as a soluble entity
during purification of the complex. However, this phosphatase has been
purified approximately 8000-fold from extracts of bovine kidney
mitochondria (Damuni et al., 1984). The highly purified phosphatase
has a native M of about 460000 as estimated by gel permeation 
r
chromatography, but its subunit structure is unknown. In contrast to 
the PDH phosphatase, the BCOAD complex phosphatase is apparently metal 
ion-independent. Activity of the latter phosphatase is inhibited by 
nucleoside tri- and diphosphates, and is stimulated by basic
polypeptides such as protamine* poly (L-lysine) and poly (L-arginine). 
Damuni and coworkers (Damuni et al., 1985; Damuni et al., 1986) have 
recently identified and purified to near homogeneity a 36000-M^ 
protein inhibitor of the BCOAD complex phosphatase, which could 
conceivably be of major regulatory significance.
Despite the realisation that the BCOAD complex is regulated by a 
phosphorylation-dephosphorylation cycle, much remains to be learned 
concerning the factors which govern the "activity state" or degree of 
phosphorylation of the complex. The significance of the activity state 
in determining the level of BCOAD complex activity in a particular 
tissue is reflected by the finding that, in fed rats, about 70% of the 
whole-body BCOAD complex activity is located in the liver, although 
the heart and muscle contain significant amounts of phosphorylated and 
hence inactive complex (Wagenmakers et a l ., 1984; Patston et al., 
1986). Furthermore, when rats are fed a low protein diet, a small 
decrease in the total amount of liver enzyme is detectable, but a 
substantial decrease in the active form of liver complex is observed, 
indicating that the decrease in flux through the complex results from 
increased phosphorylation (Patston et al., 1986; Harris et al. , 1986). 
It is not known at this stage whether the increased phosphorylation is 
mediated by changes in the levels of the liver kinase and/or 
phosphatase, or by allosteric or covalent control of one or both of 
these regulatory enzymes. In addition, the BCOAD complex "activator 
protein", described by Fatania et al. (1982) and identified as the 
dissociated, non-phosphorylated El component of the complex by Yeaman 
et al. (1984) may have a role in buffering covalent modification of 
the hepatic BCOAD complex.
44
1.7 BIOSYNTHESIS OF THE BCOAD COMPLEX
Biosynthesis of the BCOAD complex remains largely uninvestigated, 
although the E3 component (which is common to all three 2-oxoacid 
dehydrogenases) has been shown to be synthesised as a higher 
precursor (Matuda et al., 1983; Hunter, 1985).
With the identification of all but two of the protein-coding 
reading frames in mammalian mitochondrial DNA, and the observation that 
defects in BCOAD complex activity are inherited as an autosomal 
recessive disorder, it can be concluded that the four component 
polypeptides of the BCOAD complex are coded for by nuclear genes. 
Consequently, the biogenesis of the BCOAD complex is likely to proceed 
via the general pathway for cytoplasmically-synthesised mitochondrial 
polypeptides outlined in section 1.2.1.
Key features of the BCOAD complex include the covalently-bound 
lipoic acid moiety of the E2 component, the presence of TPP and FAD 
which are non-covalently bound to the El and E3 components, 
respectively, and the highly structured, multimeric array of the 
native complex. These features are pertinent in the context of BCOAD 
complex biogenesis, since they raise intriguing questions such as the 
following; At what stages are the cofactors attached or bound to the 
appropriate polypeptides? How is complex assembly in the correct 
submitochondrial location mediated? How is the synthesis and import of 
the four component polypeptides coordinated? Thus, a detailed 
knowledge of the biosynthesis of the BCOAD complex would provide 
information concerning aspects of mitochondrial biogenesis which are 
at present relatively poorly understood.
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1.8 SUCCINATE DEHYDROGENASE
Succinate dehydrogenase (SDH; E.C. 1.3.99.1) occupies a unique 
position in energy-yielding metabolism, being a component of both the 
tricarboxylic acid cycle and the electron transport chain. Succinate 
dehydrogenases have been purified from several mitochondrial and 
bacterial sources and they invariably comprise two subunits, each 
containing iron-sulphur centres; a large flavoprotein subunit (M 
65-72000) containing covalently-bound FAD, and a smaller iron- 
sulphur protein subunit (M^ 25-30000). Additionally, these subunits 
may be associated with two small polypeptides (M 13500-17000 and
1C
7000-14000) or a cytochrome b (reviewed by Hederstedt and Rutberg, 
1981).
The most extensively studied eukaryotic succinate dehydrogenase
is probably that from bovine heart mitochondria. A water soluble form
of the bovine heart enzyme was isolated by Davis and Hatefi (1971),
which consisted of two subunits with M values of 70000 and 27000. The
r
large subunit contains one molecule of FAD, which is covalently bound 
via the 8oC-methyl group of the isoalloxazine ring and the N(3) atom 
of a histidyl residue on the polypeptide chain (Salach et al., 1972; 
Singer and Edmondson, 1974). The active site is also thought to be 
located on this subunit (Kenney et a l ., 1976).
Biophysical methods have revealed that the bovine heart SDH 
holoenzyme contains three different Fe-S clusters, which are of the 
[2Fe-2S], [3Fe-xS] and [4Fe-4S] types. However, definitive evidence 
concerning their subunit location has yet to emerge (reviewed by 
Singer and Johnson, 1985).
Studies on succinate dehydrogenase have been performed using
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three main types of preparation, namely 1) inner membrane preparations 
2) membraneous preparations exhibiting succinate-ubiquinone reductase 
activity (complex II), and 3) preparations of homogeneous soluble 
enzyme. In its membrane environment, the enzyme is stabilised against 
oxygen (Beinert et al., 1977; Ohnishi et al., 1976), shows high 
succinate-ubiquinone reductase activity which is inhibited by carboxin 
and thenoyltrifluoroacetone (Ziegler, 1961; Mowery et al., 1977) and 
has a high turnover number when phenazine methosulphate is used as 
electron acceptor. The properties of SDH in preparations of complex II 
and of soluble enzyme differ from each other and from the membrane- 
bound form of the enzyme.
Preparations of complex II are also stable to oxygen and exhibit 
ubiquinone reductase activity, but the turnover number of this form of 
the dehydrogenase in the phenazine methosulphate assay is much lower 
than that of the enzyme in the inner membrane. Complex II preparations 
contain, in addition to succinate dehydrogenase, at least two other 
polypeptides, termed CII-3 and CII-4, which have values of 13500 
and 7000 respectively (Capaldi et al., 1977). The oxygen stability and 
reactivity with ubiquinone is dependent on the presence of these 
polypeptides (Ackrell et al., 1980).
The soluble enzyme which may be extracted from complex II has an 
intermediate turnover number using phenazine methosulphate as electron 
acceptor (Ackrell et al., 1977; Baginsky and Hatefi, 1969), is devoid 
of ubiquinone reductase activity, and is very labile, so that exposure 
to oxygen results in destruction of Fe-S centre 3 (Beinert et al., 
1977). These changes are coupled with the appearance of a new 
catalytic activity, a "low K^" succinate-ferricyanide reductase 
(Vinogradov et al., 1975) which is functional at low concentrations of
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ferricyanide. The latency of this activity is presumed to reflect the 
inaccessibility of the reaction site when the enzyme is associated 
with other membrane components.
SDH is tightly associated with the mitochondrial inner membrane 
and is partially buried within the lipid bilayer. Ferricyanide 
binding, immunological and chemical labelling studies have indicated 
that SDH is located both functionally and physically on the matrix 
side of the inner membrane (Klingenberg and Buchholz, 1970; Merli et 
al., 1979; Girdlestone et a l ., 1981). The topographical aspects of 
succinate dehydrogenase are discussed more fully in Chapter Four.
Despite the considerable attention which has been directed at 
understanding the structure and enzymology of succinate dehydrogenase, 
the question of its biosynthesis has scarcely been addressed. When I 
embarked on this project in October, 1983, only one study concerning 
the biosynthesis of SDH had been reported (Hattori et el., 1983). This 
study documented that the SDH large subunit in sweet potato (Ipomoea 
batatas) is synthesised in vitro as a precursor with an value which 
is 3000 greater than the mature form, when sweet potato poly(A)+ RNA 
is used to direct protein synthesis in a wheat germ cell-free system. 
Furthermore, the biosynthetic machinery involved in the covalent 
attachment of FAD to the large subunit and insertion of the Fe-S 
clusters has yet to be characterised, and the points in the SDH 
biogenetic pathway at which these prosthetic group attachments occur 
are completely unknown. Thus, succinate dehydrogenase represents an 
attractive candidate- for research into mitochondrial biogenesis.
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1.9 AIMS OF THIS STUDY
Previous sections of this chapter have served to illustrate how 
few data exist concerning the biogenesis of the branched chain 2- 
oxoacid dehydrogenase (BCOAD) complex and of succinate dehydrogenase, 
in comparison with other mitochondrial enzymes. The lack of knowledge 
is more pronounced when the relatively sophisticated biogenetic 
pathways of these two dehydrogenases is taken into account. This study 
was therefore directed at investigating the biosynthesis of the 
components of the BCOAD complex in cultured mammalian cells, and to 
perform an analogous study on succinate dehydrogenase.
The question of the topographical arrangement of succinate 
dehydrogenase within the mitochondrial^membrane was also addressed, 
since the availability of specific antisera allowed application of a 
membrane digestion/immune blotting approach to this problem.
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CHAPTER TWO
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 CHEMICALS AND BIOCHEMICALS
Benzamidine-HCl, p-aminobenzamidine-HCl, PMSF, leupeptin, DOC
(sodium salt), Tween 20, DNP, TEMED, Coomassie Brilliant Blue R250,
branched chain 2-oxoacids (sodium salts), NAD+ , TPP, NEM and antifoam
A concentrate were purchased from Sigma Chemical Co., Fancy R d . ,
Poole, Dorset, U.K. PPO, toluene and sucrose came from Koch-Light
Laboratories Ltd., Colnbrook, Berks., U.K.
Tris, CoA (trilithium salt) and DTT were the products of
Boehringer Corporation (London) Ltd., Lewes, East Sussex, U.K.
Acrylamide, N,N'-methylenebisacrylamide, SDS, Folin Ciocalteu’s
Phenol reagent and L-cysteine-HCl were obtained from BDH Chemicals
Ltd., Poole, Dorset, U.K.
PEG 6000 was purchased from Serva, Heidelberg, West Germany.
TM
Iodogen came from Pierce and Warriner (U.K.) Ltd., Chester, U.K. 
Triton X-100 was purchased from Rohm and Haas (U.K.) Ltd., Croydon, 
Surrey, U.K. Pyronin Y was obtained from George T. Gurr Ltd., London 
SW6, U.K. 2-mercaptoethanol was supplied by Riedel-de-Ha8n, via A. & J. 
Beveridge Ltd., Edinburgh, U.K. Salicylic acid came from Aldrich 
Chemical Co., Gillingham, Dorset, U.K. FCCP was provided by Dr. P.G. 
Heytler, Du Pont De Nemours and Co. (Inc.), Delaware, U.S.A. All other 
reagents were of the highest grades available commercially.
2.1.2 RADIOCHEMICALS
N-ethyl [2,3-^C]maleimide ( 10. lmCi/mmol) , Na^"*I (carrier free) 
35
and L-[ S]methionine (>1100 Ci/mmol) were obtained from Amersham
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International pic, PO Box 16, Amersham, Bucks., U.K.
2.1.3 PROTEINS AND ENZYMES
The following protein and enzyme preparations were obtained from
Sigma Chemical Co., Fancy Rd., Poole, Dorset, U.K.
bovine serum albumin (essentially fatty acid and globulin free); 
lipoamide dehydrogenase, type III (E.C. 1.6.4.3) from porcine heart; 
papain, type III (E.C. 3.4.22.2) from Papaya latex; protein A from 
Staphylococcus aureus, Cowan I strain; TLCK-treatedo(-chymotrypsin, 
type VII (E.C. 3.4.21.4) from bovine pancreas; TPCK-treated trypsin, 
type XIII (E.C. 3.4.21.4) from bovine pancreas.
Protease K (E.C. 3.4.21.14) from Tritirachium album and lipoamide
dehydrogenase (E.C. 1.6.4.3) from porcine heart were from Boehringer 
Corporation (London) Ltd., Lewes, East Sussex, U.K.
Electrophoresis calibration kit for low M^ _ proteins ("low M^ 
markers") came from Pharmacia (G.B.) Ltd., Milton Keynes, Bucks., U.K.
Purified bovine heart succinate dehydrogenase was a generous gift 
from Professor Tsoo E. King, Department of Chemistry, State University 
of New York at Albany, Albany, NY 12222, U.S.A.
Purified El subcomplex from bovine kidney branched chain 2- 
oxoacid dehydrogenase (BCOAD) complex and some of the native BCOAD 
complex used in this study were kindly provided by Dr. Steve J.
Yeaman, Department of Biochemistry, University of Newcastle Upon Tyne.
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2.1.4 MATERIALS FOR CHROMATOGRAPHY
Bio-Gel HTP was purchased from BioRad Laboratories Ltd., Holywell 
Industrial Estate, Watford, Herts., U.K.
Sephadex G-25 (medium grade) was the product of Pharmacia (G.B.) 
Ltd., Milton Keynes, Bucks., U.K.
2.1.5 CELL CULTURE MATERIALS
Glasgow-modified Eagle's medium without L-glutamine or without L- 
glutamine and L-methionine, newborn calf serum, MEM non-essential amino 
acids (lOOx), trypsin solution [(10x; 2.5% (w/v)], NaHCO^ solution 
[(7.5% (w/v)] and Nunc tissue culture flasks and petri dishes were 
obtained from Gibco Europe Ltd., Renfrew Rd., Paisley, Renfrewshire, 
U.K.
Sterile glassware and filter-sterilised versene solution (8mM Na^
HPO , 1.5mM KH PC), pH 7.5, 0.137M NaCl, 2.7mM KC1, 0.5 mM EDTA,
4 2 4
0.0015% (w/v) phenol red) were supplied by the staff of the Wellcome 
Tissue Culture Unit associated with this department. Trypsin/versene 
solution consisted of a 10-fold dilution of lOx trypsin solution in 
versene solution.
2.1.6 PHOTOGRAPHIC MATERIALS
X-Omat S and XAR-5 X-ray films, Kodak FX-40 liquid fixer and 
Kodak LX-24 X-ray developer were purchased from Kodak Ltd., Dallimore 
R d., Manchester, U.K.
Cronex "Lightning-Plus" intensifying screens were purchased from
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Du Pont (U.K.) Ltd., Stevenage, Herts., U.K.
Plast-X cassettes, for exposure of X-ray films, were obtained 
from Anthony Monk (England) Ltd., Sutton-in-Ashfield, U.K.
2.1.7 BIOLOGICAL MATERIALS
PK-15 (pig kidney), NBL-1 (bovine kidney) and BRL (Buffalo rat 
liver) cell lines were purchased from Flow Laboratories Ltd., Second 
Avenue Industrial Estate, Irvine, Ayrshire, U.K.
New Zealand White rabbits were provided by the Departmental 
Animal House. Bovine hearts and kidneys were obtained from Glasgow 
Abattoir, Duke St., Glasgow, or from Paisley Abattoir, Sandyford Rd., 
Paisley, Renfrewshire, U.K. Organs were obtained within one hour of 
the animal's slaughter, transported to the laboratory on ice, and used 
within two hours of slaughter.
Normal rabbit serum was provided by the Scottish Antibody 
Production Unit, Law Hospital, Carluke, Lanarkshire, U.K.
Heat inactivated horse serum was purchased from Gibco Europe 
Ltd., Renfrew Rd., Paisley, Renfrewshire, U.K.
Pansorbin (standardised 10% (w/v) formalinised S. aureus cells) 
was obtained from Calbiochem-Behring Corp., Bishops Stortford, Herts., 
U.K.
2.1.8 MISCELLANEOUS
Freund's adjuvants (complete and incomplete) were from Difco 
Laboratories, Central Avenue, West Molesey, Surrey, U.K.
Nitrocellulose paper (0.45jjm pore size) was supplied by
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Schleicher and Schllll, via Anderman and Co. Ltd., Laboratory Supplies 
Division, Kingston-upon-Thames, Surrey,U.K.
Nalgene filter sterilisation units (0.20|jun pore size) were from 
Nalge Company, Rochester, New York, U.S.A.
2.2 METHODS
2.2.1 ASSAY OF BCOAD COMPLEX ACTIVITY
The initial rate of overall BCOAD complex activity was determined
o
by monitoring NADH formation at 340nm and 30 C, as described by Pettit 
et al. (1978). The assay mixture comprised 50mM potassium phosphate 
buffer, pH 8.0, 2.5mM NAD+ , 0.2mM TPP, ImM M g C l ^  0.13mM CoASH, 2.6mM 
cysteine-HCl, 2mM 2-oxoacid (sodium salt) supplemented with 10 units 
of lipoamide dehydrogenase (Sigma) per ml. The final pH was 7.4. The 
reaction was initiated by addition of enzyme sample to the assay 
mixture.
2.2.2 PROTEIN DETERMINATION
Protein was determined using a modification of the procedure of 
Lowry et al. (1951) as described by Markwell et al. (1978). Bovine 
serum albumin was used as a protein standard.
2.2.3 SDS/POLYACRYLAMIDE GEL ELECTROPHORESIS
a ) Preparation Of Analytical And Preparative Gels
Proteins were electrophoresed on SDS-containing polyacrylamide 
gels using the discontinuous Tris-glycine buffer system of Laemmli 
(1970).
For analytical purposes, gels were cast using home-made apparatus
in slabs of 19.0cm x 9.5cm x 0.15cm, or when greater resolution was
TM
required, using a BioRad Protean 16cm apparatus in slabs of 16.0cm x 
14.0cm x 0.15cm.
Preparative gels were cast using the home-made apparatus with a 
thickness of 0.3cm. The stacking gel was cast with a single well of 
16.0cm x 1.2cm x 0.3cm.
Resolving gels were polymerised from a solution containing 0.375M 
Tris-HCl, pH 8.8, 0.1% (w/v) SDS, 0.05% (w/v) ammonium persulphate, and 
acrylamide at a concentration of between 6% (w/v) and 15% (w/v). The 
ratio of acrylamide to N,N'-methylenebisacrylamide was 36.5:1. The 
solution was degassed before polymerisation was initiated by adding 
TEMED to 0.025% (v/v) final concentration. Stacking gels were 
polymerised from a solution containing 0.12M Tris-HCl, pH 6.8, 0.1% 
(w/v) SDS, 0.19% (w/v) ammonium persulphate, 0.03% (v/v) TEMED, 5.26% 
(w/v) acrylamide and 0.14% (w/v) N,N'-methylenebisacrylamide.
b ) Preparation Of Samples For Electrophoresis
Protein solutions were mixed with an equal volume of Laemmli 
sample buffer (0.0625M Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (w/v) 
sucrose, 0.001% (w/v) Pyronin Y) containing 5% (v/v) 2-mercaptoethanol 
or lOmM DTT and boiled for 5 min prior to electrophoresis. When 
protein samples were in pellet form, these were dissolved in an 
appropriate volume of Laemmli sample buffer and boiled as above.
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c  ^ Conditions Of Electrophoresis
Electrophoresis was performed in a water-cooled apparatus at a 
constant current of 40-60mA per gel until the Pyronin Y tracker was 
within 0.5cm of the bottom of the gel. The electrode buffer contained 
0.025M Tris-HCl, pH 8.3, 0.192M glycine, 0.1% (w/v) SDS.
d ) Staining And Scanning Of Gels
Gels were stained for protein in either 0.1% (v/v) Coomassie 
Brilliant Blue R250, 50% (v/v) methanol, 10% (v/v) acetic acid for lh 
or 0.04% (w/v) Coomassie Brilliant Blue R250, 25% (v/v) propan-2-ol, 
10% (v/v) acetic acid for 16-20h and destained in 20% (v/v) methanol,
10% (v/v) acetic acid.
Densitometric scanning of gels was performed using an LKB 2202 
Ultroscan laser densitometer.
2.2.4 RADIOLABELLING TECHNIQUES
14
a) Modification Of BCOAD Complex With N-ethyl [2,3- CJmaleimide
A portion (200jig) of purified BCOAD complex was diluted to 100|il
with 20mM Tris-HCl, pH 7.2 and precipitated overnight with 4 volumes
of acetone at -20°C. The precipitate was collected by centrifugation
at 14000xg for 2 min. The pellet was air dried, dissolved in 100|il
of 20mM Tris-HCl, pH 7.2, 2% (w/v) SDS and boiled for 5 min.
14
2uCi (0.2|imol) of N-ethyl [2,3- CJmaleimide was then added and 
the reaction was allowed to proceed for 18h at room temperature. The
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reaction was terminated by the addition of 2-mercaptoethanol to 5% 
(v/v) final concentration. Radiolabelled protein was precipitated and 
air dried as above, and redissolved in 100|j1 of Laemmli sample buffer 
(section 2.2.3b) containing 5% (v/v) 2-mercaptoethanol. After boiling 
for 5 min, a 3ul aliquot was counted for radioactivity (sectionT
o
2.2.5b) and the remainder was stored at -20 C until required.
b ) Iodination Of Protein A And Low Mr Markers
TM
Protein A and low M^ _ markers were iodinated using the Iodogen
method of Salacinski et al. (1981).
TM
lmg of Iodogen was dissolved in 0.5ml of chloroform and coated 
over the bottom of a glass vial by blowing off the solvent using an 
air stream. Protein A (lmg) or low M^ _ markers (578jig) dissolved in
TM
0.5ml of 20mM Tris-HCl, pH 7.2, 0.15M NaCl was added to the Iodogen -
coated vial. The reaction was initiated by adding 300-500|iCi of 
125
Na I. After 20 min at room temperature, the reaction mixture was
gel-filtered on a column of Sephadex G-25 (5.1cm x 1.5cm) equilibrated
125
in 20mM Tris-HCl, pH 7.2, 0.15M NaCl. Fractions containing I-
labelled protein A were pooled, divided into small aliquots, and 
o
stored at -20 C until required.
2.2.5 DETECTION OF RADIOACTIVITY
a) Measurement Of Gamma Radiation
125
Aqueous samples containing I-labelled proteins were counted in 
an LKB Wallac 1275 minigamma counter.
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b ) Liquid Scintillation Spectrometry
Aqueous radioactive samples were made up to 0.5ml with distilled 
water. After the addition of 4.5ml of scintillation fluid (0.5% (w/v) 
PPO in 35% (v/v) Triton X-100, 65% (v/v) toluene), the samples were 
counted in a Beckman LS 6800 liquid scintillation counter.
c) Fluorography
Polyacrylamide gels were processed for fluorography using the
method of Chamberlain (1979). After fixing for lh in 50% methanol,
10% (v/v) acetic acid or overnight in 25% (v/v) propan-2-ol, 10% (v/v)
acetic acid, the gel was washed over a period of 30 min in five
changes of distilled water. The gel was then soaked in 1M sodium
salicylate, pH 6.0, for 30 min before being dried down under vacuum
onto Whatman 3MM filter paper. The dried gel was exposed to XAR-5 or
o
X-Omat S X-ray film at -80 C in the presence of a Cronex Lightning- 
Plus" intensifying screen. Films were developed after exposure for a 
suitable number of days.
d ) Autoradiography 
125
I-labelled proteins bound to nitrocellulose paper were 
visualised by exposing the dried paper to X-Omat S X-ray film, as 
described above.
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2.2.6 CELL CULTURE
a ) Growth Media
Normal growth medium (NGM) for routine growth of PK-15 cells 
consisted of Glasgow-modified Eagle's medium supplemented with 5%
(v/v) newborn calf serum, 1% (v/v) non-essential amino acids and 0.2% 
(w/v) NaHCO^. NBL-1 and BRL cells were grown in the same medium, 
except that the concentration of newborn calf serum was 10% (v/v).
Minus methionine medium (MMM) consisted of Glasgow-modified 
Eagle's medium (without L-glutamine or L-methionine) supplemented with 
1% (v/v) non-essential amino acids, 2mM L-glutamine, and newborn calf 
serum at the appropriate concentration for each cell line, as 
described above. Low methionine medium (LMM) consisted of 5% (v/v) 
normal growth medium, 95% minus methionine medium.
b) Routine Maintenance Of Cells
2
Cells were routinely grown in NGM in 175cm plastic tissue 
culture (Roux) flasks at 37°C in an atmosphere of 95% air/5% CO^ and 
were subcultured when confluent monolayers were observed (generally 
every 3-5 days).
Cell monolayers were rinsed once with versene solution (section 
2.1.5), once with 5ml of trypsin/versene solution (section 2.1.5) then 
incubated with approx. 0.5ml of trypsin/versene solution until 
complete detachment of the cells from the flask surface was observed. 
10ml of NGM was then added to the flask and the cells were gently 
passaged up and down a sterile pipette until a suspension of single
cells was obtained. A sample of the cell suspension was counted using
6
a haemocytometer and 3-5 x 10 cells were returned to the flask in 
approx. 50ml NGM.
35
c ) M etabo lic Labelling Of Cells With [ S jMethionine
Sterile plastic petri dishes (10cm diam.) were seeded with 10ml
of NGM containing cells at a concentration of 3 x 10"* cells/ml. The
o
petri dishes were incubated at 37 C in an atmosphere of 95% (v/v) 
air/5% (v/v) CO^ for 24-48h until the monolayers were semi-confluent. 
The monolayers were rinsed once with 4ml of LMM, then incubated for
90 min at 37°C with a further 4ml of LMM. After addition of L-
35 o
[ S]methionine (100-200|jCi ) , dishes were incubated at 37 C for either
4h or overnight. After the appropriate labelling period, cell lysates
were prepared as described in section 2.2.7b.
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d) Metabolic Labelling Of Cells With [ SjMethionine In The Presence
Of Uncouplers Of Oxidative Phosphorylation
Cells were preincubated with LMM as above. 10 minutes prior to 
the addition of isotope, DNP or FCCP was added to the medium from lOOx 
ethanolic stock solutions to give final concentrations of l-2mM or 
lOpM, respectively. After labelling for 4h, cell lysates were prepared 
as described in section 2.2.7b.
For pulse-chase experiments, monolayers were labelled in the 
presence of uncouplers as above, rinsed once with 10ml of warm (37°C) 
NGM, then incubated at 37°C with a further 10ml of NGM with or without 
uncoupler, as required. After the appropriate chase periods, cell
lysates (section 2.2.7b) were prepared.
2.2.7 PREPARATION OF CELLULAR EXTRACTS AND SUBFRACTIONS
a) Iso lation Of M itochondria From Cultured Cells
The method of Attardi and Ching (1979) was used to obtain crude
mitochondrial and post-nuclear supernatant fractions from cultured
o
BRL, NBL-1, or PK-15 cells. All operations were performed at 4 C.
To prepare mitochondria, the cell monolayers from two 2.51 
capacity glass roller bottles were each rinsed twice with 20ml of PBS 
(20mM potassium phosphate, pH 7.4, 0.15M NaCl) and then scraped off 
into the same volume of PBS. The cells were pooled and pelleted by 
centrifugation at 1500xg for 15 min. The cells were then washed twice 
in 20ml of 0.13M NaCl, 5mM KCl, ImM MgCl^ before being resuspended in 
six volumes of lOmM Tris-HCl, pH 6.7, lOmM KCl, 0.15mM MgCl^. After 
two minutes on ice, the cells were homogenised with three passes of a 
Potter-Elvenhjem teflon/glass homogeniser. Cell breakage was confirmed 
by examining the homogenate under a light microscope. After addition 
of sucrose to 0.25M final concentration, the homogenate was 
centrifuged at llOOxg for 3 min to remove nuclei. Mitochondria were 
pelleted from the supernatant fluid by centrifugation at 5000xg for 
10 min. The pellet was suspended in 2ml of lOmM Tris-HCl, pH 6.7, 
0.15mM MgCl^, 0.25M sucrose. The last two steps were repeated before 
the final mitochondrial pellet was resuspended in 1ml of 0.0625M Tris- 
HCl, pH 6.8, 2% (w/v) SDS, 10% (w/v) sucrose and a small aliquot was 
taken for protein determination (section 2.2.2). The protein 
concentration of the remaining solution was adjusted to 4.0mg/ml and 
the composition of the buffer was adjusted to that of Laemmli sample
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buffer (section 2.2.3b) containing lOmM DTT.
b ) Isolation Of Post-Nuclear Supernatant Fractions
From Cultured Cells
2
The cell monolayer from a 175cm plastic Roux flask was rinsed 
twice with 10ml of PBS (section 2.2.7a) and then scraped off into 20 
ml of PBS. After pelleting the cells by centrifugation at 1500xg for 
5 min, they were lysed in 1ml of 0.1M Tris-HCl, pH 8.2, 0.1M KCl, 5mM 
MgCl^, 1% (v/v) Triton X-100 and nuclei were removed by centrifugation 
at llOOxg for 5 min. An aliquot of the resulting supernatant fraction 
was utilised for protein determination (section 2.2.2) and the 
remainder was precipitated overnight with 4 volumes of acetone at 
-20°C.
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c ) p a r a t i o n _ 0 f  S]Methionine-Labelled Cell Lysates
The following buffers were filter-sterilised using a nalgene filter 
(0.2jjm pore size):
PBS: 20mM potassium phosphate, pH 7.4, 0.15M NaCl.
Triton-TKM: 0.1M Tris-HCl, pH 8.2, 0.1M KCl, 5mM MgCl2 , 1% (v/v)
Triton X-100.
3D-Lysis: 0.1M Tris-HCl, pH 8.2, 0.1M KCl, 5mM MgCl2> 1% (v/v) Triton
X-100, 1% (w/v) SDS, 2% (w/v) DOC.
Each buffer was supplemented with ImM PMSF and ImM p-amino-
benzamidine-HCl immediately before use, and all operations were 
o
performed at 4 C.
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Cell monolayers were washed three times with approx. 4ml of PBS.
lml of Triton-TKM buffer per petri dish was added and the lysed cells
were scraped off using a rubber policeman. Nuclei were removed by
centrifugation at lOOOxg for 5 min. The resulting supernatant fraction
was then mixed with an equal volume of 3D-Lysis buffer and centrifuged
at 27000xg for 30 min. A 5jj1 aliquot of the final supernatant was
counted for radioactivity (section 2.2.5b) and the remainder was 
o
stored at -80 C until required,
d ) Preparation Of Bovine Heart Mitochondria
Mitochondria were isolated from bovine heart by the method of 
Smith (1967). All operations were performed at 4°C. 300g of heart 
tissue was freed of fat and connective tissue and cut into cubes of 
approx. 5cm. The cubes of tissue were passed through a mincer and the 
minced tissue was placed in 400ml of 0.01M Tris-HCl, pH 7.8, 0.25M 
sucrose (solution A). The pH of the solution was immediately adjusted 
to 7.5+0.1 by adding 2M Tris base. Excess solution A was removed by 
placing the minced tissue in a double layer of cheesecloth and 
squeezing. The sucrose-free material was suspended in 400ml of 0.01M 
Tris-HCl, pH 7.8, 0.25M sucrose, ImM Tris-succinate, 0.2mM EDTA 
(solution B). 3ml of 2M Tris base was added and the suspension was 
blended in a Philips food blender for 15s. After the addition of a 
further 3ml of 2M Tris base, the material was reblended for 5s. The 
blended material was adjusted to pH 7.8 using 2M Tris base, and then 
centrifuged at lOOOxg for 15 min to sediment debris. The resulting 
supernatant was centrifuged at 5000xg for 30 min to pellet 
mitochondria. The mitochondria were washed a further once or twice by
resuspending in a small volume of solution B and centrifuging at
5000xg for 15 min. Mitochondria were routinely stored in pellet form 
o
at -80 C until required.
For protease digestion experiments, mitochondria were kept at 4°C 
at a protein concentration of 4.0mg/ml and used within 24h of 
isolation.
e) Preparation Of Bovine Heart Submitochondrial Particles
Bovine heart mitochondria were thawed from -80°C and resuspended 
at a protein concentration of approx. lOmg/ml in 50mM sodium
o
phosphate, pH 7.5. All further manipulations were performed at 4 C.
The mitochondria were then pelleted by centrifugation at 5000xg for 
15 min. The resuspension/centrifugation step was repeated once and the 
resulting pellet was resuspended in phosphate buffer at approx. 
lOmg/ml protein concentration.
To generate submitochondrial particles, the mitochondrial 
suspension was subjected to three 15s bursts of sonication, at 15s 
intervals, using an MSE sonicator at amplitude setting 3 (high power). 
The sonicated material was centrifuged at lOOOOxg for 10 min to pellet 
unbroken mitochondria. The supernatant fraction was recentrifuged at 
lOOOOOxg for lh and the final pellet was resuspended in 50mM sodium 
phosphate, pH 7.5 at a protein concentration of 4.0mg/ml. 
Submitochondrial particles were stored in 1.1ml aliquots at -80°C 
until required.
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2.2.8 IMMUNOLOGICAL PROCEDURES
a ) Immune Blotting
The immune blotting procedure of Towbin et al. (1979) as modified
by Batteiger et al. (1982), was employed to allow immunological
detection of polypeptides after their electrophoretic transfer from
polyacrylamide gels to nitrocellulose paper.
Proteins were resolved by SDS/polyacrylamide gel electrophoresis
(section 2.2.3) and then transferred electrophoretically onto
nitrocellulose paper at 400mA for 3h or 40mA for 16-20h using a BioRad 
TM
Trans-Blot cell. The transfer buffer comprised 25mM Tris, pH 8.3,
192mM glycine, 0.02% (w/v) SDS, 20% (v/v) methanol, and was cooled to 
o
4 C before use.
After electrophoretic transfer, nitrocellulose-bound polypeptides 
were visualised by staining the paper in 0.1% (w/v) Amido Black, 45% 
(v/v) methanol, 10% (v/v) acetic acid for 5 min followed by destaining 
in 45% (v/v) methanol, 10% (v/v) acetic acid for 5 min. Excess binding 
sites on the paper were then blocked by incubation with 20mM Tris-HCl, 
pH 7.2, 0.15M NaCl, 0.5% (v/v) Tween 20, 0.005% (w/v) NaN^ (blocking 
buffer) for lh at room temperature or overnight at 4°C. The 
nitrocellulose was then incubated with blocking buffer supplemented 
with 5% (v/v) heat inactivated horse serum and antiserum at a dilution 
of 1:50-1:100 for 90 min at room temperature. Excess antibody was 
removed by washing with five changes of blocking buffer over a period
of 45 min, before incubation for 90 min at room temperature with
125 6
blocking buffer containing I-labelled protein A (approx. 3 x 10
125
c.p.m. per blot). Excess I-labelled protein A was removed by 
washing with blocking buffer as above. The processed blot was allowed
to dry at room temperature prior to analysis by autoradiography 
(section 2.2.5d).
35
b) Immunoprecipitation From [ S]Methionine-labelled Cell Lysates
35
Aliquots of [ S]methionine-labelled cell lysates (section 
2.2.7c) containing 10^ c.p.m. (100-600pl) were incubated with 10|jl of 
antiserum for 2h at room temperature. 20|jl of Pansorbin (equilibrated 
in 0.1M Tris-HCl, pH 8.2, 0.1M KCl, 1% (v/v) Triton X-100 , 0.5% (w/v) 
SDS, 1% (w/v) DOC, 5mM MgCl^, - "3D-TKM buffer") was added and the 
mixture incubated for a further lh at room temperature with occasional 
mixing. Pansorbin was then pelleted by centrifugation at 14000xg for 
2 min. Each pellet was resuspended in 1ml of 3D-TKM and recentrifuged 
as above. The wash in 3D-TKM was repeated twice, and the pellets were 
finally washed in 1ml of lOmM Tris-HCl, pH 7.4. The final pellets were 
resuspended in 50jil of Laemmli sample buffer (section 2.2.3b) 
containing lOmM DTT and boiled for 5 min. A 5jil sample of the super­
natant fraction obtained after boiling was counted for radioactivity 
(section 2.2.5b) and the remainder was analysed by SDS/polyacrylamide
gel electrophoresis (section 2.2.3) and fluorography (section 2.2.5c) 
o
or stored at -80 C.
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CHAPTER THREE
IMMUNOLOGICAL AND BIOSYNTHETIC STUDIES 
ON SUCCINATE DEHYDROGENASE
3.1 INTRODUCTION
A key tool in the majority of studies on mitochondrial biogenesis 
has been a high titre, monospecific antiserum to the mitochondrial 
protein of interest. To be of value, it is desirable that such an 
antiserum meets the following requirements; a) it should be capable of 
recognising the precursor form of the antigen to which it was raised, 
and b) it should exhibit cross-reactivity with equivalent antigens 
from sources different to that of the antigen. The antiserum is most 
commonly used to immunoprecipitate radiolabelled antigens which are 
subsequently analysed by SDS/polyacrylamide gel electrophoresis and 
fluorography.
When immunological detection of mitochondrial polypeptides is 
performed in vitro, using isolated mRNA to direct protein synthesis in a 
cell-free system, the primary translation product is the precursor form of 
the mitochondrial polypeptide. However, in v ivo studies are hindered by 
the fact that most precursors have a short half-life, so that they rarely 
accumulate outside the mitochondrion under normal conditions. As described 
in Chapter One (section 1.2.5), import of polypeptides which are 
inserted into or translocated across the mitochondrial inner membrane 
requires an electrochemical potential gradient across that membrane. 
Therefore, by employing uncouplers of oxidative phosphorylation to 
dissipate the transmembrane gradient we can effect accumulation of 
precursors, provided that these molecules are relatively stable in the 
cytosolic compartment of the cell. This approach was adopted to 
investigate the in vivo biosynthesis of succinate dehydrogenase.
This chapter describes a) the production of antiserum to native 
succinate dehydrogenase from bovine heart and its individual large and
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small subunits, b) demonstration of the cross-reactivity of these
antisera with the subunits of SDH in mammalian cell lines and c)
immunoprecipitation of the SDH subunits from BRL and PK-15 cells
35
metabolically labelled with [ S j m e t h i o n i n e s and the corresponding 
precursor forms from cells labelled in the presence of uncouplers of 
oxidative phosphorylation.
3.2 METHODS
3.2.1 PREPARATION OF ANTISERUM TO SDH AND ITS INDIVIDUAL LARGE 
AND SMALL SUBUNITS
Antiserum to native succinate dehydrogenase (anti-SDH serum) was
prepared as follows. Purified SDH (0.5mg) in 50mM sodium phosphate, pH
7.4 was made up to 0.6ml with 0.9% (w/v) NaCl and mixed with an equal
volume of Freund's complete adjuvant. The mixture was injected
subcutaneously at multiple sites on the neck and back of a New Zealand
White rabbit. 0.5mg portions of enzyme in Freund's incomplete adjuvant
were administered at 2-3 week intervals thereafter. Two weeks after
the fourth injection, blood was drawn from a marginal ear vein. After 
o
standing at 4 C overnight, the serum fraction was centrifuged at 
1500xg for 10 min, then stored in 1.0ml aliquots at -20°C until 
required. Before subsequent bleedings the rabbit was injected two 
weeks previously with 0.2-0.5mg of enzyme in Freund's incomplete 
adjuvant.
Subunit-specific antisera to the individual large and small 
subunits of succinate dehydrogenase (anti-L serum and anti-S serum, 
respectively) were prepared as follows. Portions of SDH (1.3mg) were 
made up to 1.0ml with Laemmli sample buffer (section 2.2.3b)
containing lOmM DTT and boiled for 5 min prior to resolution by 
preparative SDS/polyacrylamide gel electrophoresis (section 2.2.3).
The Coomassie blue-stained bands corresponding to the large and small 
subunits (Fig.3.1) were excised from the gel, soaked in three changes 
(5 min each) of distilled water, sliced into small pieces and ground 
to a powder with a small volume of liquid nitrogen using a mortar and 
pestle. The powder was weighed and stored frozen at -20°C.
Before injection, an amount of powder corresponding to half of 
one band was homogenised in 0.75ml of distilled water and mixed with 
an equal volume of Freund's complete adjuvant. The mixture was 
injected subcutaneously at multiple sites on the neck and back of the 
rabbit. This treatment was repeated at 2 week intervals thereafter, 
with the fourth injection being in Freund's incomplete adjuvant. Blood 
was collected two weeks after the fourth injection, and serum was 
obtained as described above. Similar amounts of antigen were 
administered in Freund's incomplete adjuvant two weeks before 
subsequent bleedings.
3.3 RESULTS
3.3.1 IMMUNE BLOT ANALYSIS OF PURIFIED SUCCINATE DEHYDROGENASE WITH 
ANTI-SDH SERUM AND SUBUNIT-SPECIFIC ANTI-L AND ANTI-S SERA
Fig.3.2A shows the Coomassie blue profile of different amounts 
of the purified succinate dehydrogenase preparation after electro­
phoresis on a 10% (w/v) SDS/polyacrylamide slab gel. In addition to
the major M 70000 and M 27000 bands (corresponding to the large and 
r r
small subunits of SDH, respectively), the preparation was found to
contain several minor contaminants with intermediate M values. By the
r
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Fig.3.1 Preparative SDS/Polyacrylamide Gel Electrophoresis
Of Bovine Heart Succinate Dehydrogenase
A sample of succinate dehydrogenase (1.3mg) was subjected to 
electrophoresis on a preparative 10% (w/v) SDS/polyacrylamide gel 
(section 2.2.3). After staining the gel with Coomassie blue, bands 
were excised and used for preparation of subunit-specific antisera 
(section 3.2).
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criterion of densitometric scanning the preparation was judged to be
90% pure. Fig.3.2 panels B-D show the results of immune blot analysis
of the purified SDH with anti-SDH serum (B) or subunit-specific anti-L
(C) or anti-S (D) serum, after detection of immune complexes with 
125
I-labelled protein A. In addition to reaction with their parent
antigens, anti-SDH and anti-L serum both exhibited cross-reaction with
all the minor bands in the preparation. Thus, the contaminant
polypeptides appear to be immunologically related to the M^ _ 70000
polypeptide, and are most likely proteolytic fragments of this
subunit. Fig.3.2D shows that, at higher loadings of SDH, anti-S serum
exhibits weak cross-reactivity with the M 70000 subunit and with an
r
M 50000 large subunit fragment. These observations are discussed more 
fully in the last section of this chapter (section 3.4).
3.3.2 IMMUNOLOGICAL DETECTION OF THE SUBUNITS OF SUCCINATE
DEHYDROGENASE IN SUBCELLULAR FRACTIONS FROM CULTURED CELLS
For a successful investigation of the in vivo biosynthesis of 
succinate dehydrogenase in mammalian cell lines, the antisera produced 
to native bovine heart SDH and its individual subunits would have to 
show cross-reactivity with the corresponding polypeptides in extracts 
of the cultured cells. To test whether this was the case, post-nuclear 
supernatant and mitochondrial fractions from BRL, NBL-1 and PK-15 cell 
lines were prepared (section 2.2.7) and samples of these fractions 
were electrophoresed on 10% (w/v) SDS/polyacrylamide slab gels 
(Fig.3.3). Panel A shows the Coomassie blue profile of these samples 
while panels B-D show the results of immune blot analysis performed 
with anti-SDH (B), anti-L (C) or anti-S (D) serum.
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F i g. 3.2 Immuneblot Analysis Of Purified Succinate Dehydrogenase With
Anti-SDH Serum And Subunit-Specific Anti-L And Anti-S Sera
Varying amounts of purified SDH were electrophoresed on a 10%
(w/v) SDS/polyacrylamide slab gel (section 2.2.3). One portion of the
gel (A) was stained with Coomassie blue. Polypeptides on replicate
portions were transferred electrophoretically onto nitrocellulose
paper for incubation with anti-SDH (B), anti-L (C) or anti-S (D) serum
(section 2.2.8a). Immune complexes were detected by autoradiography
125
(section 2.2.5.d) after incubation with I-labelled protein A. Lanes
2-5 (A) 25, 10, 5 or ljig of enzyme, respectively. Lanes 2-5 (B and D)
or 1-4 (C) 5, 2, 1 or 0.2|ag of enzyme, respectively. Lane 1, low
125
marker proteins (A) or I-labelled low marker proteins (B and D).
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Fig.3.3 Immunological Detection Of The Large (L) And Small (S)
Subunits Of Succinate Dehydrogenase In Cultured 
Cell Subfractions
Post-nuclear supernatant and mitochondrial fractions were
prepared from cultured BRL, PK-15 and NBL-1 cells (section 2.2.7).
Samples of the extracts were electrophoresed on 10% (w/v)
SDS/polyacrylamide slab gels. A portion of one gel (A) was stained
with Coomassie blue. Replicate portions of gel were processed for
detection of immunoreactive polypeptides using anti-SDH (B), anti-L
125
(C) or anti-S (D) serum. Lane 1, low markers (A) or I-labelled 
low markers (B-D); lane 2, 10|ig (A) or 0.5jjg (B-D) purified SDH; 
lane 3, BRL post-nuclear supernatant fraction (80pg); lane 4, BRL 
mitochondria (40pg); lane 5, PK-15 post-nuclear supernatant fraction
; lane 6, PK-15 mitochondria (40|jg); lane 7, NBL-1 post­
supernatant fraction ; lane 8, NBL-1 mitochondria
-nuclear
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These data show that each antiserum permits detection of the 
corresponding parent antigen(s) in mitochondrial or post-nuclear 
supernatant fractions from each cell line tested. Additional, weaker 
bands were observed with each antiserum, particularly with anti-S 
serum. The strength of the signals from the pig kidney and bovine 
kidney samples were comparable, in contrast to the relatively weaker 
signals obtained from the corresponding Buffalo rat liver samples. It 
was not determined whether differences in signal strength reflected 
differences in cross-reactivity or different levels of the subunits of 
SDH in the three cell lines.
It was also apparent from this analysis was that there was no 
striking difference in the electrophoretic mobility of either subunit 
of SDH in the rat (lanes 3 and 4) porcine (lanes 5 and 6) or bovine 
kidney (lanes 7 and 8) cell lines when compared with the bovine heart 
enzyme (lane 2).
3.3.3 IMMUNOPRECIPITATION OF NEWLY-SYNTHESISED AND PROCESSED
SUBUNITS OF SUCCINATE DEHYDROGENASE IN PULSE-LABELLED AND 
PULSE-CHASED BRL CELLS
35
Cultured BRL cells were incubated with [ S]methionine for 3h,
then a radiolabelled cell lysate was prepared as described in section
2.2.7c. After treatment of an aliquot of this extract with anti-SDH
35
serum (section 2.2.8b) and analysis of the recovered [ S]methionine- 
labelled polypeptides by SDS/polyacrylamide gel electrophoresis and 
fluorography, only two major bands, with M values of 70000 and 27000 
were observed (Fig.3.4, lane 3). When a second aliquot of extract was 
treated with non-immune serum, these two bands were absent from the
71
Fig.3.4 Immunoprecipitation Of Newly-Synthesised And Processed
Subunits Of Succinate Dehydrogenase From Pulse-Labelled And 
Pulse-Chased BRL Cells
35
BRL cells were pulsed for 3h with [ S]methionine (200jjCi/dish)
both in the presence and absence of uncoupler, or pulse-labelled in
the presence of uncoupler and then chased for 45 min after removal of
35
uncoupler. After preparation of [ SJmethionine-labelled cell extracts
(section 2.2.7c), indirect immunoprecipitation was performed using
non-immune or anti-SDH serum and formalinised S. aureus cells (section
2.2.8b). The resulting immunoprecipitates were resolved on a 10% (w/v)
SDS/ polyacrylamide gel, and visualised by fluorography (section 
125
2.2.5c). Lane 1, I-labelled low markers; lane 2, 3h pulse, non- 
immune serum; lanes 3-9, immunoprecipitates obtained with anti-SDH 
serum; lane 3, pulse, no uncoupler; lane 4, pulse + ImM DNP; lane 5, 
as 4, but with 45 min chase; lane 6, pulse + 2mM DNP; lane 7, as 6, 
but with 45 min chase; lane 8, pulse + IOjiM FCCP; lane 9, as 8, but 
with 45 min chase.
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resulting immunoprecipitate (lane 2), confirming their identification
as the large and small subunits of SDH. When a similar labelling
experiment was performed in the presence of 1 or 2mM DNP (lanes 4 and
6, respectively), newly-synthesised (precursor) forms of the large and
small subunits, exhibiting values approximately 1-2000 and 4-5000
greater than the corresponding mature forms, were immunoprecipitated.
An identical pattern was obtained when the cells were labelled in the
presence of IOjjM FCCP (lane 8).
To monitor processing of the precursors to the subunits of SDH,
35
BRL cells were labelled with [ S]methionine in the presence of 
uncouplers and then chased for 45 min in the absence of uncoupler.
Lanes 5, 7 and 9 show the products recovered from cells where the 
chase was preceded by a 3h pulse in the presence of ImM DNP, 2mM DNP 
and IOjjM FCCP, respectively. In each case, complete conversion of the 
precursor forms of both subunits to the corresponding mature forms was 
observed.
3.3.4 BIOSYNTHETIC STUDIES IN PK-15 CELLS
a) Immunoprecipitation Of Newly-Synthesised And Processed Subunits 
Of SDH In Pulse-Labelled And Pulse-Chased PK-15 Cells
Fig.3.5 demonstrates that higher precursor forms of the large and
small subunits of SDH could also be detected in PK-15 cells which had been
35
pulse-labelled with [ S]methionine in the presence of uncouplers. The
data shows a) the M values of the precursor forms of each subunit in this
r
cell line are similar, if not identical, to the corresponding precursors 
in BRL cells; b) complete conversion of the precursor forms to the
Fig.3.5 Immunoprecipitation Of Newly-Synthesised And Processed
Subunits Of Succinate Dehydrogenase In Pulse-Labelled And 
Pulse-Chased PK-15 Cells
35
PK-15 cells were pulse-labelled for 4h with [ Sjmethionine both
in the absence and presence of uncoupler, or pulse-labelled in the
presence of uncoupler and then chased for 45 min after uncoupler
removal. After preparation of radiolabelled cell lysates,
immunoprecipitation was performed using anti-L serum (A) and anti-S
serum (B). The resulting immunoprecipitates were analysed by
SDS/polyacrylamide electrophoresis on 6% (w/v) (A) or 10% (w/v) (B)
125
slab gels followed by fluorography. Panel A; lanes 1 and 8, I-
labelled low markers; lane 2, pulse (no uncoupler), non-immune
serum; lane 3, pulse, no uncoupler; lane 4, pulse + 2mM DNP; lane 5,
as 4, but with 45 min chase; lane 6, pulse + 10|iM FCCP; lane 7, as 6,
125
but with 45 min chase. Panel B; lanes 1 and 7, I-labelled low M
r
markers; lanes 2-6, as lanes 3-7 in A except with anti-S serum.
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corresponding mature forms occurs during a 45 min chase in the absence 
of uncoupler; c) pulse-labelling of PK-15 cells in the presence of 
IOjjM FCCP results in only partial accumulation of precursors; d) the 
quality of the immunoprecipitates obtained from PK-15 cells were 
superior to those obtained from BRL cells, since fewer contaminating 
polypeptides were found to co-precipitate with the bona fide antigens. 
The pig kidney cell line was therefore utilised in further experiments 
designed to investigate the stability and kinetics of processing of 
the SDH large subunit precursor.
b) Kinetics Of Processing Of The SDH Large Subunit Precursor After
Reversal Of Precursor Accumulation
Fig.3.6 shows the result of an experiment in which precursor 
accumulation in the presence of 2mM DNP was followed by chases of 
increasing duration in the absence of uncoupler. Lane 4 shows the 
precursor accumulated at the start of the chase after labelling for 4h 
in the presence of DNP; lanes 5-10 show the products recovered after 
2, 5, 7.5, 10, 15 and 30 min chases respectively, in the absence of 
uncoupler.
After removal of uncoupler from the cells, the onset of precursor 
processing is rapid. The immunoprecipitate obtained after a 2 min 
chase in the absence of DNP (lane 5) contains a small amount of M
r
70000 (mature) subunit. Although it proved difficult to achieve 
complete resolution of the precursor and mature forms, even on the 6% 
(w/v) gel used in this experiment, it was estimated that the half-life 
of the large subunit precursor is between 5 and 7.5 min. Longer chase
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Fig.3.6 Kinetics Of Processing Of The Large Subunit Of Succinate
Dehydrogenase After Reversal Of Precursor Accumulation
35
PK-15 cells were incubated with [ S]methionine in the absence or
presence of 2mM DNP, as before. After pulse-labelling in the presence
of DNP, a set of dishes was utilised to perforin chases of increasing
duration in the absence of uncoupler. After preparation of cell
lysates at the appropriate time points, immunoprecipitation was
performed using non-immune or anti-L serum. The resulting
immunoprecipitates were resolved by SDS/polyacrylamide electrophoresis
125
on a 6% (w/v) slab gel and visualised by fluorography. Lane 1, I- 
labelled low markers; lane 2, pulse (no uncoupler), non-immune 
serum; lane 3, pulse (no uncoupler), anti-L serum; lane 4, pulse + 2mM 
DNP, anti-L serum; lanes 5-10, as 4, but with 2 min, 5 min, 7.5 min,
10 min, 15 min and 30 min chase, respectively.
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periods (lanes 9 and 10) revealed that processing was complete after 
15 min.
c) Stability Of The Accumulated Precursor To The Large Subunit Of 
Succinate Dehydrogenase
To monitor stability of the large subunit precursor accumulated 
during the pulse-label, a chase was performed for different time 
periods in the presence of uncoupler (Fig.3.7). Lane 4 shows the 
precursor recovered after a 4h pulse with 2mM DNP, while lanes 5-7 
show the precursor recovered after a 4h pulse with uncoupler followed 
by a 1, 3 and 5h chase, respectively, also in the presence of 
uncoupler. Although the intensity of the precursor band decreases over 
this time period, a substantial proportion remains detectable even 
after a 5h chase. When the 5h chase in DNP-containing medium was 
followed by a 45 min chase in the absence of uncoupler, complete 
conversion of precursor to mature form was again observed (lane 8).
3.4 DISCUSSION
The data presented in Fig.3.1 establishes that the minor 
components present in the purified SDH preparation cross-react 
specifically with antiserum raised against the large subunit excised 
from an SDS/polyacrylamide gel. These species are most probably 
proteolytic fragments of the 70000 polypeptide generated during the 
isolation procedure. Similar immunologically-reactive fragments of the 
large subunit can be detected after limited proteolysis of sub-
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Fig.3.7 Stability Of The Accumulated Precursor To The Large Subunit
Of Succinate Dehydrogenase
35
PK-15 cells were pulsed for 4h with [ S]methionine in the
absence or presence of 2mM DNP and then chased in the presence of DNP
for the times indicated. In addition, cells which had been subjected
to a 5h chase in the presence of DNP were incubated for a further 45
min in medium minus uncoupler. Immunoprecipitates were obtained from
radiolabelled cell lysates and analysed as in Fig.3.6. Lanes 1 and 9, 
125
I-labelled low markers; lane 2, pulse (no uncoupler), non-immune 
serum; lane 3, pulse (no uncoupler), anti-L serum; lane 4, pulse + 2mM 
DNP; lanes 5-7, same as 4, but with lh, 3h, and 5h chases, 
respectively; lane 8, same as 7, but with additional 45 min chase 
minus uncoupler.
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mitochondrial particles in experiments designed to probe the
organisation of SDH within the lipid bilayer (see Chapter Four).
Antiserum was produced also to the small subunit of SDH isolated
in a similar manner. The weak cross-reactivity of anti-S serum with
the large subunit may reflect genuine immunological similarity between
the M 70000 and M 27000 subunits. This situation is not entirely 
r r
unlikely, since both polypeptides contain sequences which participate 
in the formation of iron-sulphur clusters in the holoenzyme. However, 
the possibility that the material used for production of small subunit 
antiserum contained a 27000 large subunit fragment cannot be 
excluded.
Several points have emerged from the immune blot analyses
presented in this chapter. Firstly, immune blotting can be used to
monitor potential loss of a polypeptide by proteolysis during its
isolation. Secondly, the ability to detect proteolytic fragments in
pure preparations offers an alternative criterion by which to assess
the homogeneity of a purified protein. Clearly, the purity of the
preparation used for immunisation in this case was greater than the
original estimate. Finally, the cross-reactivity exhibited by the
various antisera to SDH with the corresponding parent antigens from
other tissues and species illustrates a potential immunologically-
based method of identifying equivalent proteins in closely or even
distantly-related sources.
The energy-dependent nature of the import of cytoplasmically-
synthesised mitochondrial polypeptides was exploited to accumulate
newly-synthesised forms of the subunits of succinate dehydrogenase in
cultured mammalian cells. Fig.3.4 shows that when Buffalo rat liver
35
(BRL) cells are incubated with [ S]methionine and uncouplers of
oxidative phosphorylation, higher precursor forms of both subunits
can be immunoprecipitated. The precursors to the large and small
subunits exhibit values which are approximately 1-2000 and 4-5000
higher than the corresponding mature forms. The data for the precursor
to the large subunit is in agreement with the estimate published by
Ono and Tuboi (1986) during the latter stages of this study. These
workers detected a large subunit precursor either in vitro , using rat
liver mRNA to direct a cell-free translation system, or in vivo in
ascites hepatoma cells. The data concerning the biosynthesis of the
small subunit provides the first demonstration that the M 27000
r
polypeptide is also synthesised as a higher M^ _ precursor.
The existence of higher M^ _ precursor forms of the components of
SDH in PK-15 cells was also demonstrated (Fig.3.5). The M values of
r
the precursor forms in this cell line were comparable to the
corresponding precursors in BRL cells. An interesting observation in
the PK-15 cell line is that when cells are pulse-labelled with 
35
[ S]methionine in the presence of 10|jM FCCP, both precursor and 
mature forms of each subunit are detectable, indicating that 
translocation and processing are only partially inhibited in this 
case.
The reversible nature of uncoupler-induced precursor accumulation 
was demonstrated in experiments where complete conversion of precursor 
to mature form was observed after a 45 min chase in the absence of 
uncoupler. Chases of shorter duration revealed that onset of precursor 
processing after uncoupler removal is rapid, and that processing 
occurs with an estimated half-life of 5-7.5 min. Similar half-lives 
have been reported for other mammalian mitochondrial polypeptide 
precursors (Fenton et al., 1984; Mori et al., 1981; Raymond and Shore,
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1981).
A noteable feature of the pig kidney large subunit precursor is 
its stability when import into the mitochondrion is inhibited. An 
appreciable amount of this polypeptide persists for at least 5h after 
synthesis. Furthermore, the accumulated precursor remains in an 
import-competent form, since processing is still observed when PK-15 
cells are reintroduced to uncoupler-free medium after a 5h chase plus 
uncoupler. Similar long term stability has been reported for methyl- 
malonyl-CoA mutase (Fenton et al., 1984).
What is the basis for this long term stability? Although the 
possibility exists that DNP acts on the cells to inhibit general 
proteolysis, this explanation is not favoured for two reasons.
Firstly, pre-aspartate aminotransferase exhibits marked instability, 
being rapidly destroyed with a half-life of approximately 5 min when 
the accumulated precursor is chased in the presence of uncoupler 
(Jaussi et al., 1982). Secondly, in an experiment analogous to that 
shown in Fig.3.7, the precursors to the three component enzymes of the 
mitochondrial 2-oxoglutarate dehydrogenase complex were found to 
exhibit differing stabilities (Hunter, 1985). Thus, we propose that 
the observed long term stability is an inherent property of certain 
precursors, rather than a reflection of the experimental conditions 
employed.
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CHAPTER FOUR
TOPOGRAPHICAL STUDIES ON SUCCINATE DEHYDROGENASE
4.1 INTRODUCTION
Although succinate dehydrogenase activity has traditionally been 
regarded as an enzymatic marker for the mitochondrial inner membrane 
(Ernster and Kuylenstierna, 1970), several major lines of evidence 
suggest that SDH is not completely buried in the inner membrane, but 
rather displays an asymmetric distribution with respect to the lipid 
bilayer.
Firstly, submitochondrial particles (everted vesicles, matrix 
side outermost) catalyse antimycin-insensitive electron transfer 
between succinate dehydrogenase and the membrane-impermeant anion 
ferricyanide, whereas intact mitochondria (outer membrane removed) do 
not (Klingenberg and Buchholz, 1970). Secondly, Merli et al. (1979) 
have shown that antiserum raised to the SDH holoenzyme is a potent 
inhibitor of succinate dehydrogenase activity in submitochondrial 
particles, but not in intact mitochondria. Moreover, when submito­
chondrial particles or intact mitochondria are modified with the
35
membrane impermeant, protein-modifying reagent [ S]diazobenzene- 
sulphonate, the large subunit of SDH is labelled only when the 
modification is performed from the matrix side of the inner membrane. 
Thirdly, by using radiolabelled (arylazido)phospholipids containing a 
photoactive group in the fatty acid or head group region of the 
molecule, Girdlestone et al. (1981) were able to investigate the 
interaction of purified succinate dehydrogenase or complex II with 
lipids by incubating the enzyme with lipid vesicles containing either 
probe, and effecting covalent cross-linking of protein with the lipid 
analogues by UV irradiation. The results of these experimemts led 
Girdlestone and coworkers to propose that the small subunit of SDH is
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partially embedded in the lipid bilayer, whereas the large subunit is 
bound predominantly through electrostatic interactions with the 
membrane surface. Taken together, the above data strongly indicate 
that succinate dehydrogenase is located both functionally and 
physically on the matrix side of the mitochondrial inner membrane.
With the availability of high-quality antisera to the bovine 
heart SDH holoenzyme and its constituent large and small subunits, the 
opportunity existed to investigate further the topographical 
arrangement of this enzyme using an approach which had not been 
exploited in this context, i.e. protease treatment of the cytoplasmic 
or matrix face of the mitochondrial inner membrane followed by 
detection of protease-resistant, membrane-associated SDH fragments by 
immune blotting. This chapter describes the insights gained into the 
topography of succinate dehydrogenase using such an approach.
4.2 METHODS
4.2.1 PROTEASE TREATMENT OF FRESHLY-ISOLATED OR FREEZE-THAWED 
BOVINE HEART MITOCHONDRIA
Portions of a 4mg/ml solution of bovine heart mitochondria 
(prepared as described in section 2.2.7d) were incubated for 60 min at 
30°C with o(-chymotrypsin or trypsin at 4% (w/w) protease: 
mitochondrial protein ratio. A control incubation (no protease 
addition) was performed in parallel. Samples (lmg) were removed from 
each incubation at 0, 15, 30 and 60 min, and these were dissolved in 
an equal volume of hot (70°C) Laemmli sample buffer (section 2.2.3b) 
containing lOmM DTT. The dissolved samples were boiled for 5 min 
before analysis by SDS/polyacrylamide gel electrophoresis and immune
blotting using anti-SDH serum.
An identical protocol was followed for protease treatment of 
mitochondria which had been frozen at -80°C and subsequently thawed.
A.2.2 PROTEASE TREATMENT OF BOVINE HEART SUBMITOCHONDRIAL PARTICLES
Bovine heart submitochondrial particles, prepared as described in
section 2.2.7e, were subjected to incubation with single or multiple
additions of a range of proteases, including o(-chymotrypsin, trypsin,
o o
papain and protease K. Incubations were performed at 30 C or 37 C, for 
periods of up to 90 min. The specific conditions used in each 
experiment are detailed in the appropriate figure legend and in 
section A.3.
In some cases, proteolysis was terminated by mixing samples with 
0.33 volumes of 2x Laemmli sample buffer (section 2.2.3b) containing 
20mM DTT and 0.8mg/ml leupeptin (for inactivation of papain) or 2mM 
PMSF (for inactivation of O^-chymotrypsin, trypsin or protease K ) .
After 5 min at room temperature the samples were boiled for 5 min 
before analysis by SDS/polyacrylamide gel electrophoresis and immune 
blotting. Alternatively, aliquots of protease-treated submitochondrial 
particles were diluted with 3 volumes of ice-cold 50mM sodium 
phosphate, pH 7.5, 0.15M NaCl, containing 0.8mg/ml leupeptin or 2mM 
PMSF. Subsequent manipulations were performed at A°C. The samples were 
centrifuged at 27000xg for 20 min then the pelleted membrane fractions 
were resuspended in 0.5ml of buffer containing protease inhibitor and 
recentrifuged as above. The wash procedure was performed once more 
with buffer, once with distilled water, and the resulting pellets were 
dissolved in Laemmli sample buffer (section 2.2.3) containing lOmM DTT
80
by boiling for 5 min.
Where double digestion experiments using papain and -chymo- 
trypsin were performed, the first digestion was terminated before^ 
addition of the second protease to the sample. Papain was inactivated 
by adding a 5-fold excess (by weight) of leupeptin from a lmg/ml 
aqueous solution. oC-chymotrypsin was inhibited by adding PMSF from a 
200mM solution in propan-2-ol to a final concentration of 2mM. After 
addition of protease inhibitors, samples were incubated for 5 min at 
room temperature before further manipulations.
4.3 RESULTS
4.3.1 PROTEASE TREATMENT OF FRESHLY ISOLATED AND FREEZE-THAWED 
BOVINE HEART MITOCHONDRIA
It is well recognised that in preparations of freshly-isolated 
bovine heart mitochondria, the cytoplasmic surface of the inner 
membrane is exposed to labelling agents such as lactoperoxidase, 
suggesting that the outer membrane has been removed by the isolation 
procedure (Boxer, 1975). Therefore, by applying the protease 
treatment/immune blotting procedure described above to fresh 
mitochondria, it was possible to investigate the existence of exposed 
regions of the subunits of SDH on the cytoplasmic surface of the inner 
membrane.
Fig.4.1A shows the results of incubation of freshly-isolated
o
bovine heart mitochondria at 30 C for up to 60 min in the absence of 
protease (lanes 2-5), and after addition of 4% (w/w) o(-chymotrypsin 
(lanes 6-9) or trypsin (lanes 10-13), as analysed by immune blotting 
using anti-SDH serum. Inspection of this figure reveals that in the
Fig.4.1 Immune Blot Analysis Of The Effect Of Proteases On SDH
In Bovine Heart M itochondria
Portions of freshly isolated (A) or freeze-thawed (B) bovine heart
mitochondria were incubated for 60min at 30°C with c^-chymotrypsin or
trypsin (4% (w/w) proteasermitochondrial protein), or with no protease
addition (control incubation). Samples were removed from each
incubation at the indicated times, proteolysis was terminated, and the
samples were subjected to electrophoresis on 10% (w/v) SDS/poly-
acrylamide slab gels. Resolved polypeptides were then electrophoresed
onto nitrocellulose paper for detection of immunoreactive species
125
using anti-SDH serum. Panels A and B; lanes 1 and 14, I-labelled 
low M^ _ markers; lanes 2-5, control samples; lanes 6-9, digestion with 
o(-chymotrypsin; lanes 10-13, digestion with trypsin. 40|jg of protein 
was loaded in lanes 2-13 inclusive.
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control incubation, neither the large nor small subunit of SDH is 
susceptible to degradation, indicating that the enzyme is stable under 
the conditions employed. Inclusion of either o(-chymotrypsin or trypsin 
during the incubation had no effect on the intensity of the bands 
corresponding to the large and small subunits of SDH. This observation 
suggested that neither subunit is exposed on the cytoplasmic face of 
the inner membrane.
To eliminate the possibility that SDH in its membrane environment
is inherently resistant to proteolysis under the conditions described
above, the experiment was repeated using mitochondria which had been 
o
frozen at -80 C and then thawed, since freeze-thawing is known to 
result in fracturing of the inner membrane (Pettit et al., 1978).
Fig.4.IB (lanes 6-9) illustrates that when freeze-thawed mitochondria 
are incubated with c?(-chymotrypsin for 60 min at 30°C, degradation can 
indeed be observed. Diminution of the band corresponding to the 
large subunit was paralleled by the appearance of an immunoreactive 
species of approx. 32000, i.e. a large subunit proteolytic 
fragment. In contrast, there was little discernible decrease in the 
intensity of the band corresponding to the small subunit. When freeze- 
thawed mitochondria were similarly incubated with trypsin (lanes 10- 
13), degradation of both subunits of SDH was observed, with the 
concomitant appearance of immunoreactive species with M values of 
approx. 34000, 32000 and 24000, respectively. Although the two larger 
species can be identified as large subunit fragments, the 24000-M^ 
species may have been derived from either subunit. However, on the 
basis of the above observations, protease digestion experiments were 
subsequently performed using submitochondrial particles.
4.3.2 PROTEASE TREATMENT OF BOVINE HEART SUBMITOCHONDRIAL PARTICLES
Bovine heart submitochondrial particles (SMPs), generated by 
sonication of intact mitochondria, are predominantly vesicles of inner 
membrane with an inverted orientation (Godinot and Gautheron, 1979). 
Hence, the exposure of SDH on the matrix side of the mitochondrial 
inner membrane was investigated by immune blot analysis of protease- 
treated SMPs.
o
Submitochondrial particles were incubated at 30 C in the absence 
of protease, and with 4% (w/w) o(-chymotrypsin or trypsin for up to 
60 min. Fig.4.2 illustrates the immune blot patterns obtained when 
control or protease-treated particles were probed with subunit- 
specific anti-L serum (panel A) or anti-S serum (panel B). The data 
indicates that in the absence of protease both subunits of SDH were 
stable during the incubation (lanes 2-5), whereas in the presence of 
Q(-chymotrypsin (panel A, lanes 6-9) or trypsin (lanes 10-13) the large 
subunit was degraded with the parallel appearance of a fragment of M^ _ 
approx. 32000. The tryptic digests contained in addition a fragment of 
M^ approx. 24000, which was subsequently shown to be soluble rather 
than membrane-associated (see Fig.4.3).
The immune blot obtained using anti-S serum reveals that 
treatment with 0(-chymotrypsin resulted in a slight diminution in the 
intensity of the band corresponding to the small subunit, although a 
chymotryptic small subunit fragment was not detectable (panel B, lanes 
6-9). Incubation with trypsin resulted in degradation of the small 
subunit (lanes 10-13), with the parallel appearance of a 24000-M^ 
immunoreactive species. Although anti-S serum exhibits weak cross­
reactivity with the large subunit (section 3.3.1 and this figure),
Fig.A.2 The Effect Of Proteases On The Subun its Of SDH In Bovine Heart 
Submitochondrial Particles
Bovine heart submitochondrial particles were incubated for 60 min 
o
at 30 C in the absence of protease, or after addition of
o(-chymotrypsin or trypsin (4% (w/w) protease:particle protein ratio).
In each case, samples were removed at 0, 15, 30, and 60 min, mixed with
0.33 volumes of 2x Laemmli sample buffer (section 2.2.3b) containing
lOmM DTT, then boiled for 5 min. The samples were subjected to
electrophoresis on 10% (w/v) SDS/polyacrylamide slab gels followed by
immune blotting using subunit-specific anti-L (A) or anti-S (B) sera.
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Panels A and B; lanes 1 and 14, I-labelled low M markers: lanes 2-
r
5, control samples; lanes 6-9, digestion with o(-chymotrypsin; lanes 
10-13, digestion with trypsin. 40pg of protein was loaded in lanes 2- 
13 inclusive.
A.
x 10 -3
Control a-CHYMO Trypsin
nr n r
0 15 30 60 0 15 30 60 0 15 30 60 Time (min )
—  L
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4
B.
Control a-CHYMO Trypsin
0 15 30 60 0 15 30 60 0 15 30 60 Time (min )xr
— S30 —
1 2 3 H 5 6 7 8 9 10 11 12 13 14
this 24000-M tryptic fragment is most probably derived from the small 
subunit, since even the levels of intact large subunit in the trypsin- 
treated samples are undetectable using anti-S serum.
To test whether the proteolytic fragments observed in Fig.4.2 
were membrane-associated, protease-treated SMPs were washed with 
buffer containing 0.15M NaCl before immune blot analysis. Fig.4.3 
illustrates the patterns obtained when SMPs which had been incubated 
at 30°C for up to 90 min with 4% (w/w) o(-chymotrypsin (lanes 4-7), 
trypsin (lanes 8-11) or papain (lanes 12-15) were salt-washed and 
analysed by immune blotting using anti-L (panel A) or anti-S (panel B) 
serum. The blot in panel A reveals that the previously observed 
chymotryptic and tryptic fragments (M^ approx. 32000) remained 
membrane-associated after the salt wash treatment. Incubation with 
papain generated two membrane-associated fragments; one exhibited an 
identical electrophoretic mobility to the 32000-M^ tryptic fragment, 
while the second had an M^ value of 27000. The latter fragment was not 
recognised by anti-S serum.
The previously observed 24000-M^ tryptic fragment (Fig.4.3B, 
lanes 10-13) was not detectable after the protease-treated membranes 
were salt washed (lanes 8-11). This observation suggested that this 
species was not a bona fide membrane-associated fragment. The small 
subunit was also susceptible to degradation by papain, although as 
with trypsin, no proteolytic fragment was readily detectable.
It was also found that treatment of SMPs with 4% (w/w) protease K
o
at 30 C for 30 min generated two large subunit fragments, with M^ _ 
values of approx. 32000 and 27000, similar to the doublet obtained by 
papain digestion. This was paralleled by virtually complete cleavage 
of the intact large subunit (Fig.4.4). Both protease K large subunit
F i g. 4.3 Immune Blot Analysis Of Salt-Washed, Protease-Treated
Submitochondrial Particles Using Anti-L And Anti-S Sera
Bovine heart submitochondrial particles were incubated at 30°C in
the absence of protease, or after addition of ck -chymotrypsin, trypsin
or papain (4% (w/w) protease:particle protein). In each case, samples
(lmg particle protein) were removed at 0, 30, 60 and 90 min, and mixed
with 3 volumes of ice-cold 50mM sodium phosphate, pH 7.5, 0.15M NaCl
containing 2mM PMSF or 0.8jig/jal leupeptin. The samples were then
processed as described in section 4.2.2, resolved by electrophoresis
on 15% (w/v) SDS/polyacrylamide slab gels (section 2.2.3), and
analysed by immune blotting (section 2.2.8a) using subunit-specific
anti-L (A) or anti-S (B) serum. Panels A and B; lanes 2 and 3, control
samples; lanes 4-7, digestion with o(-chymotrypsin; lanes 8-11,
digestion with trypsin; lanes 12-15, digestion with papain. Lanes 1 (A
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and B) and 16 (B) contain I-labelled low M markers.
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Fig.4.A Immune Blot Analysis Of Protease K-Treated Submitochondrial
Particles Using Anti-L Serum
Bovine heart submitochondrial particles were incubated for 30 min
at 30°C in the absence of protease or after addition of protease K (4%
(w/w) protease:particle protein). Samples (lOOpg particle protein)
were removed at 5, 10, 20 and 30 min, mixed with 0.33 volumes of 2x
Laemmli sample buffer containing lOmM DTT and 2mM PMSF, and boiled for
5 min. The samples were then subjected to electrophoresis on a 10%
(w/v) SDS/polyacrylamide slab gel followed by immune blot analysis
125
using anti-L serum. Lane 1, I-labelled low markers; lanes 2 and 
3, control samples (0 and 30 min); lanes 4-7, digestion with 
protease K.
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fragments were subsequently found to remain membrane-associated after 
salt washing (data not shown).
The existence of two membrane-associated large subunit fragments 
is consistent with two alternative models for the arrangement of the 
SDH large subunit in the mitochondrial inner membrane. These 
alternatives are depicted in Fig.4.5. In one case (model A), the large 
subunit is associated with the lipid bilayer via a single domain. 
Proteolytic cleavage by o(-chymotrypsin, trypsin* papain or protease K 
generates a membrane-associated 32000-M^ fragment. In addition, 
cleavage with papain or protease K generates in some cases a 27000-M^ 
membrane-associated fragment which is derived from the above 32000-M^ 
species by removal of an additional 5000-M^ peptide.
Thus, model A predicts that, if SMPs are treated with o(-chymo- 
trypsin to completely cleave the intact large subunit and generate the 
32000-M^ large subunit fragment, subsequent incubation with papain 
or protease K (after inactivation of o(-chymotrypsin) will result in 
appearance of the 27000-M^ large subunit fragment. Conversely, if the 
order of protease addition is reversed, the 27000-M^ papain (or 
protease K) fragment will remain after incubation with -chymotrypsin.
The alternative model (B in Fig.4.5) proposes that the large
subunit polypeptide is associated with the bilayer via two distinct
regions; a 32000-M^ region which is generated by cleavage with (?<*-
chymotrypsin, trypsin, papain or protease K, and a second region, of
undetermined size, which is detected as a 27000-M membrane-associated
r
papain or protease K fragment, but is not detectable in o(-chymo- 
trypsin- or trypsin-treated SMPs. In this case, the model predicts 
that when ^ (-chymotrypsin treatment is followed by treatment with 
papain (or protease K ) , there will be no change observed in the immune
F i g. 4.5 Alternative Models For The Arrangement Of The Large Subunit
Of SDH In The Mitochondrial Inner Membrane
Schematic representation, based on protease digestion/immune
blotting data. The arrows (— indicate sites of proteolytic
cleavage. The numerical values refer to the sizes of the different
-3
proteolytic fragments, given as M^ x 10 . In model A, one region of
the large subunit is membrane-associated; in B, the polypeptide has 
an additional membrane-associated domain, of unknown size. o(-CHYM0; 
p(-chymotrypsin.
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blot pattern, i.e. the 32000-M^ chymotryptic fragment will be
present before and after papain treatment. Also, if the order of
protease addition is reversed, the 27000-M fragment generated by
r
papain (or protease K) would disappear since it will be degraded 
further by o(-chymotrypsin to an undetectable species.
Fig.4.6 illustrates the pattern of large subunit fragments 
obtained when submitochondrial particles were treated successively 
with papain and o(-chymotrypsin, in both possible orders of protease 
addition. Incubation at 37°C for 30 min with 4% (w/w) papain resulted 
in complete disappearance of the intact large subunit, and, as 
expected, appearance of 32000-M^ and 27000-M^ large subunit fragments 
(lane 3). These two fragments remained detectable in papain-treated 
vesicles which had been subjected to a further 20 min incubation after 
the addition of leupeptin (lane 4).
When digestion with papain was followed by incubation with 4%
(w/w) 0(-chymotrypsin for 10 min (lane 5), or for a further 10 min
after addition of a second identical aliquot of o(-chymotrypsin (lane
6), the ratio of 32000-M fragment : 27000-M fragment was increased.
r r
This result, which was confirmed by densitometric scanning of the 
autoradiograph shown in Fig.4.6, indicated that o(-chymotrypsin caused 
preferential degradation of the 27000-M^_ polypeptide in papain-treated 
submitochondrial particles.
Incubation with 4% (w/w) o(-chymotrypsin at 37°C for 10 min 
resulted in partial degradation of the large subunit, with the 
concomitant appearance of a 32000-M^ species (lane 7). When the 
vesicles were subjected to one or two further identical additions of 
o(-chymotrypsin and one or two subsequent 10 min incubations (lanes 8 
and 9 respectively), there was little if any decrease in the ratio of
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Fig.4.6 Effects_Of_Double_Digestions_Using_Papain_And_-Chymotrypsin
On The SDH Large Subunit In Submitochondrial Particles
of protease, or after addition of papain and o(-chymotrypsin, as 
detailed below. Where double digestions were performed, the first 
protease was inactivated (see section 4.2.2) before addition of the 
second. At the end of the appropriate incubation, each sample was 
mixed with 3 volumes of ice-cold 50mM sodium phosphate, pH 7.5, 0.15M
processed as in section 4.2.2, resolved by electrophoresis on a 10% (w/v) 
SDS/polyacrylamide slab gel (section 2.2.3), and analysed by immune 
blotting (section 2.2.8a) using anti-L serum. Lanes 1 and 2, control 
samples (0 and 60 min); lane 3, digestion with 4% (w/w) papain for 30 
min; lane 4, as 3, but sample incubated for additional 20 min after 
papain inactivation; lane 5, as 3, but with additional 10 min 
incubation with 4% (w/w) o^-chymotrypsin; lane 6, as 5, but with 
subsequent 10 min incubation after a second addition of 4% (w/w) oC“ 
chymotrypsin ; lane 7, digestion with 4% (w/w) o(-chymotrypsin for 10 
min; lane 8, as 7, but with subsequent 10 min incubation after a 
second addition of 4% (w/w)o(-chymotrypsin; lane 9, as 8, but with 
subsequent 10 min incubation after a third addition of 4% (w/w)o^- 
chymotrypsin; lane 10, as 9, but sample incubated for a further 15 min 
after inactivation of ©(-chymotrypsin; lane 11, as 9, with additional 
15 min incubation after adding 4% (w/w) papain.
Submitochondrial particles were incubated at 37°C in the absence
NaCl containing 2mM PMSF then
L1 2 3 4 5 6 7 8 9 10 11
70000-M : 32000-M polypeptides. When vesicles which had been
r r
incubated identically to those shown in lane 9 were subjected to a
further 15 min incubation with 4% (w/w) papain, further degradation of
the large subunit was observed, coupled with the appearance of a
27000-M species (lane 11). In a control incubation, in which o(- 
r
chymotrypsin-treated vesicles were incubated for a further 15 min 
after the addition of PMSF, there was no degradation of the 32000-M^ 
fragment to the 27000-M^ species (lane 10), although the amount of 
protein in the final pellet was reduced relative to the sample in 
lane 9.
4.4 DISCUSSION
In this chapter, the topographical arrangement of succinate 
dehydrogenase within the mitochondrial inner membrame was investigated 
using an approach which combined protease treatment of either face of 
this lipid bilayer with subsequent detection of the resulting 
proteolytic fragments by immune blot analysis. Bovine heart 
mitochondria were used for these experiments, since antisera had been 
raised to the bovine heart enzyme, and also because the commonly used 
method of isolating these mitochondria (Smith, 1967) renders the 
cytoplasmic face of the inner membrane accessible to exogenously-added 
enzymes (Boxer, 1975).
When freshly-isolated mitochondria were treated with o(-chymo- 
trypsin or trypsin and then analysed by SDS/polyacrylamide gel 
electrophoresis and immune blotting, both subunits of succinate 
dehydrogenase were found to be resistant to proteolytic degradation. 
Although a means of detecting degradation of the outer face of the
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inner membrane (e.g. an antiserum directed against a polypeptide which 
protrudes into the intermembrane space) was not available, a 
Coomassie blue-stained gel of the protease-treated samples revealed 
that limited proteolysis of many polypeptides had occurred. Moreover, 
when freeze-thawed mitochondria were subjected to protease treatment 
in an identical manner, degradation of both subunits of SDH was 
observed. These data are consistent with neither subunit being exposed 
at the cytoplasmic surface of the mitochondrial inner membrane.
Inverted inner membrane vesicles (submitochondrial particles), 
generated by sonicating isolated bovine heart mitochondria, were used 
to investigate the accessibility of succinate dehydrogenase to 
proteases added from the matrix side of the inner membrane.
Samples of protease-treated submitochondrial particles were 
processed in one of two ways. Using the simpler procedure, 
proteolysis was terminated by mixing samples with concentrated Laemmli 
sample buffer containing protease inhibitors and incubating at room 
temperature for 5 min prior to boiling. This method of sample 
treatment was advantageous since it was rapid, and allowed equal 
amounts of starting material from each sample to be loaded on an 
SDS/polyacrylamide gel; however, a major drawback was that membrane- 
associated SDH fragments could not be distinguished from soluble 
peptides, since in this case the material analysed contained the 
complete range of digestion products.
Alternatively, protease-treated samples were subjected to three 
washes with buffer containing protease inhibitor and 0.15M NaCl, and a 
final wash with distilled water before the final membrane pellets 
were dissolved in Laemmli sample buffer. This procedure permitted 
removal of loosely-associated soluble peptides from the protease-
treated vesicles, but loss of membrane during the repeated 
centrifugations was a factor which had to be taken into account.
Proteolytic degradation of succinate dehydrogenase in
submitochondrial particles was monitored using subunit-specific 
antisera. A common effect of a range of proteases, including (X“ 
chymotrypsin, trypsin, papain, protease K (this study) and pronase and 
elastase (A. Phelps, personal communication) was the appearance of a 
large subunit fragment of approx. 32000. In each case, this species 
was shown to be tightly bound to the inner membrane, since it was not 
removed by the salt wash procedure described above, and was stable
while membrane integrity was preserved.
The generation of such a large subunit fragment, even by low- 
specificity proteases, is evidence of a membrane-associated 32000-M^ 
large subunit domain. This domain may be joined to the remainder of 
the large subunit by a protease-sensitive 'hinge' region.
The reproducible appearance of an additional membrane-associated
27000-M^ large subunit fragment in samples of papain- and protease K-
treated vesicles can be rationalised in one of two ways (Fig.4.5). The
smaller fragment may be derived from the larger by removal of an
additional 5000-M peptide from the 32000-M membrane-associated 
r r
domain (model A in figure). Alternatively, it may represent a separate 
membrane-associated region (model B). In the latter case, digestion 
with proteases such as o(-chymotrypsin generates a second large subunit 
fragment which evades detection by immune blot analysis. Lack of 
detection of such a species can be explained by a) lack of reactivity 
towards anti-L serum; b) migration near or at the dye front during 
SDS/polyacrylamide gel electrophoresis and c) the 32000-M^ species 
seen in immune blots representing two different proteolytic fragments
of identical size.
The above models enable predictions to be made concerning the 
effect on the fragment pattern generated by one protease of subsequent 
digestion with a second protease. Accordingly, submitochondrial 
particles were treated either with papain then 0(-chymotrypsin or with 
o( -chymotrypsin followed by papain. When papain—treated vesicles, 
devoid of intact large subunit, were incubated subsequently witho(- 
chymotrypsin specific and preferential degradation of the 27000-M 
papain fragment was observed. This result argues for an arrangement of 
the type shown in Fig.4.5B, where the second chymotryptic fragment is 
smaller than both papain fragments.
When the proteases were added in reverse order, (X-chymotrypsin 
generated the expected 32000-M^ fragment, but failed in this case to 
effect complete cleavage of the large subunit. Subsequent addition of 
papain caused more complete degradation of the large subunit, and 
appearance of a 27000-M^ fragment. However, since in this instance the 
27000-M^_ fragment may be derived from intact large subunit or the 
32000-M^_ chymotryptic fragment, the observed effect is not 
inconsistent with a double domain structure as proposed above.
Additional, indirect evidence exists concerning the nature of the 
27000-M^_ large subunit fragment. If this species arose through further 
proteolysis of the 32000-M fragment, a precursor-product relationship 
should exist between these two polypeptides. Such an effect was not 
observed during prolonged incubation of papain- or protease K-treated 
vesicles after generation of the pair of fragments. This finding also 
suggests that the 27000-M^ species is derived from a separate region 
of the intact large subunit.
Although the small subunit of succinate dehydrogenase was shown
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to be susceptible to the action of several different proteases added 
from the matrix side of the inner membrane, no direct evidence of 
protease-resistant, membrane-associated regions of this molecule was 
obtained. However, a putative small subunit fragment corresponding to 
most of the intact polypeptide (M^ approx. 24000) was observed in 
trypsin-treated submitochondrial particles, but only in the absence 
of salt washing. This finding is consistent with an arrangement where 
the bulk of the small subunit protrudes from the inner membrane, and 
only a small portion of the polypeptide extends into the interior of 
the bilayer. In addition, the rate of small subunit degradation was 
generally observed to be slower than that of the large subunit. This 
may reflect protection of the small subunit by the 70000 
polypeptide.
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CHAPTER FIVE
PURIFICATION OF 
BRANCHED CHAIN 2-OXOACID DEHYDROGENASE COMPLEX 
FROM BOVINE KIDNEY AND 
CHARACTERISATION OF ANTISERA RAISED AGAINST THIS ENZYME
5.1 INTRODUCTION
As described in section 3.1, a requirement for the investigation 
of mitochondrial polypeptide biosynthesis is a high-quality antiserum 
to the component(s) of interest. Therefore, an early objective of this 
project was to obtain highly purified BCOAD complex which could be 
used for production of antisera to the complex.
It was decided to isolate the BCOAD complex from bovine kidney 
for two main reasons. Firstly, a bovine kidney (NBL-1) cell line was 
available which could be used for in vivo biosynthetic studies on the 
BCOAD complex, and which had already been successfully employed for 
similar studies on other mitochondrial polypeptides. Secondly, a new 
procedure (Lawson et a l ., 1983) had recently been published for the 
isolation of milligram quantities of high-purity enzyme from this 
tissue. This procedure had the advantage of being relatively rapid, 
since it dispensed with the need for prior stock-piling of 
mitochondria, a feature of an earlier purification procedure (Pettit 
et a l ., 1978).
The BCOAD complex isolated from bovine kidney was used for 
production of antiserum to the native complex. The E2 component of the 
BCOAD complex was purified by preparative SDS/polyacrylamide gel 
electrophoresis and used for immunisation purposes. This method of 
isolating E2 was advantageous since it circumvented the need to employ 
more cumbersome separation procedures, and afforded the opportunity to 
raise antibodies to the SDS-denatured E2 component. The latter point 
was of relevance since a previous case had been encountered where 
antibodies to the native 2-oxoglutarate dehydrogenase E2 subunit 
cross-reacted only weakly with pre-E2 when compared with antibodies
raised to denatured E2 (Hunter and Lindsay, 1986).
Latterly, it proved possible to obtain samples of purified BCOAD 
complex and the isolated El subcomplex from Dr. S.J. Yeaman (Dept, of 
Biochemistry, University of Newcastle upon Tyne). Antiserum was 
therefore also raised to the native El subcomplex of bovine kidney 
BCOAD.
This chapter deals with the purification of the BCOAD complex 
from bovine kidney and the production of antibodies to the native 
BCOAD complex (anti-BCOAD serum), the native El subcomplex (anti-El 
serum) and the denatured E2 subunit (anti-E2 serum). The character­
isation of these antisera by immune blot analysis with their parent 
antigens and with cultured cell subfractions is also described.
5.2 METHODS
5.2.1 PURIFICATION OF BCOAD COMPLEX FROM BOVINE KIDNEY
o
The following buffers were prepared and cooled to 4 C:- 
Buffer A; 50mM potassium phosphate, pH 7.5, 2mM EDTA, 3% (v/v) Triton 
X-100, ImM benzamidine-HCl, ImM PMSF, O.lmM DTT.
Buffer B; 30mM potassium phosphate, pH 7.3, O.lmM EDTA, O.lmM EGTA, 
ImM benzamidine-HCl, ImM PMSF, ImM DTT.
Buffer C; 30mM sodium phosphate, pH 7.3, O.lmM EDTA, O.lmM EGTA, ImM 
benzamidine-HCl, ImM PMSF, ImM DTT.
Buffer D; 200mM potassium phosphate, pH 7.3, O.lmM EDTA, O.lmM EGTA, 
ImM benzamidine-HCl, ImM PMSF, ImM DTT.
Buffer E; 350mM potassium phosphate, pH 7.3, O.lmM EDTA, O.lmM EGTA, 
ImM benzamidine-HCl, ImM PMSF, ImM DTT.
Benzamidine-HCl, DTT and PMSF were added to the buffers
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immediately before use from concentrated stock solutions.
Fresh bovine kidneys were transported on ice to the laboratory.
All subsequent operations were performed at 4°C. Approximately 220g of 
cortex tissue was cut into small pieces and homogenised in a Moulinex 
blender for 5 min with two volumes of buffer A containing 0.05% (v/v) 
antifoam A. The resulting homogenate was mixed with an equal volume of 
buffer A and centrifuged at 15000xg for 26 min. The pH of the 
supernatant fluid was measured and, when necessary, adjusted to 7.3 
with 10% (v/v) acetic acid.
0.12 volumes of 35% (w/v) polyethylene glycol (PEG) was then 
added and the mixture was stirred for 30 min. The resulting 
precipitate was collected by centrifugation at 15000xg for 30 min and 
resuspended in buffer B (0.33 initial volume) by homogenisation in a 
Potter-Elvenhejm teflon/glass homogeniser. The resuspended material 
was stirred for 30 min (PEG I) and then clarified by centrifugation at 
19000xg for 27 min (PEG I clarified). 0.12 volumes of 35% (w/v) PEG 
was added to the clarified material, and the mixture was stirred for 
30 min before the precipitate was collected by centrifugation at 
15000xg for 30 min. The precipitate was resuspended in buffer B (0.05 
initial volume), then homogenised, stirred (PEG II) and clarified (PEG 
II clarified) as above.
The material obtained in this manner was applied at a flow rate 
of 12ml/h to a column of Bio-Gel HTP (2.6 x 5.5cm) equilibrated in 
buffer B. The column was then washed at 24ml/h with buffer D until the 
absorbance at 280nm of the eluate was less than 0.01. BCOAD complex 
was eluted from the column with buffer E at a flow rate of 24ml/h. 
Fractions from the peak of BCOAD activity were centrifuged separately 
at 40000xg for 16h. The resulting pellets of purified BCOAD complex
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were each resuspended in 1ml of buffer C. The resuspended material was 
o
stored at -20 C after addition of glycerol to 25% (v/v) final 
concentration.
5.2.2 PREPARATION OF ANTISERUM TO BOVINE KIDNEY BCOAD COMPLEX 
AND ITS El AND E2 COMPONENTS
Antisera to native BCOAD complex (anti-BCOAD serum) and the 
native El subcomplex (anti-El serum) were prepared by adopting the 
protocol described for the production of anti-SDH serum (section 
3.2.1). Preparative SDS/polyacrylamide gel electrophoresis (section 
2.2.3) was employed to resolve purified BCOAD complex into its three 
constituent polypeptides. Subunit-specific anti-E2 serum was prepared 
in an analogous manner to anti-L and anti-S sera (section 3.2.1), 
using the denatured E2 band excised from preparative gels.
5.2.3 INCUBATION OF PURIFIED BCOAD COMPLEX WITH NON-IMMUNE, ANTI- 
BCOAD, ANTI-El OR ANTI-E2 SERUM
Purified BCOAD complex (25mg/ml) was diluted to a concentration 
of 2.2 mg/ml with 50mM sodium phosphate buffer, pH 7.0, containing 
12mg/ml BSA, 0.2mM TPP, ImM MgCl^, 2mM DTT, and 0.2mM EDTA (diluent
werebuffer). 20jil (44pg) portions of enzyme diluted in this way
o
incubated for 18h at 4 C with various volumes (4-40jil) of serum. In 
each case, the reaction was performed in a final volume of 220jj1 
(final enzyme concentration 0.2|ig/pl) by adding the appropriate volume 
of diluent buffer. After the incubation period, duplicate 10|ig 
portions of enzyme from each tube were assayed for overall BCOAD
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activity, as described in section 2.2.1. Results were expressed as a 
percentage of the activity of the enzyme after dilution to a final 
concentration of 0.2mg/ml with diluent buffer.
5.3 RESULTS
5.3.1 PURIFICATION OF BRANCHED CHAIN 2-0X0ACID DEHYDROGENASE COMPLEX 
FROM BOVINE KIDNEY
The method of Lawson et al. (1983) was employed to purify the 
BCOAD complex from bovine kidney cortex. Fig.5.1 shows the result of 
chromatography of partially purified BCOAD complex (PEG II clarified 
material, section 5.2.1) on Bio-Gel HTP. The complex was bound 
relatively tightly by the hydroxylapatite matrix, remaining bound 
after washing of the column with buffer containing 200mM potassium 
phosphate (buffer D, section 5.2.1). The majority of contaminating 
polypeptides were eluted from the column using this buffer. The 
complex could, however, be eluted using buffer containing 350mM 
potassium phosphate (buffer E, section 5.2.1). Under these 
conditions, the enzymic activity eluted essentially as a single peak
which correlated closely with the A profile of the eluate.
280
Fig.5.2 illustrates the polypeptide pattern of samples from each 
stage of a preparation which yielded high-purity enzyme, as analysed 
by SDS/polyacrylamide slab gel electrophoresis and Coomassie blue 
staining. It is apparent from this figure that the hydroxylapatite 
step results in extensive removal of contaminating polypeptides from 
the final product (e.g. compare lanes 6 and 7). The highly purified 
fractions contained three major bands. By comparison with the electro­
phoretic mobilities of a set of low M^ marker proteins, the apparent
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Fig.5.1 Chromatography Of Partially Purified Bovine Kidney BCOAD 
Complex On Bio-Gel HTP
Partially purified BCOAD complex (PEG II clarified material, 
section 5.2.1) was applied to a column (2.6 x 5.5cm) of Bio-Gel HTP 
equilibrated with 30mM potassium phosphate, pH 7.3, O.lmM EDTA, O.lmM 
EGTA, ImM benzamidine-HCl, ImM PMSF, ImM DTT. After washing the column 
at 24ml/h with 50 bed volumes of 200mM potassium phosphate, pH 7.3, 
O.lmM EDTA, O.lmM EGTA, ImM benzamidine-HCl, ImM PMSF, ImM DTT, BCOAD 
complex was eluted with 350mM potassium phosphate buffer at a flow 
rate of 24ml/h. Fractions of 4ml were collected, on which were 
determined protein content (0— 0) as in section 2.2.2 and overall 
BCOAD complex activity (©— ©) as in section 2.2.1.
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Fig.5.2 SDS/Polyacrylamide Gel Electrophoresis Of Samples From
Stages In The Purification Of Bovine Kidney Branched Chain 
2-0xoacid Dehydrogenase Complex
Samples from various stages of the purification procedure 
described in section 5.2.1 were analysed by electrophoresis on a 12.5% 
(w/v) SDS/polyacrylamide slab gel followed by staining of the gel with 
Coomassie blue. Lanes 1 and 12, low markers; lane 2, 1st 
supernatant fraction (60pg); lane 3, PEG I ; lane 4, PEG I
(60jjg); lanes 7-11, consecutive Bio-Gel HTP eluate fractions from peak 
of BCOAD activity (10
clarified (60pg); lane 5 lane 6, PEG II clarified
1 2 3 4 5 6 7 8 9 10 11 12
M values of these bands were estimated to be 52500 + 1000, 44700 +
r - -
1000 and 37200 + 1000 (Fig.5.3). In order of decreasing value, the 
three major components were identified as the BCOAD complex E2, El 
and E l p o l y p e p t i d e s  respectively, by comparison with the purified 
complex described by Pettit et al. (1978) and Lawson et al. (1983).
The purity of the individual fractions of BCOAD complex eluted 
from the hydroxylapatite column (see Fig.5.2) was assessed by 
densitometric scanning of the Coomassie blue profiles of these
samples. The result of such an analysis for the fraction in lane 7 of
this figure is presented in Fig.5.4. The homogeneity of this fraction 
was estimated to be 9(?%. The ratio of the peak areas corresponding to 
the (?C and jS> polypeptides of El was 2.4:1. Densitometric scanning also 
revealed the absence of the E3 (lipoamide dehydrogenase) component 
from the purified complex, since no peak was detectable in the 55000- 
region of the gel. The absence of E3 was also indicated by the fact 
that the final product showed no overall BCOAD activity until excess 
pig heart lipoamide dehydrogenase (Sigma) was added to the assay 
mixture.
The purified complex was tested for its ability to catalyse the 
oxidative decarboxylation of 2-oxoisovalerate, 2-oxoisocaproate and 2- 
oxo 3-methylvalerate. The complex was active towards all three 
branched chain 2-oxoacids, in the ratio 2.2:1.2:1.0.
A summary of one of the purifications performed during this study 
is presented in Table 5.1. The specific activity of the final material, 
using 2-oxoisovalerate as substrate, was 36.4 nkat/mg, in broad 
agreement with the value reported by Lawson et al. (1983). Although 
the amount of purified material obtained is low in comparison to that 
reported by Lawson et al. (1983) (0.64mg/100g tissue versus 3.5mg/100g
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Fig.5.3 Determination Of The Apparent Values Of BCOAD Complex
Components By SDS/Polyacrylamide Gel Electrophoresis
Samples of purified BCOAD complex and low marker proteins were
co-electrophoresed on a 12.5% (w/v) SDS/polyacrylamide slab gel, as
described in section 2.2.3. After electrophoresis, proteins were
visualised by Coomassie blue staining, as illustrated in Fig.5.2. A
standard curve of relative migration (R^) value versus l o g ^  subunit
M value was constructed, and from this the apparent M values of the 
r r
BCOAD complex components were determined.
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Fig.5.A Densitometric Scan Analysis Of Purified BCOAD Complex 
Resolved By SDS/Polyacrylamide Gel Electrophoresis
Purified BCOAD complex (lOjig) was resolved into its component 
polypeptides by electrophoresis on a 12.5% (w/v) SDS/polyacrylamide 
slab gel (section 2.2.3). After staining of protein bands with 
Coomassie blue, the gel was scanned using an LKB 2202 Ultroscan laser 
densitometer.
A; Coomassie blue profile.
B; corresponding densitometer trace.
C; table showing percentage total area corresponding to each, 
subunit.
S u b u n i t % total a r e a
E2 27
E 1cx 49
E1y6 20
Total 96
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tissue), the percentages of enzymic activity recovered from the PEG I 
material are comparable. Thus, the small amount of protein recovered 
correlates with an approx. six-fold lower level of BCOAD complex 
activity in the first PEG precipitate. In other preparations, the 
recovery of purified BCOAD complex per lOOg tissue was comparable to 
or higher than that described by Lawson et al. (1983).
The apparent increase in the total amount of enzymic activity 
present in the Bio-Gel HTP eluate relative to that in the PEG II 
clarified material may be due to removal of NADH oxidase activity or 
an inhibitor of the BCOAD complex during the hydroxylapatite 
chromatography step.
5.3.2 REACTIVITY OF ANTI-BCOAD, ANTI-E1 AND ANTI-E2 SERA WITH THEIR 
PARENT ANTIGENS
Preparative SDS/polyacrylamide slab gel electrophoresis allowed 
the resolution of at least 1.7mg of purified bovine kidney BCOAD 
complex into its E2, Elo(. and E lj$ components (Fig.5.5). The Coomassie 
blue-stained band corresponding to the E2 subunit was excised from the 
gel and used for the production of subunit-specific anti-E2 serum.
Fig.5.6A shows the Coomassie blue profile of varying amounts of 
bovine kidney BCOAD complex after electrophoresis on a 12.5% (w/v) 
SDS/polyacrylamide slab gel, while panels B and C show the results of 
immune blot analysis when the purified enzyme was probed with anti- 
BCOAD and anti-E2 sera, respectively. The data in this figure 
illustrates that both of these antisera show cross-reaction with their 
parent antigens, although anti-E2 serum exhibits a relatively low 
titre of antibodies. Examination of the immune blot pattern in panel B
Fig.5.5 Preparative SDS/Polyacrylamide Gel Electrophoresis Of Bovine
Kidney BCOAD Complex
A sample of purified BCOAD complex (approx. 1.7mg) was resolved 
into its three constituent polypeptides by electrophoresis on a 
preparative 10% (w/v) SDS/polyacrylamide gel (section 2.2.3). The 
Coomassie blue-stained E2 band was excised for production of subunit- 
specific anti-E2 serum as described in section 5.2.2.
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Fig.5.6 Reactivity Of Anti-BCOAD And Anti-E2 Sera With
Purified Bovine K idney BCOAD Complex
Varying amounts of purified BCOAD complex were electrophoresed on
a 12.5% (w/v) SDS/polyacrylamide slab gel (section 2.2.3). One portion
of gel (A) was stained with Coomassie blue. Polypeptides on duplicate
portions of gel were transferred electrophoretically onto
nitrocellulose paper for incubation with anti-BCOAD serum (B) or anti-
E2 (C) serum (section 2.2.8a). Immune complexes were detected by
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autoradiography (section 2.2.5d) following incubation with I- 
labelled protein A. Panel A; lanes 1 and 6, low markers; lanes 2-5,
25, 10, 5 and 2.5pg of enzyme, respectively. Lanes 1-4 in B and C 
contain 5, 2, 1 and 0.5ug of enzyme, respectively.
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reveals that anti-BCOAD serum exhibits a weak cross-reaction with the 
El ^ subunit of the complex, relative to the reaction with the ElcK and 
E2 subunits. In addition, at higher loadings of enzyme (Fig.5.6B, 
lanes 2 and 3), this antiserum also cross-reacts with a high-M^ band, 
which could feasibly represent an aggregate of BCOAD complex 
components. However, this high-M^_ immunoreactive species did not 
interfere with subsequent biosynthetic studies performed with this 
antiserum (see Chapter Six).
Fig.5.7 shows the reactivity of anti-El serum with its parent
antigen the purified BCOAD El subcomplex. Panel B illustrates that
this antiserum also showed cross-reaction with both subunits of El,
although the reaction with the E l p o l y p e p t i d e  was again relatively
weak. It is worth noting at this stage that anti-El serum did not
exhibit reactivity with an 60000 band in the preparation of El
subcomplex used as antigen, although such a band was efficiently
immunoprecipitated by this antiserum from detergent extracts of 
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[ SJmethionine-labelled PK-15 and NBL-1 cells (see section 6.3.3).
5.3.3 IMMUNOLOGICAL DETECTION OF THE BCOAD COMPLEX COMPONENTS IN 
SUBCELLULAR FRACTIONS FROM CULTURED CELLS
The antisera raised to the various components of the bovine 
kidney BCOAD complex were tested for their ability to detect the 
corresponding parent antigen(s) in post-nuclear supernatant and 
mitochondrial fractions derived from BRL, PK-15 and NBL-1 cell lines 
(Fig 5.8). Panel A shows the Coomassie blue profile of samples of 
these fractions after their electrophoretic resolution on a 10% (w/v) 
SDS/polyacrylamide slab gel. Panels B and C show the results of immune
Fig.5.7 Reactivity Of Anti-El Serum With The Bovine Kidney 
BCOAD El Subcomplex
Varying amounts of purified BCOAD El subcomplex were electro- 
phoresed on a 12.5% (w/v) SDS/polyacrylamide slab gel (section 2.2.3). 
One portion of gel (A) was stained with Coomassie blue. A second 
portion was processed for detection of immunoreactive polypeptides 
using anti-El serum (section 2.2.8a). Panel A; lanes 1 and 6, low M
r
markers; lanes 2-5, 25, 12.5, 5 and ljig of enzyme, respectively. Lanes 
1-4 in B contain 5, 2.5, 1 and 0.2pg of enzyme, respectively.
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Fig.5.8 Immunological Detection Of The BCOAD Complex Components
In Cultured Cell Subfractions
Post-nuclear supernatant and mitochondrial fractions were
prepared from cultured BRL, PK-15 and NBL-1 cells (section 2.2.7), and
samples of the extracts were electrophoresed on 10% (w/v)
SDS/polyacrylamide slab gels. A portion of one gel (A) was stained
with Coomassie blue. Replicate portions of gel were processed for
detection of immunoreactive polypeptides using anti-BCOAD (B) or anti-
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El (C) serum. Lanes 1 and 8, low M^ _ markers (A) or I-labelled low
markers (B and C ) ; lane 2, 10pg (A) or 0.5pg (B-D) purified BCOAD
complex; lane 3, BRL post-nuclear supernatant fraction lane 4
BRL mitochondria ; lane 5, PK-15 mitochondria (40ug); lane 6,
NBL-1 post-nuclear supernatant fraction lane 7, NBL-1
mitochondria
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blot analysis (section 2.2.8a) when the samples were probed with anti- 
BCOAD (B) and anti-El sera, respectively.
The data in panel B demonstrates that the BCOAD complex E2 and El 
subunits are detectable in each of the three cell lines using anti- 
BCOAD serum. In contrast, the E l ^  subunit is detected less easily. 
Indeed, detection of the band corresponding to E 1^ 5 in the PK-15 and 
NBL-1 mitochondrial fractions required overexposure of the blot (not 
shown). As will become apparent later (see Chapter Six), it is 
important to stress that anti-BCOAD serum did not exhibit cross­
reaction with a 55000-M^ species (i.e. E3, the lipoamide 
dehydrogenase) in any of the three cell lines.
Fig.5.8C demonstrates that anti-El serum also permits detection 
of BCOAD ElO^ and E l j ^ in the three cell lines. Again the strength of 
signal from the E l s u b u n i t  was relatively weak. It was also apparent 
from this blot that anti-El serum does not exhibit cross-reaction 
with the E2 subunit of the purified BCOAD complex (panel C, lane 2).
The E2 subunit of the BCOAD complex in the BRL, PK-15 and NBL-1 
cell lines could also be detected when the aforementioned subcellular 
fractions were probed with anti-E2 serum, although the strength of 
signal and specificity of reaction obtained with this serum was lower 
than that obtained with anti-BCOAD serum (not shown).
5.3.A THE EFFECT OF ANTI-BCOAD, ANTI-El, ANTI-E2 AND NORMAL 
(CONTROL) SERUM ON OVERALL BCOAD COMPLEX ACTIVITY
The effect of various sera on the enzymic activity of purified 
bovine kidney BCOAD complex was investigated. Initial attempts at 
performing this analysis were hampered by the fact that the purified
100
complex was found to lose most (approx. 90%) of its activity after
incubation for 90 min at room temperature. However, it was
found subsequently that enzymic activity was retained after an 18h 
o
incubation at 4 C when the purified complex was diluted to a final 
concentration of 0.2mg/ml with 50mM sodium phosphate, pH 7.0, 
containing 12mg/ml BSA, 0.2mM TPP, ImM MgCl^» 2mM DTT and 0.2mM EDTA. 
Hence the antibody inhibition experiments were performed using the 
incubation and dilution conditions described above.
Fig.5.9 shows the effects of incubating purified BCOAD complex 
with increasing amounts of normal (control), anti-BCOAD, anti-El or 
anti-E2 serum. At the highest ratio of serum:enzyme tested (40pl 
serum:44^ig enzyme), anti-BCOAD serum reduced enzymic activity to less 
than 20% of the initial value. In contrast, enzyme which had been 
incubated with the same amount of normal serum retained more than 90% 
of its activity. The effects of anti-El and anti-E2 sera were 
intermediate with respect to those of normal and anti-BCOAD sera, 
reducing the original enzymic activity by approximately 20% and 30%, 
respectively.
At low ratios of serum:enzyme, anti-El, anti-E2 and normal sera 
each caused a small increase in enzymic activity, which was reversed 
in each case at higher levels of serum. The basis of this apparent 
stabilisation of the complex is unclear and was not investigated 
further.
5.4 DISCUSSION
The purified bovine kidney BCOAD complex described in this 
chapter was similar to that described by Lawson et al. (1983) in
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Fig.5.9 The Effect Of Various Antisera On BCOAD Complex Activity
Portions of purified bovine kidney BCOAD complex were incubated 
for 18h at 4°C with varying amounts of normal (ik), anti-BCOAD (□) , 
anti-El (o), or anti-E2 (®) serum as described in section 5.2.3. At 
the end of the incubation, duplicate aliquots from each tube were 
assayed for overall BCOAD complex activity (section 2.2.1). The points 
represent the means of two determinations, expressed as a percentage 
of the initial enzymic activity.
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terms of polypeptide composition, purity, yield, substrate specificity 
and specific activity. The complex isolated by Lawson et al. (op. 
cit.) was reported to contain endogenous kinase activity, capable of 
phosphorylating the Elo( subunit and thus inactivating the complex, 
although the activity was not assigned to a specific component(s) of 
the preparation. The presence of such a kinase in the preparation 
described here was not investigated, since this point was considered 
to be essentially irrelevant to the present study.
The material obtained included fractions which were sufficiently 
pure to be used for production of antiserum to the native BCOAD 
complex as well as fractions which, although of lower purity, could be 
resolved by preparative SDS/polyacrylamide gel electrophoresis for 
production of antiserum to the denatured E2 subunit.
The precise reactivities of the antisera produced to the BCOAD 
complex (anti-BCOAD serum), the native El subcomplex (anti-El serum) 
and the denatured E2 subunit (anti-E2 serum) were investigated by 
immune blot analysis versus their respective parent antigens. Use of 
this technique revealed that each of these antisera were essentially 
monospecific. The strength of signal obtained for the Elj*> polypeptide 
with both anti-BCOAD and anti-El sera was low in comparison with the 
signal obtained for Elc>( with these sera. The difference could, in 
theory, be partially accounted for both by the smaller size of the El 
polypeptide (ElcX, = 46000; Elj$ t = 35000) or by the material used 
as antigen in this blot containing a molar excess of Elo( relative to 
El^, although it is likely that the difference in signal strengths 
arose at least in part through the E l p o l y p e p t i d e  being less 
immunogenic. A similar situation has been observed with antiserum 
raised to the native form of the analogous pyruvate dehydrogenase
complex from bovine kidney (Sheu et al., 1985).
The low titre of E2 antibodies in anti-E2 serum relative to anti- 
BCOAD serum can be rationalised on consideration of the modes of 
production of these two antisera. Production of anti-E2 serum relied 
upon injection of small amounts of antigen which was in a denatured 
and monomeric form. In contrast, anti-BCOAD serum was produced using 
larger amounts of native complex (M^ = 3.2 x 10^) which would contain 
three-dimensional antigenic determinants. Since the immune response is 
in general enhanced by a physically larger immunogen which possesses 
three dimensional antigenic determinants, and is dependent on the 
amount of antigen administered (Maurer and Callaghan, 1980), it can be 
seen that the production of a high titre antiserum was favoured in the 
case of anti-BCOAD serum.
Anti-BCOAD, anti-El and anti-E2 sera were tested for their 
ability to inhibit overall BCOAD complex activity. Although each of 
these antisera had been shown by immune blot analysis to be specific 
for their respective parent antigens, only anti-BCOAD serum was 
capable of significantly inhibiting the enzymic activity of the 
purified complex. This result can be explained by postulating that the 
antibodies in these two sera recognise antigenic determinants which 
are sufficiently distant from sites essential for catalytic 
functioning, so as not to interfere extensively with enzymic activity. 
The discrepancy between the antibody inhibition and immune blotting 
analysis data illustrates one aspect of the usefulness of the latter 
technique.
Based on the observed cross-reactivity of antisera to bovine 
heart succinate dehydrogenase with equivalent antigens from 
heterologous sources (i.e. Buffalo rat liver, pig kidney and bovine
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kidney cell lines), it was felt that there was good reason to expect 
that the antisera raised to bovine kidney BCOAD complex would exhibit 
similar heterologous cross-reactivity. Since it was known that the 
aforementioned cell lines maintained high levels of aerobic 
respiration, the level of succinate dehydrogenase expression in these 
cells could be expected to be reasonably normal. However, since in 
cultured cells BCOAD complex activity does not constitute a key 
requirement for normal cellular energy production, an initial point of 
uncertainty was whether the cell lines would continue to synthesise 
appreciable amounts of BCOAD complex. Loss of specific enzyme 
functions from cells grown in culture is not without precedent, for 
example the rapid shutdown of synthesis of the mitochondrial urea 
cycle enzyme carbamyl phosphate synthetase from rat hepatocytes after 
their dispersal from the intact organ (Raymond and Shore, 1981). 
However, as illustrated in Fig.5.8, the cell lines in question did in 
fact continue to synthesise BCOAD complex.
Since the antisera were raised to bovine kidney antigens, and 
because of the superiority of the immunoprecipitates obtained from pig 
kidney (PK-15) cells over those obtained from Buffalo rat liver (BRL) 
cells (see Chapter Three), biosynthetic studies on the BCOAD complex 
were performed using the bovine kidney (NBL-1) and PK-15 cell lines, 
as described in Chapter Six.
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CHAPTER SIX
BIOSYNTHETIC STUDIES ON THE 
BRANCHED CHAIN 2-OXOACID DEHYDROGENASE COMPLEX
6.1 INTRODUCTION
Biogenesis of the BCOAD complex can conceptually be divided 
into the following steps; 1) synthesis of the individual subunits as 
cytosolic precursors; 2) binding of the precursors to the mito­
chondrial surface and translocation of these species across both 
mitochondrial membranes; 3) processing of the precursors, which 
involves insertion of TPP, lipoic acid and FAD into the El, E2 and E3 
components, respectively; 4) assembly of the mature polypeptides 
within the inner membrane-matrix compartment to generate a functional 
high-M^ assembly. Thus, it can be seen that the biogenetic pathway 
pertaining to this mitochondrial component is relatively 
sophisticated, and therefore of special interest. However, at the 
outset of this project it was apparent from the literature that none 
of the events described above had been characterised.
The in vivo strategy which had been employed to investigate the 
biosynthesis of succinate dehydrogenase, i.e. immunoprecipitation of 
specific antigens from cells pulse-labelled in the absence or presence 
of uncouplers of oxidative phosphorylation, was also adopted to 
perform biosynthetic studies on the mammalian BCOAD complex. These 
studies utilised the various antisera raised against the bovine kidney 
BCOAD complex, preparation and characterisation of which was dealt 
with in Chapter Five.
In addition to describing an investigation of the biosynthesis of 
the BCOAD complex using the metabolic labelling/j.mmunoprecipitation 
approach, this chapter examines the feasibility of effecting long-term 
precursor accumulation in cultured mammalian cells during prolonged 
incubation in the presence of uncouplers.
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6.2 METHODS
6.2.1 PREPARATION OF ANTI-E3 SERUM
The antiserum to pig heart E3 used in this chapter was prepared by 
Miss Anne Phelps in our laboratory. Commercially purified pig heart 
lipoamide dehydrogenase (Boehringer) was employed to immunise a New 
Zealand White rabbit using a regime similar to that described for the 
production of antiserum to native bovine heart succinate dehydrogenase 
(section 3.2.1). The rabbit received four injections of E3 (lmg each) 
in Freund's complete adjuvant before the initial bleeding. Subsequent 
booster injections of E3 (lmg) were carried out in Freund's incomplete 
adjuvant. The serum obtained was stored in 1ml aliquots at -20°C.
6.2.2 PROLONGED GROWTH OF PK-15 CELLS IN THE PRESENCE OF UNCOUPLERS OF 
OXIDATIVE PHOSPHORYLATION
2
175cm plastic Roux flasks were each seeded with 50ml of NGM 
containing PK-15 cells at a concentration of 3.6 x 10"* cells/ml. When 
semi-confluent cell monolayers were observed, the growth medium was 
removed and replaced with 40ml of NGM containing either 2mM DNP, IOjjM FCCP 
or no addition (control incubation). The flasks were then incubated for a 
further 40h, with the medium being replaced after 24h. At the end of this 
period, post-nuclear supernatant fractions from each flask were prepared 
essentially as described in section 2.2.7b, except that the PBS and 
Triton-TKM solutions were supplemented with ImM PMSF and ImM p- 
aminobenzamidine-HCl and filter-sterilised before use.
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6.3 RESULTS
6.3.1 IMMUNOPRECIPITATION OF THE BCOAD COMPLEX COMPONENTS FROM 
35
[ S]METHIONINE-LABELLED PK-15 CELLS
The antisera raised to various components of the bovine kidney
BCOAD complex were tested for their ability to recover specifically
35
the equivalent antigens from extracts of [ SJmethionine-labelled pig
kidney cells. Fig.6.1 shows a fluorograph of the products of
immunoprecipitation obtained with these antisera, after
electrophoresis on a 10% (w/v) SDS/polyacrylamide slab gel. Each
antiserum was found to effect specific precipitation of the components
to which it was directed, as well as certain additional bands, as
follows. The immunoprecipitates obtained with anti-El serum (lanes 2
and 3) contained, in addition to Elo( and El^, a small amount of E2
subunit, as well as an intense 60000-M^_ polypeptide. The identity of
this latter band was unclear at this stage, but is discussed further
in section 6.3.3. Anti-BCOAD immunoprecipitates (lanes 5 and 6)
contained in addition to the E2, Elo( and E l c o m p o n e n t s  an extra band
which had the same electrophoretic mobility as the E3 component
precipitated by antiserum raised to pig heart E3 (lanes 8 and 9).
Although the immune blot analyses described in Chapter Five had
revealed that there was no striking differences in the electrophoretic
mobilities of the components of purified bovine kidney BCOAD complex
and the corresponding components in the pig kidney cell line,
differences in electrophoretic mobility were observed between the
14
immunoprecipitated PK-15 BCOAD complex components and the [ C]NEM- 
modified bovine kidney complex resolved on the same gel. To test 
whether NEM modification resulted in altered mobility, samples of
F i g. 6.1 Immunoprecipitation Of The Subunits Of BCOAD Complex From
35
PK-15 Cells Labelled W ith [ S ]Methionine
35
PK-15 cells were incubated overnight with [ S]methionine
(150jjCi/dish) as described in section 2.2.6c. After preparation of 
35
[ SJmethionine-labelled cell extracts (section 2.2.7c), indirect
immunoprecipitation was performed using various antisera in
conjunction with formalinised S. aureus cells (section 2.2.8b). The
resulting immunoprecipitates were resolved on a 10% (w/v)
SDS/polyacrylamide slab gel and visualised by fluorography (section
2.2.5c). Immunoprecipitates obtained using; lane 1, non-immune serum;
lanes 2 and 3, anti-El serum; lane 4, anti-E2 serum; lanes 5 and 6,
anti-BCOAD serum; lanes 7 and 8, anti-E3 serum; lane 9, anti-PDH ElO( 
14
serum; lane 10, [ C]NEM-modified BCOAD complex. The immunoprecipitate 
in lane 9 was included as a positive control.
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untreated and NEM-modified bovine kidney BCOAD complex were 
electrophoresed in parallel on a 10% (w/v) SDS/polyacrylamide slab 
gel. As illustrated in Fig.6.2, NEM modification did indeed increase 
the apparent M^ _ value of each polypeptide. The increase was most 
pronounced in the case of the Elj§ polypeptide. Thus, the observed 
difference in electrophoretic mobilities seen in Fig.6.1 could be 
accounted for by the effect of NEM modification.
6.3.2 IDENTIFICATION OF THE 55000-M POLYPEPTIDE PRESENT IN IMMUN0-
r
PRECIPITATES OBTAINED WITH ANTI-BCOAD SERUM
To further investigate the identity of the 55000-M band observed
r
in immunoprecipitates obtained with anti-BCOAD serum, the following
35
experiments were performed: 1) an aliquot of [ SJmethionine-labelled 
PK-15 cell extract was heated at 60°C for 5 min before immuno­
precipitation with anti-BCOAD serum; 2) lOpg of unlabelled pig heart 
lipoamide dehydrogenase (E3) was mixed with an aliquot of labelled 
extract before addition of anti-BCOAD serum; 3) lOjjg of unlabelled pig 
heart E3 was added to an aliquot of labelled extract before addition 
of anti-E3 serum. The products of immunoprecipitation obtained in each 
case are illustrated in Fig.6.3.
Lanes 4 and 5 of this figure compare the polypeptide composition 
of anti-BCOAD immunoprecipitates obtained from control (lane 4) and 
heat-treated (lane 5) extracts. The profiles obtained in each case
were essentially identical, with no apparent loss of the 55000-M band
r
after heat treatment. Immunoprecipitation was performed using anti-E3 
serum in the absence (lane 7) or presence (lane 8) of competing levels 
of unlabelled pig heart E3. The addition of unlabelled E3 greatly
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Fig.6.2 Effect Of NEM Modification On The Electrophoretic Mobility
Of The Subunits Of Bovine Kidney BCOAD Complex
A portion (lOOpg) of purified bovine kidney BCOAD complex was 
modified with unlabelled NEM using the protocol described in section 
2.2.4a. Samples of this material were electrophoresed in parallel with 
unmodified enzyme and low M^ _ markers on a 10% (w/v) SDS/polyacrylamide 
slab gel (section 2.2.3). After electrophoresis, the gel was stained 
with Coomassie blue. Lanes 1 and 6, low M^ markers; lanes 2 and 4, 
unmodified BCOAD complex (10|ig); lanes 3 and 5, NEM-modified BCOAD 
complex (lOug).
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Fig.6.3 Identification Of The 55000-M Band Present In Immuno-  r-----------------------------
Precipitates Obtained From PK-15 Cells Using
Anti-BCOAD Serum
Immunoprecipitation from extracts of PK-15 cells labelled 
35
overnight with [ S]methionine (section 2.2.6c) was performed using
various antisera. In some cases, aliquots of extract were mixed with
lOjig of pig heart E3 or heat treated (60°C for 5min) before addition
of antiserum. Products of immunoprecipitation were isolated using
formalinised S. aureus cells, resolved by electrophoresis on a 10%
(w/v) SDS/polyacrylamide slab gel, and the radiolabelled polypeptides
125
visualised by fluorography (section 2.2.5c). Lane 1, I-labelled low 
M^ _ markers; lanes 3-8, immunoprecipitates obtained with the following 
sera; lane 3, non-immune serum; lane 4, anti-BCOAD serum; lane 5, as 
4, using heat-treated extract; lane 6, as 4, plus lOpg E3; lane 7, 
anti-E3 serum; lane 8, as 7, plus lOug E3.
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diminished the intensity of the E3 band observed on the fluorograph, 
demonstrating that the pig heart E3 was effective in competing out the 
equivalent polypeptide from pig kidney cells. When immunoprecipitation 
with anti-BCOAD serum was preceded by addition of unlabelled pig heart 
E3 to the extract, the radiolabelled 55000-M^ band was specifically 
excluded from the immunoprecipitate (lane 6). This result strongly 
suggested that the 55000-M^ band in question was in fact E3.
The finding that immunoprecipitates obtained using antiserum 
raised to the native bovine kidney BCOAD complex contained E3 was 
unexpected, since characterisation of anti-BCOAD serum by immune blot 
analysis versus its parent antigen or subcellular fractions from 
cultured BRL, PK-15 or NBL-1 cells had demonstrated that this 
antiserum did not react with a 55000-M^_ species either in the purified 
complex or subcellular fractions.
Purified bovine kidney BCOAD complex was probed with anti-E3 
serum (Fig.6.4) to test for the presence of E3 at the level of 
sensitivity afforded by the immuneblotting procedure. Anti-E3 serum 
(1:50 dilution) was capable of readily detecting the E3 component of 
both the bovine heart OGDC (lane 3) and PDH (lane 6) complexes when 
2jig of each were present on the blot. In contrast, when 2jig o f  bovine 
kidney BCOAD complex was probed with anti-E3 serum, no band 
corresponding to E3 was detectable (lane 4). However, when lO^ig of 
BCOAD complex was probed (lane 5), a relatively faint signal was 
observed.
Anti-BCOAD serum was tested for its reactivity towards pig heart 
E3 or the E3 component of the bovine heart OGDC and PDH complexes 
(Fig.6.5). (Samples of purified OGDC and PDH were provided by Dr. Jeff 
Hodgson from this laboratory). It is apparent from panel B of this
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Fig.6.4 Immuneblot Analysis Of Bovine Heart PDH And OGDC Complexes
And Bovine Kidney BCOAD Complex Using Anti-E3 Serum
Samples of purified pig heart E3, bovine heart PDH and OGDC
complexes and bovine kidney BCOAD complex were electrophoresed on a
10% (w/v) SDS/polyacrylamide slab gel. One portion of the gel (A) was
stained with Coomassie blue; the remaining portion was processed for
detection of immunoreactive polypeptides using a 1:50 dilution of
anti-E3 serum (section 2.2.8a). Panel A: lane 1. low M markers; lane
r
2, pig heart E3 (3|ig); lane 3, OGDC complex (lOjig); lane 4, BCOAD
125
complex (10 ; lane 5, PDH complex (15ug). Panel B: lane 1, I-
labelled low markers; lane 2, pig heart E3 (0.5 ; lane 3» OGDC
complex (2jjg); lane 4, BCOAD 
(10 ; lane 6, PDH complex
lane 5, BCOAD complex
QQ
1
O  rx 
r—  <D
X
3^“  hn
*- LxJ
LOi O  r— 
cr CNJ
1 1!1
1 I
1
1 1
1 11 i
1 [ 1
I
O c n i r \
<T> CD
ln 
^r
o
LH
cr
f 'O
CNI
CNJ
Fig.6.5 Immuneblot Analysis Of PDH , OGDC And BCOAD Complexes And Pig
Heart E3 Using Anti-BCOAD Serum
Samples of purified pig heart E3, bovine heart PDH and OGDC 
complexes and bovine kidney BCOAD complex were electrophoresed on a 
10% SDS/polyacrylamide slab gel. One portion (A) of the gel was 
stained with Coomassie blue. Polypeptides on the remaining portion (B) 
were electrophoresed onto nitrocellulose paper for incubation with a 
1:50 dilution of anti-BCOAD serum (section 2.2.8a). Panel A: lane 1,
low M markers; lane 2
r
lane 3, OGDC complex
(10 ; lane 4, BCOAD complex (10 ; lane 5» PDH complex (15
125
Panel B: lane 1, I-labelled low markers; lane 2, pig heart E3
(2jjg); lane 3, OGDC complex (2|ig); lane 4, BCOAD complex (0.5|ig); lane 
5, PDH complex (2jjg). Panel C: blot in panel B after subsequent 
incubation with anti-E3 serum (1:75 dilution).
N'A
UJ
(_)
QQ
CNJ
O
X
o
CN
O
O
X CN
LU
<C
o
oX CN
cr
CN
figure that anti-BCOAD serum did not exhibit reactivity with the 
bovine heart E3 (lanes 3 and 5) although an extremely faint signal was 
obtained from 2pg of purified pig heart E3 (lane 2). The blot whose 
autoradiographic image is shown in panel B was subsequently probed 
with anti-E3 serum (panel C ) . The E3 components were readily detected 
using this antiserum (panel C, lanes 2, 3 and 5).
6.3.3 IMMUNOPRECIPITATION OF BCOAD COMPLEX COMPONENTS FROM
PK-15 AND NBL-1 CELLS LABELLED WITH [35S ]METHIONINE IN THE 
PRESENCE OF UNCOUPLERS OF OXIDATIVE PHOSPHORYLATION
35
PK-15 cells were incubated for 4h with [ Sjmethionine in the 
presence of DNP (2mM) or FCCP (lOjuiM). In some instances, the cells 
were then incubated for a further 45 min in normal growth medium minus 
uncoupler. The polypeptide profiles obtained from extracts of these 
cells, after immunoprecipitation with anti-BCOAD, anti-El and anti-E2 
sera, are illustrated in Fig.6.6.
Comparison of lanes 6 and 8 with lane 4 in panel A of this figure 
reveals that the bands corresponding to the mature subunits of the 
BCOAD complex are absent in anti-BCOAD immunoprecipitates from 
extracts of cells labelled in the presence of uncouplers, although a 
band which exhibits a marginally smaller M^ _ value than mature E10( (M^ 
approx. 45000) is observed in these tracks. (The significance of this 
band is discussed later in this section). In addition, disappearance 
of mature subunits is accompanied by the appearance of two new bands, 
with M^ values of 56000 and 49000. These two species are most likely 
to be the precursor forms of the E2 and El0( polypeptides, 
respectively. Appearance of a higher M^ _ precursor form of the El
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Fig.6.6 Biosynthesis Of BCOAD Complex Components In PK-15 Cells
35
Metabolically Labelled W ith [ S]Methionine In The Absence
Or Presence Of Uncouplers Of Oxidative Phosphorylation
Pig kidney cells were incubated either overnight or for 4h with
35
[ S]methionine (150-200jiCi/dish) in the absence of uncoupler, or
labelled for 4h in the presence of uncoupler. In some cases, cells
which had been pulsed in the presence of uncoupler were subsequently
chased for 45 min after removal of uncoupler. After preparation of 
35
[ S]methionine-labelled cell extracts (section 2.2.7c), indirect 
immunoprecipitation was performed using various antisera in 
conjunction with formalinised S. aureus cells (section 2.2.8b). The 
resulting immunoprecipitates were resolved on a 10% (w/v) 
SDS/polyacrylamide slab gel and visualised by fluorography (section 
2.2.5c). Lane 1, *^I-labelled low markers; lane 2, [^C]NEM- 
modified BCOAD complex; lane 3, overnight label, non-immune serum. 
Panels A, B and C illustrate immunoprecipitates obtained with anti- 
BCOAD, anti-El and anti-E2 sera, respectively, from the following 
extracts; lane 4, overnight label; lane 5, 4h pulse, no uncoupler; 
lane 6, pulse + 2mM DNP; lane 7, as 6, but with 45 min chase minus 
uncoupler; lane 8, pulse + IOjjM FCCP; lane 9, as 8, but with 45 min 
chase minus uncoupler.
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polypeptide was not detected using anti-BCOAD serum.
After a 45 min chase in normal growth medium minus uncoupler, 
reappearance of components with values of 52000 and 46000, 
corresponding to the processed (mature) E2 and Elo( polypeptides 
respectively, was observed (lanes 7 and 9), confirming that pre-E2 and 
pre-Elo( had accumulated while precursor uptake was inhibited.
Analysis of the immunoprecipitates obtained with anti-El serum 
(panel B) reveals the following: a) anti-El serum precipitates the 
49000-M^ putative ElcX. precursor recognised by anti-BCOAD serum (lanes 
6 and 8); b) a higher precursor form of the E l f e polypeptide is 
again undetectable; c) the appearance of mature (processed) El 
subunit again parallels the disappearance of the 49000-M^ species, 
when a 45 min chase in the absence of uncoupler is performed (lanes 7 
and 9); d) the efficiently-precipitated 60000-M^_ band observed in 
mature anti-El immunoprecipitates (lanes 4 and 5) remains detectable 
in immunoprecipitates from cells labelled in the presence of 
uncouplers (lanes 6 and 8). The last finding would appear to suggest 
that the 60000-M^ band is a cytoplasmically-synthesised component 
which is not synthesised as a higher precursor; however, the 
possibility that in the uncoupler-treated tracks this species 
represents an aggregate form of BCOAD complex precursors cannot be 
excluded.
The corresponding immunoprecipitates obtained using anti-E2 serum 
are shown in Fig.6.6C. As noted previously (Fig.6.1), this antiserum 
was capable of precipitating the mature form of E2 (lanes 1 and 2). 
When the cells were pulse-labelled in the presence of 2mM DNP (lane 6) 
or lOuM FCCP (lane 8), the band corresponding to mature E2 was no
111
longer detectable, although no higher species was observed.
The presence of a band with a similar M value to mature-sized El
r
in anti-BCOAD immunoprecipitates obtained from uncoupler-treated cells
warrants comment. The separate identity of this species from mature El
is indicated by two independent lines of evidence. Firstly, a similar
band is absent from anti-El immunoprecipitates obtained from aliquots
of the same uncoupler-treated cell extracts, ruling out the
possibility that precursor processing is only partially inhibited.
Secondly, closer inspection of the anti-BCOAD immunoprecipitates
obtained from pulse-chased PK-15 cells (Fig.6.6A, lanes 7 and 9)
reveals the presence of two closely migrating bands in the region of
the gel corresponding to mature-sized El .
The 45000 band is most probably actin, which has been reported
previously to be commonly associated with immunoprecipitates (Barber
and Delovitch, 1978).
In a set of experiments analogous to those shown in Fig.6.6,
immunoprecipitation using anti-BCOAD, anti-El or anti-E2 sera was
performed on extracts of bovine kidney (NBL-1) cells which had been
pulse-labelled in the absence or presence of uncoupler, or pulse-
labelled plus uncoupler then chased for 45 min in medium minus
uncoupler (Fig.6.7).
The immunoprecipitates obtained from this cell line resembled
their counterparts from the pig kidney cell line in the following
35
respects; a) immunoprecipitates obtained from [ Sjmethionine-labelled
NBL-1 cells using anti-BCOAD serum contained a 55000-M^ species, in
addition to the expected E2, Eloi and Elpo lyp ep ti des ;  b) the products
of immunoprecipitation recovered with anti-BCOAD serum from cells
pulse-labelled in the presence of DNP or FCCP contained 56000-M and
r
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Fig.6.7 Immunoprecipitation Of BCOAD Complex Components From NBL-1
35
Cells Labelled W ith [ S ]Methionine In The Presence Or
Absence Of Uncouplers Of Oxidative Phosphorylation
Bovine kidney cells were incubated either overnight or for 4h 
35
with [ S]methionine (150-200|jCi/dish) in the absence of uncoupler, or
labelled for 4h in the presence of uncoupler. In some cases, cells
which had been pulsed in the presence of uncoupler were subsequently
chased for 45 min after removal of uncoupler. After preparation of 
35
[ S]methionine-labelled cell extracts (section 2.2.7c), indirect 
immunoprecipitation was performed using various antisera in 
conjunction with formalinised S. aureus cells (section 2.2.8b). The 
resulting immunoprecipitates were resolved on a 10% (w/v) 
SDS/polyacrylamide slab gel and visualised by fluorography (section 
2.2.5c). Lane 1, ^^I-labelled low markers; lane 2, [*^C]NEM- 
modified BCOAD complex; lane 3, overnight label, non-immune serum. 
Panels A, B and C illustrate immunoprecipitates obtained with anti- 
BCOAD, anti-El and anti-E2 sera, respectively, from the following 
extracts; lane 4, overnight label; lane 5, 4h pulse no uncoupler; 
lane 6, pulse + 2mM DNP; lane 7, as 6, but with 45 min chase minus 
uncoupler; lane 8, pulse + 10|iM FCCP; lane 9, as 8, but with 45 min 
chase minus uncoupler.
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49000-M^ species, which appeared in response to uncoupler treatment;
c) the putative EloC precursor (M^ _ 49000) was also recognised by anti-
El serum; d) no precursor form of the E l p o l y p e p t i d e  was observed; e)
the 45000-M putative actin band was observed in anti-BCOAD 
r
immunoprecipitates.
6.3.4 IDENTIFICATION OF THE 56000-M BAND OBSERVED IN ANTI-BCOAD
r
IMMUNOPRECIPITATES FROM PK-15 CELLS LABELLED WITH 
35
[ S]METHIONINE IN THE PRESENCE OF UNCOUPLERS
Since the lipoamide dehydrogenase of pig kidney cells is
synthesised as a precursor of approx. 57000 (De Marcucci et al.,
1986b), the possibility existed that the 56000-M species observed in
r
anti-BCOAD immunoprecipitates from PK-15 cells pulse-labelled in the 
presence of uncouplers was in fact pre-E3 (rather than pre-E2), which 
may have been precipitated because of a hypothetical association with 
the E2 core component. To investigate this possibility,
immunocompetition experiments were performed using purified unlabelled 
pig heart E3 (Fig.6.8).
As observed previously, (Fig.6.3), addition of purified E3 
competed out the 55000-M^ species from anti-BCOAD immunoprecipitates 
(compare lanes 4 and 5), and the mature E3 component precipitated by 
anti-E3 serum (lanes 8 and 9). In addition, unlabelled pig heart E3 
was observed to compete out pre-E3 precipitated by anti-E3 serum from 
extracts of PK-15 cells labelled in the presence of 2mM DNP (lanes 10 
and 11). In contrast, no effect on the presence of the 56000-M
r
species was observed when unlabelled E3 was added to aliquots of 
extract from DNP-treated, labelled cells, prior to immunoprecipitation
Fig.6.8 Identification Of The Precursor Form Of The BCOAD Complex
E2 Subunit In PK-15 Cells
35
Immunoprecipitates were obtained from [ SJmethionine-labelled
extracts of PK-15 cells which had been pulse-labelled (4h) in the
absence or presence of 2mM DNP using various antisera (section
2.2.8b). In some cases, antiserum addition was preceded by addition of
125
unlabelled pig heart E3 (10|jg). Lane 1, I-labelled low markers; 
14
lane 2, [ C]NEM-modified BCOAD complex; lane 3, 4h pulse (minus DNP),
non-immune serum; lanes 4-6, immunoprecipitates obtained with anti-
)'  ' ~
BCOAD serum; lane 4, 4h pulse (minus DNP); > lane 5, as 4, plus lOug E3;
 :-----_----_ _ _  -------- i . I
lane 6, pulse + 2mM DNP; lane 7, as 6, plus lOjjg E3; lanes 8-11, 
immunoprecipitates obtained with anti-E3 serum; lane 8, 4h pulse 
(minus DNP); lane 9, as 8, plus 10|jg E3; lane 10, pulse + 2mM DNP; 
lane 11, as 10, plus lOug E3.
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with anti-BCOAD serum (lanes 6 and 7). This result demonstrates that 
the 56000-M^ species is immunologically unrelated to E3 and is most 
probably the precursor form of the BCOAD complex E2 subunit.
6.3.5 THE EFFECT ON PK-15 CELLS OF PROLONGED INCUBATION WITH 
UNCOUPLERS OF OXIDATIVE PHOSPHORYLATION
As an alternative approach to accumulating precursor forms of the 
BCOAD complex, PK-15 cells in logarithmic phase were transferred to 
normal growth medium containing either 2mM DNP or IOjuM FCCP and 
incubated for a further 40h. Cells treated with uncouplers in this way 
displayed an abnormal morphology when examined under the light 
microscope and divided at a slower rate than control cells. The 
uncoupler-induced inhibition of cell growth was reflected by the 
smaller amounts of total protein recovered from flasks of uncoupler- 
treated cells relative to a control flask seeded with the same number 
of cells.
Post-nuclear supernatant fractions (section 2.2.7b) were prepared 
from uncoupler-treated cells and control cells under conditions which 
avoided artifactual proteolysis by bacterial or cytosolic proteases or 
by the matrix processing protease. Samples of these fractions were 
then analysed by immune blotting (Fig.6.9) using anti-BCOAD serum, 
anti-El serum or subunit-specific antiserum to the bovine heart PDH E2 
component (a gift from Dr. O.G.L. De Marcucci), to determine whether 
precursor accumulation could be detected. The fractions were probed 
with the latter antiserum since it had been shown previously that 
accumulated PDH pre-E2 was relatively stable in PK-15 cells maintained 
in the presence of uncoupler (De Marcucci, 1985).
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F i g. 6.9 The Effect On Cultured PK-15 Cells Of Prolonged Growth
In The Presence Of DNP Or FCCP
Pig kidney cells were grown for 40h in the presence of either 2mM
DNP or IOjjM FCCP, or in the absence of uncoupler (control incubation)
as described in section 6.2.1. Post-nuclear supernatant fractions
obtained from cells treated in this manner were prepared and samples
of these fractions were subjected to electrophoresis on 10% (w/v)
SDS/polyacrylamide slab gels followed by immuneblot analysis (section
2.2.8b) with anti-PDH E2 (A), anti-El (B) or anti-BCOAD (C) serum.
In each panel, lanes 1, 3, 4 and 5 contain the following samples; lane 
125
1, I-labelled low markers; lane 3, post-nuclear supernatant
fraction from control cells lane 4, post-nuclear supernatant
fraction from DNP-treated cells lane 5, post-nuclear
supernatant fraction from FCCP-treated cells Lane 2 contains
BCOAD

Panel A of Fig.6.9 reveals that when equal amounts of post- 
nuclear supernatant fractions from control (lane 3), DNP-treated (lane 
4) and FCCP-treated (lane 5) cells are probed with anti-PDH E2 serum* 
a decrease in the intensity of the band corresponding to mature E2 
subunit is observed in the extracts from uncoupler-treated cells. 
However, the appearance of a higher band, corresponding to pre-E2 
was not detected in the uncoupler-treated cell extracts. These 
results suggested that import and processing of newly-synthesised pre- 
E2 had been inhibited, and that this species had not accumulated in 
the cytosol, but had undergone degradation in this compartment.
Similar effects on the BCOAD complex E2, Elo( and E l p o l y p e p t i d e s  were 
observed when the post-nuclear supernatant fractions were probed with 
anti-El serum (B) or anti-BCOAD serum (C).
6.4 DISCUSSION
In recent years, the biosynthesis of mammalian nuclear-coded 
mitochondrial polypeptides in vivo has been investigated by pulse- 
labelling cultured cells in the presence of uncouplers of oxidative 
phosphorylation. This experimental approach, which was used in this 
study to facilitate the detection of higher M^ _ precursor forms of the 
large and small subunits of succinate dehydrogenase (Chapter Three), 
was also employed in an analogous study on the biosynthesis of the 
mammalian branched chain 2-oxoacid dehydrogenase (BCOAD) complex.
Experience showed that it was relatively difficult to detect the 
mature-sized subunits of the BCOAD complex, in particular the E l j 5  
subunit, in that the immunoprecipitates obtained with antisera to this 
enzyme contained fewer c.p.m., and thus detection by fluorography
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required relatively long exposure times. This difficulty can be 
accounted for in theory by the relatively low abundance of this multi­
enzyme complex in the cell lines studied, and/or by the constituent 
polypeptides of the E2 and El components having amino acid 
compositions which are low in methionine residues. In the case of the 
E lp o ly pe pt ide , it is likely that the weak anti-Elyfe reactivity of 
anti-BCOAD and anti-El sera (section 5.3.2) contributed largely to the 
poor detection of this species.
In an attempt to circumvent any paucity of methionine residues in
the polypeptides of interest, cultured PK-15 cells were metabolically
3
labelled with [4,5- H]leucine. However, any benefit gained from a
higher leucine content was offset by the 20-fold lower specific
35
activity of the tritiated radiolabel relative to [ SJmethionine,
and also because tritium is only poorly detected by fluorography.
14 14
Although [ C]amino acids (e.g. [ C]leucine) are commercially
available, the use of this isotope was not investigated because of
14
cost limitations, and also because [ Cjamino acids are poorer than
tritiated radiolabels in terms of specific activity.
An unexpected finding of the work presented in this chapter was
35
that immunoprecipitates obtained from extracts of [ SJmethionine- 
labelled PK-15 cells using antiserum to native bovine kidney BCOAD 
complex contained a 55000-M^ polypeptide which was identified as E3, 
the lipoamide dehydrogenase, in immunocompetition experiments using 
unlabelled purified pig heart E3. A polypeptide of similar electro­
phoretic mobility was also observed in anti-BCOAD immunoprecipitates 
from labelled NBL-1 cells, although this polypeptide was not 
rigorously identified as the bovine kidney lipoamide dehydrogenase.
The above finding was contrary to expectations for two reasons.
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Firstly, the material used for production of anti-BCOAD serum was 
essentially devoid of E3, as determined by absence of lipoamide 
dehydrogenase activity in the purified preparation, densitometric 
scanning of the Coomassie blue-stained enzyme and immune blot analysis 
of the preparation using anti-E3 serum. The lack of E3 in the 
immunogen made the existence of a substantial titre of antibodies to 
E3 in anti-BCOAD serum unlikely, especially when the reported low 
immunogenicity of this polypeptide (De Marcucci et al., 1985; Hunter & 
Lindsay, 1986) is taken into account. Secondly, the predicted absence 
of E3-specific antibodies in anti-BCOAD serum was confirmed by immune 
blot analysis when this serum was used to probe the parent antigen 
(section 5.3.2), subcellular fractions from cultured cells (section 
5.3.3), purified pig heart E3 or the E3 components of the bovine heart 
OGDC or PDH complexes.
The 3D-TKM buffer system (section 2.2.8b) used in these 
immunoprecipitation studies was selected for its proven ability to 
promote highly specific precipitation of maximally-dissociated 
polypeptides from cellular extracts. However, on occasions, incomplete 
dissociation of polypeptides has been observed even in the presence of 
this detergent mixture (Hunter, 1985). This finding, taken together 
with the observed reactivity of anti-BCOAD serum, leads to the 
hypothesis that the E3 present in anti-BCOAD immunoprecipitates arises 
through its physical association with the E2 core structure of the 
BCOAD complex. On this basis, one might expect that heat treatment of 
the radiolabelled extract prior to immunoprecipitation with anti-BCOAD 
serum would result in disappearance of E3. Although this was found not 
to be the case, it is possible to envisage a situation where the 
association of E3 with E2 subunits is not abolished by heat treatment,
but is sufficiently weak for exchange with added unlabelled pig heart 
E3 to occur.
The evidence discussed above suggests that in vivo, E3 may form 
an integral part of the BCOAD complex, and that absence of this 
component from preparations of purified enzyme is probably a result of 
the isolation procedures used. Isolation of E3-deficient BCOAD complex 
has been reported for the bovine and rat kidney and bovine and rabbit 
liver enzymes (Lawson et al., 1983; Odessey, 1982; Chuang et al.,
1984; Paxton and Harris, 1982). A common feature of these procedures 
is the inclusion of a hydroxylapatite column chromatography step. In 
contrast, BCOAD complex from bovine liver which has been isolated by a 
procedure which does not involve hydroxylapatite chromatography 
contains endogenous E3 (Heffelfinger et al., 1983). This finding, 
coupled with the fact that the lipoamide dehydrogenase from 
Escherichia coli (Coggins et al., 1976), Bacillus stearothermophilus 
(Henderson and Perham, 1980) and mammalian sources (Koike and Hamada, 
1971) is strongly retained by columns of hydroxylapatite lends support 
to the argument that the absence of E3 in purified BCOAD complex is a 
purification artifact.
The biosynthetic studies presented in this chapter provide
evidence that the dihydrolipoyl transacylase (E2) and o( subunit of the
branched chain 2-oxoacid decarboxylase (El) of the mammalian BCOAD
complex are synthesised as higher precursor forms. The third enzyme
of the complex, the lipoamide dehydrogenase (E3), which is common to
all three mitochondrial 2-oxoacid dehydrogenase complexes, has already
been shown to be synthesised as a precursor with an M value which is
r
approx. 2000 greater than mature E3.
The putative E2 precursor displayed an M^ _ value of 56000,
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therefore the possibility existed that this species was pre-E3 rather 
than pre-E2, since the pig kidney E3 precursor is reported to have an 
value of approx. 57000 (De Marcucci et al., 1986b). The recovery of 
the precursor form of E3 by anti-BCOAD serum (which lacked E3-specific 
antibodies) could be rationalised by proposing a physical association 
of pre-E3 with the precursor of the E2 core enzyme, although such an 
association was considered to be highly unlikely, since it would 
constitute premature assembly of the complex outside the target 
organelle. However, the demonstration that the 56000-M^ species in 
question is not competed out in the presence of purified unlabelled 
pig heart E3 provides strong evidence that it is the BCOAD E2 
precursor, and that this polypeptide is immunologically unrelated to 
the lipoamide dehydrogenase, but is similar in size to the precursor 
and mature forms of this component.
35
The immunoprecipitates obtained from [ SJmethionine-labelled 
extracts of uncoupler-treated pig kidney or bovine kidney cells did 
not contain a radiolabelled band which could be identified as the 
precursor form of the BCOAD E1^5 subunit. The lack of detection of this 
precursor could be attributed to one or more of the following reasons: 
1) synthesis of the Elj£ subunit is selectively shut down in the 
presence of uncouplers of oxidative phosphorylation; 2) p r e - E l d o e s  
not accumulate, i.e. it is rapidly degraded after being synthesised;
3) pre-El|S accumulates during pulse-labelling, but is particularly 
susceptible to degradation (for example by a serum protease) during 
the immunoprecipitation procedure; 4) the Elj^ subunit is relatively 
poorly labelled by [ ]methionine; 5) p r e - E l i s  not recognised by 
antibodies to the corresponding mature polypeptide. In the light of 
the aforementioned difficulty in detecting mature Eljs, it would seem
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reasonable to propose that reason 5) listed above is the principal 
cause of the inability to detect the newly-synthesised E l ^  subunit.
In 1982, Reid and Schatz reported that when a respiration 
deficient rho strain of Saccharomyces cerevisiae is grown for several 
hours in the presence of the uncoupler CCCP, large amounts of certain 
mitochondrial precursor polypeptides accumulate in the cytosol of 
these cells. These precursors could be detected by immune blotting, 
thus dispensing with the need for immunoprecipitation of radiolabelled 
antigens (Reid and Schatz, 1982).
With the difficulty experienced in immunoprecipitating the BCOAD 
complex components in mind, it was felt that it would be of interest 
to explore the possibility of applying the above method of precursor 
detection in cultured mammalian cells.
Accordingly, cultured PK-15 cells were subjected to long term 
incubation in the presence of the uncouplers DNP or FCCP, at 
concentrations which were known to block import and processing, but 
allow protein synthesis on cytoplasmic ribosomes to continue at up to 
50% of its normal rate. When post-nuclear supernatant fractions 
prepared from control and uncoupler-treated cells were probed by 
immune blotting analysis using anti-El serum, anti-BCOAD serum or 
antiserum to the E2 component of bovine heart PDH, no higher M 
species were detected. However, when equal amounts of protein from 
each sample were probed, a decrease in the amount of mature protein 
was observed in the uncoupler-treated tracks. These results suggested 
that import and processing had been inhibited, but without concomitant 
precursor accumulation, presumably because of instability of these 
molecules in the cytosol.
In their study, Reid and Schatz (1982) noted that not all
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mitochondrial precursor polypeptides could be accumulated during 
growth of yeast cells in the presence of CCCP. For instance, the 
cytochrome and cytochrome c oxidase subunit VI precursors were 
found not to accumulate under these conditions. Thus, it would appear 
that in yeast, the precursor forms of different mitochondrial 
components are differentially predisposed to accumulation in the 
cytosolic compartment when their import into the mitochondrion is 
prevented.
Although it is more than four years since the discovery of long 
term precursor accumulation in yeast, there have been no subsequent
reports of the same phenomenon in mammalian cells. Thus, it may be
that when mitochondrial import is prevented in mammalian cells,
all species of aberrantly-located precursor molecule are subject to
proteolytic degradation, so that only a chemically small pool of each 
precursor exists. Such pools would not be readily detectable by 
conventional immune blotting procedures.
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CHAPTER SEVEN
GENERAL DISCUSSION
7.1 BIOSYNTHETIC STUDIES ON MAMMALIAN SUCCINATE DEHYDROGENASE AND
BCOAD COMPLEX
As described in Chapter One, the process whereby nuclear coded 
mitochondrial polypeptides are imported into mitochondria from their 
cytoplasmic site of synthesis has been the subject of considerable 
attention in the last eight years.
These recent investigations have elucidated the following general 
features of the import process. Most imported mitochondrial poly­
peptides (the main exception being outer membrane components) are 
synthesised with a transient N-terminal polypeptide extension which 
has a role in targetting these higher M^ precursors to protease- 
sensitive binding sites on the mitochondrial surface, and also in 
subsequent intramitochondrial localisation. Translocation of at least 
the N-terminal sectors of precursors into or across the inner membrane 
requires a transmembrane electrochemical potential, and is accompanied 
or followed by proteolytic processing, i.e. cleavage of the extension 
sequence in one or two distinct steps. In some cases, processing also 
involves other posttranslational modifications, such as insertion of 
cofactors or attachment of prosthetic groups. The ultimate event 
undergone by a mitochondrial polypeptide during its import is the 
acquisition of a functional conformation in the correct 
submitochondrial location.
The present study was concerned largely with the biosynthesis of 
succinate dehydrogenase and of the branched chain 2-oxoacid 
dehydrogenase (BCOAD) complex - two areas which have previously 
received little attention.
Precursor forms of the succinate dehydrogenase large and small
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subunits (pre-L and pre-S, respectively) were accumulated and detected 
in BRL or PK-15 cell lines after pulse-labelling cells in the presence 
of uncouplers of oxidative phosphorylation. In both cell lines, pre-L 
and pre-S exhibit values which are 1-2000 and 4-5000 larger than 
their mature counterparts.
The extramitochondrial precursor form of the large subunit 
persists for several hours when import is inhibited using DNP, in a 
form which is capable of being imported and proteolytically processed 
when the blockade on import is removed. This long term stability 
contrasts with the differing stabilities of other extramitochondrial 
precursor polypeptides, which have previously been assessed in a 
similar manner to that used in this study (Jaussi et al., 1982;
Hunter, 1985). Thus, it is highly likely that when import is blocked, 
pre-L exists in the cytosol in a form which is particularly resistant 
to degradation by cytosolic proteases.
Weak immunoprecipitation of the small subunit precursor 
precluded investigation of the kinetics of processing and stability of 
this polypeptide. The encountered difficulty may be the result of 
several factors: a) the small subunit is less immunogenic than the 
large subunit; b) it has a much lower methionine content and c) 
accumulation of precursor depends on the long term stability of this 
species in the cytoplasmic compartment.
An analogous biosynthetic study was performed on the mammalian 
BCOAD complex. Surprisingly, this study revealed that the E3 component 
coprecipitates with other subunits of the complex using an antiserum 
which lacks antibodies to E3. This coprecipitation was attributed to a 
strong physical association between E3 and other component(s) of the 
complex. This would suggest that in the physiological state, E3 is an
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integral component of the BCOAD complex and that its association with 
the core structure can be disrupted during purification of the complex.
Precursor forms of the E1q( and E2 subunits of the BCOAD complex 
were demonstrated, which exhibited M^ _ values which are approx. 3000 
and 4000 greater than their mature counterparts, respectively.
Thus, the precursor of the BCOAD complex E2 subunit is similar in 
value to the previously characterised precursor form of E3. However, 
the separate identity of the 56000-M^ putative E2 precursor and pre-E3 
was confirmed in immunocompetition experiments using unlabelled 
purified pig heart E3.
The precursor form of the BCOAD complex El^J subunit evaded 
detection, most probably because of the difficulty experienced in 
producing a high-quality antiserum to this polypeptide.
Previous work in this laboratory has identified precursor forms 
of the component polypeptides of the pig kidney 2-oxoglutarate 
dehydrogenase (OGDC) and pyruvate dehydrogenase (PDH) multienzyme 
complexes. As illustrated in Table 7.1, the E2 components of OGDC and 
PDH are initially synthesised with presequences of 7-9000 and 6- 
8000, respectively. Thus, these transient extensions are relatively 
large in relation to the observed size range of mitochondrial 
presequences (Hay et al., 1984) and are considerably larger than the 
presequences of the other components of the two complexes. This 
observation has led to the proposal that the presequence on E2 may 
contain, in addition to "targetting" and "sorting" signals (Hurt and 
van Loon, 1986), sequence elements which function to prevent 
aggregation of E2 subunits before they have been imported into the 
mitochondrion (Hunter and Lindsay, 1986). The present finding of a 
4000-M^ extension on the BCOAD complex E2 precursor would appear to
Table 7.1 Subunit M Values For The Precursor And Mature Forms
r
Of The Components Of The Mitochondrial 2-0xoacid 
Dehydrogenase Multienzyme Complexes In Pig Kidney Cells
COMPLEX SUBUNIT
M
r
MATURE
VALUE3
PRECURSOR
M EXTENSION SEQUENCE 
r
b
OGDC El 96000 98000 2000
E2 48000 56000 8000
E3 55000 56500 1500
PDH° El 0( 42000 44500 2500
El jl 36000 39000 3000
E2 70000 78000 8000
X 50000 N.D. N.D.
E3 as above
BC0ADd E1<?C 46000 49000 3000
E l f c 37000 N.D. N.D.
E2 52000 56000 4000
E3 as above
a; determined by SDS/polyacrylamide gel electrophoresis to an accuracy 
of + 1000 
b; Hunter and Lindsay (1985). 
c; De Marcucci (1985). 
d; This study.
N.D.; Not determined.
render this hypothesis less attractive.
7.2 TOPOGRAPHICAL STUDIES ON SUCCINATE DEHYDROGENASE
The topographical arrangement of the large and small subunits of 
succinate dehydrogenase on the mitochondrial inner membrane was 
investigated by immune blot analysis of protease-treated bovine heart 
mitochondria (right side-out; outer membrane removed) or 
submitochondrial particles (inside-out). In mitochondria, both subunits 
were resistant to proteolysis provided that the integrity of the inner 
membrane was preserved, indicating that neither of these polypeptides 
is present at the cytoplasmic face of the lipid bilayer. This finding 
is in agreement with those obtained in previous ferricyanide binding, 
chemical labelling and antibody binding studies (Klingenberg and 
Buchholz, 1970; Merli et al., 1979).
Data obtained in the present study suggests that the large 
subunit interacts with the matrix side of the inner membrane via two 
distinct domains, which are detected as separate membrane-associated 
fragments after treatment of submitochondrial particles with papain or 
protease K. The lack of detection of a second large subunit fragment 
after treatment with other proteases (e.g.-chymotrypsin or trypsin) 
may arise from the low or lack of immunoreactivity of this species. 
By the same argument, additional small regions of membrane-associated 
large subunit may exist, which are also outwith the limits of 
detection of the technique used.
Girdlestone et al. (1981) have investigated the interaction of 
purified succinate dehydrogenase or complex II with phospholipids by 
reacting the proteins with lipid vesicles containing radiolabelled
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photoactive phospholipids with the reactive moiety in the head-group 
region (PL II) or on the methyl terminus of one of the fatty acid 
chains (PL I). The results of these studies led Girdlestone and 
coworkers to propose that the small subunit of SDH was partially 
inserted into the bilayer of lipid vesicles, since this polypeptide 
was labelled by PL II and PL I, whereas the large subunit was shielded 
from or held above the bilayer since it was not labelled by either 
probe. Moreover, when succinate dehydrogenase was incorporated into 
lipid vesicles at below their phase transition temperature and when 
enzyme-containing membranes were cooled rapidly to below this 
temperature, the labelling of the small subunit was drastically 
reduced. This effect is consistent with the protein being excluded 
from the bilayer in gel-state lipids, but was not seen with complex 
II, complex III or cytochrome c oxidase, suggesting that with 
succinate dehydrogenase only a small portion of the molecule enters 
the bilayer.
The existence of such a model has implications for interpretation 
of the data of the present study. If the model of Girdlestone et al. 
(1981) is applicable also to the arrangement of complex II within the 
mitochondrial inner membrane, the large subunit fragments may be bound 
to the membrane through interactions with exposed regions of the small 
subunit (or even the CII-3 and CII-4 components of complex II) rather 
than through insertion of the large subunit into the hydrophobic 
interior of the lipid bilayer. Clearly, this point merits further 
investigation. The inability to detect membrane-associated fragments 
of the small subunit in the present study does not contradict the 
model of Girdlestone et al. (1981).
The structural genes for the subunits of mammalian sucinate
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dehydrogenase are in the process of being isolated and characterised 
(T.P. Singer, personal communication). Analysis of the primary 
sequence of these two polypeptides will facilitate identification of 
putative membrane-intercalated regions of the two subunits. The 
topography data presented in this study could then be assessed in the 
light of such an analysis.
7.3 FUTURE WORK
The biosynthetic studies presented in this thesis provide a
foundation for more detailed investigations of the biogenesis of
succinate dehydrogenase and the BCOAD complex. It will be of interest
to examine the importance of FAD attachment in the import and
processing of the SDH large subunit precursor, to determine whether
this modification is a prerequisite for proteolytic processing or
possibly for assembly of the mature-sized polypeptide into functional
enzyme. It is likely that this problem can be tackled in cultured
mammalian cells. Since the biosynthesis of FAD from riboflavin
involves the incorporation of two phosphate groups from ATP, it should
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be possible to label FAD by addition of P-labelled inorganic 
phosphate to cultured cells which have been depleted of phosphate and 
riboflavin. Covalent attachment of radiolabelled FAD could then be 
monitored by immunoprecipitation using anti-L serum followed by 
SDS/polyacrylamide gel electrophoresis and fluorography.
The common lipoamide dehydrogenase (E3) component of the three 
mitochondrial 2-oxoacid dehydrogenase complexes is also a FAD-containing 
enzyme, although in this case the prosthetic group is bound 
electrostatically to the polypeptide chain, rather than covalently
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attached. Therefore, the application of any approach which monitors FAD 
incorporation into lipoamide dehydrogenase would have to safeguard 
against artefactual loss of prosthetic group from the enzyme, for 
example by denaturation of the polypeptide chain during preparation of 
samples for SDS/polyacrylamide gel electrophoresis.
The subcellular locations of the enzymes responsible for the 
attachment of FAD and lipoate to their respective substrates are 
unknown. However, from the intramitochondrial site of haem attachment 
to cytochromes c and c ,.it would seem reasonable to predict that the 
enzymes which perform these modifications are also located within the 
mi tochondrion.
It should be possible to monitor preliminary steps in the assembly 
of SDH and the BCOAD complex using cultured mammalian cells. This 
could be accomplished by gel filtration of precursor-containing 
radiolabelled cell extracts, with subsequent detection of precursor 
aggregates by immunoprecipitation analysis of the gel-filtered 
fractions. However, the presence of a precursor polypeptide in a 
species with a native value which is greater than that of the
monomeric precursor is not necessarily indicative of an assembly of 
precursor molecules. For instance, the precursor polypeptide may be 
associated with a cytosolic import factor (see section 1.2.4).
The precipitation of the E3 subunit by virtue of its physical 
association with one or more subunits of the BCOAD complex provides a 
criterion by which to investigate the kinetics of E3 incorporation.
The presence of E3 in anti-BCOAD immunoprecipitates is evidence of 
physical association of E3 with other BCOAD complex subunits; this can 
be compared with the appearance of mature-sized E3 which can be 
monitored using anti-E3 serum. A lag in the appearance of E3 subunit
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in anti-BCOAD immunoprecipitates (relative to the appearance of 
mature-sized E3) would provide evidence for the existence of a pool of 
processed, but unassembled E3 polypeptides.
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The Degree of Doctor of Philosophy is awarded under Resolution No. 38 
of the University Court, which came into effect on 19th November, 1969. 
The relevant provisions of the Resolution are as follows:
I. The Degree of Doctor of Philosophy (Ph.D.) may be conferred by the 
University of Glasgow in each of the Faculties thereof.
II. Research students within the meaning of Ordinance No. 350 
(General No. 12) who have prosecuted in the University of Glasgow, or in 
an institution recognised for the purpose by the University Court on the 
recommendation of the Senatus, a course of special study or research in 
accordance with the provisions of that Ordinance, may offer themselves 
for the Degree of Doctor of Philosophy, under the following conditions, 
namely:
(a) that they have obtained a Degree in any Scottish University, or in 
another University or College specially recognised for the purpose of this 
Section by the University Court on the recommendation of the Senatus
(provided always that a diploma or certificate recognised in like manner 
as equivalent to a Degree may be accepted in place of a Degree);
(b) that they have produced to the Senatus evidence of satisfactory 
progress in the special study or research undertaken by them;
(c) that they have prosecuted such studies on a full-time basis for a 
period of not less than three academical years, or for such period of 
part-time study as shall be determined by regulation; provided always 
that the Senatus shall have power, in exceptional cases, to reduce the 
period by one academical year, and to permit a research student during 
part of the period to prosecute elsewhere hip special study or research.
III. All candidates for the Degree of Doctor of Philosophy shall present 
for the approval of the Senatus a thesis which shall embody the results of 
the candidate's special study or research, and which shall be accom­
panied by a declaration signed by the candidate that it has been 
composed by himself. The Senatus shall appoint a Special Committee 
which shall always include the Professor or Lecturer in charge of the 
department concerned; this Committee shall, as the appropriate Faculty 
shall determine, either examine the thesis or hear the reports of the 
Examiners, and shall make an appropriate recommendation. The Univer­
sity Court may, on the recommendation of the Senatus, appoint one or 
more additional Examiners to act along with the Special Committee in 
adjudicating on the merits of the thesis. The Senatus may, on the 
recommendation of the Special Committee, require the candidate to 
present himself for oral or other examination on the subject-matter of his 
thesis.
IV. The regulations for the Degree shall be as stated in the Schedule 
hereto.
V. The Degree of Doctor of Philosophy shall in no case be conferred on 
persons who have not satisfied the conditions hereinbefore set forth, and 
shall not be conferred honoris causa.
VI. Ordinance of the University Court No. 74 (Glasgow No. 21), 
Regulations for the Degree of Doctor of Philosophy, is hereby repealed.
X
Regulations
1.A research student may prosecute for the Degree of Doctor of 
Philosophy a course of special study or research on a part-time basis:
(a) in the Faculties of Law and Financial Studies and Social Sciences, for 
a period of not less than four years;
(b) in the Faculty of Divinity, for a period of not less than five years;
(c) in the Faculty of Arts, for a period of not less than four years, of which 
a minimum total period of three months shall be spent in attendance in 
the University of Glasgow;
(d) in the Faculties of Medicine, Science, Engineering and Veterinary 
Medicine, for a period of either not less than five years of part-time study 
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recommendation of the Senatus..
A member of the teaching staff of the University, or a person who holds 
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European Nuclear Research Centre (CERN6, Geneva 
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Glasgow School of Art
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(b) On the recommendation of the Faculty concerned, and of the 
Senatus, the University Court may recognise, in the case of individual 
candidates, other institutions for the purpose of Section II of the 
Resolution, where satisfactory arrangements can be made for the 
supervision of the candidate.
(c) A full-time member of staff of a recognised Institution may be 
nominated to Senate as a supervisor and as an internal examiner or a 
member of a Special Committee, but not in a sole capacity.
8. A candidate for the Degree of Ph.D. must normally expect to be asked 
to present himself for oral examination on the subject-matter of his thesis.
9. (a) In the Faculty of Arts, if the examiners consider that the thesis has 
not achieved the standard required for the award of the Degree of Ph.D. 
but is of sufficient merit, they may allow the candidate to revise and 
resubmit the thesis for the Degree of M.Litt.
(b) In appropriate cases the Faculty of Social Sciences may recommend 
that after suitable alteration, some of the material or allied material of a 
rejected Ph.D. thesis might be submitted for the Degree of M.Litt.
(c) In the Faculty of Divinity, if the Examiners consider that the thesis 
has not achieved the standard required for the award of the degree of 
Ph.D. but is of sufficient merit, they may allow the candidate to revise and 
resubmit the thesis for the degree of M.Th.
10. (a) In the Faculty of Arts, the normal standard of admission w ill be 
that of First or Upper Second Class Honours but another qualification, 
being a qualification approved by the University Court as provided in 
Section II of the Resolution, may be accepted by this Faculty as being 
suitable for the programme of study which it is proposed that the 
applicant should follow.
(b) In the Faculties of Science and Social Sciences, the normal standard 
of admission w ill be that of a Degree with First or Second Class Honours 
of a Scottish University, or ari approved equivalent qualification.
53. In the Faculty of Arts a research student intending to offer himself for 
the Degree of Ph.D. must obtain the Faculty's approval of his candidature 
at least one year before applying for the Degree.
4. (a) In the Faculties of Medicine, Science, Engineering and Veterinary 
Medicine, the period of study or research elsewhere permitted by Section 
11(c) shall not normally exceed twelve months.
(b) In the Faculty of Social Sciences, although the period of research 
elsewhere permitted by Section 11(c) might exceed twelve months, a 
candidate must reside in Glasgow for a minimum total period of eighteen 
months; provided always that the Senatus shall have the powers to vary 
this requirement on due cause shown.
(c) In the Faculty of Arts, a candidate must be in attendance in the 
University of Glasgow for a minimum total period of twelve months.
5. (a) In the Faculty of Arts, a candidate must submit his thesis no later 
than six years from the date of initial registration.1 The Faculty's Higher 
Degrees Committee may in special circumstances grant one year exten­
sions on annual application up to a maximum of ten years from 
admission.
(b) In the Faculty of Divinity, except by special permission of the 
Senatus Academicus on the recommendation of the Faculty, a thesis may 
not be presented later than ten years after the date of the candidate's 
admission to study for the Degree of Ph.D.2
(c) In the Faculty of Law and Financial Studies, except by special 
permission of the Senatus Academicus on the recommendation of the 
Faculty, a thesis may not be presented later than five years from the date 
on which the candidate ceases to be a matriculated student.2
(d) In the Faculties of Science, Engineering, Medicine and Veterinary 
Medicine, except by special permission of the Senatus Academicus on 
the recommendation of the Faculty, a thesis may not be presented later 
than three years after the date on which the candidate ceases to be a 
matriculated student.2
(e) In the Faculty of Social Sciences the time iim it for submission of 
theses is six years from first registration for full-time students and eight 
years from first registration for part-time students. Students who have 
reached the time lim it without submitting a thesis may apply annually to 
the Higher Degrees Committee for an extension of one year, giving 
reasons for the delay and/or evidence of progress. Any such submissions 
must be supported by the supervisor or head of department.
1 In the case of candidates admitted before 10ctober 1981, the six-year period shall expire on 1 
October 1987, and the ten-year period on 1 October 1991.
1 This provision shall not apply to candidates admitted prior to session 1982/83.
6. In submitting a thesis a candidate must state, generally in the preface
X and specifically in the notes, the sources from which his information is derived, the extent to which he has availed himself of the work of others, and the portions of the thesis which he claims as original. The thesis must 
be in English.
7. A candidate must submit two copies of the thesis which must include 
a summary of 250-1000 words. The summary must be an adequate and 
informative abstract of the work, suitable for publication by the Univer­
sity. The layout and binding of the thesis should generally conform to the 
British Standard Institution's "Recommendations for the presentation of 
theses" (BS4821:1972), a isummary of which is available in the University
^ I ^ ^ ^ ^ O p r a r y  or from the Clerk to the appropriate Faculty. Both copies of the 
approved for the Degree, become the property of the University, 
5 - r n ^ L & h d  are deposited in the University Librarv.
